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Abstract 
 
During its egress, Vaccinia virus induces a series of events at the plasma membrane of 
infected cells that ultimately enhance the spread of infection.  Immediately following 
fusion with the plasma membrane, the virus recruits the endocytic adaptor protein, AP-2 
and clathrin in an A36-dependent manner. Clathrin recruitment acts to cluster the viral 
integral membrane protein, A36 underneath the virion to generate a robust signalling 
platform that recruits the adapters Nck and Grb2 downstream of phosphorylated 
tyrosines 112/132 respectively. This subsequently results in the recruitment of the 
WIP:N-WASP complex, which stimulates Arp2/3 complex dependent actin 
polymerization to propel the virus along the plasma membrane and onto neighbouring 
uninfected cells.  In addition, the virus also promotes Arp2/3 driven actin 
polymerization via recruitment and activation of the GTPase Cdc42, facilitating its 
interaction with N-WASP.  The ability of the virus to activate Cdc42 is dependent on 
the RhoGEF Intersectin-1, which is also capable of interacting with AP-2.  My studies 
have sought to investigate the molecular mechanism and role of AP-2 and clathrin 
recruitment during viral egress.  I found that three highly conserved Asn-Pro-Phe (NPF) 
motifs at the C-terminus of A36 interact directly with the Eps15 Homology (EH) 
domains of intersectin-1 and Eps-15.   A recombinant virus lacking all three NPF motifs 
(∆NPF) is unable to recruit clathrin, AP-2 or intersectin-1. Besides changes in actin 
polymerization this virus also has defects in viral release and spread.  NPF motifs are 
conserved endocytic interaction modules that a found in all eukaryotes, however A36 is 
the first viral protein containing functional NPF motifs to be identified to date. 
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Chapter 1. Introduction 
1.1 Vaccinia Virus  
1.1.1 The Poxvirus family 
Vaccinia virus is the prototypical member of the poxvirus family and is best known for 
its role as a vaccine in the worldwide eradication of smallpox (Variola Virus) (WHO, 
1972). Smallpox is estimated to have killed over 500 million people in the 20th century 
alone, and over a thousand years of combined luck and research have led to the 
development of vaccinia virus as the first live vaccine against smallpox. The first 
evidence of variolation to combat smallpox goes back to first century China (960-1280). 
Smallpox scabs were dried, powdered, and inhaled, in order to prevent smallpox 
infection (Oldstone, 1998). Much later, in the 18th century, Dr. Jenner observed that 
milkmaids, who often caught the non-lethal cowpox virus in their line of work, were 
unaffected during smallpox epidemics. In 1796 he performed the first modern 
vaccination with cowpox that successfully prevented subsequent smallpox infection 
(Jenner, 1798; Oldstone, 1998). By 1972, the closely related vaccinia virus was isolated 
and used as the vaccinating agent against smallpox. A successful worldwide vaccination 
effort coordinated by the World Health Organization, led to the last outbreak of 
naturally occurring smallpox to be recorded in Somalia in 1977 (Newmark, 1980; WHO, 
1972).  
 
The poxvirus family are subdivided into two distinct subfamilies: the Entomopoxviridae 
(insect specific) and the Chordopoxviridae (vertebrate specific). The Chordopoxviridae 
are further subdivided into ten genera, with vaccinia virus classified under the 
Orthopoxviridae (Figure 1.1). Ninety genes are conserved throughout the 
Chordopoxviridae subfamily, 49 of which are conserved among the entire poxvirus 
family, and are thought to represent the minimal poxvirus genome (Gubser et al., 2004; 
Upton et al., 2003). Poxviruses possess relatively wide cellular tropism within their 
respective host and are able to infect epithelial cells, fibroblasts, and hematopoietic cell 
types (McFadden, 2005).  
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Figure 1.1 Phylogenetic tree of the Poxvirus family  
Phylogeny based on sequence alignment of the poxvirus DNA polymerase sequence. Linkage 
tree based on Clustal Omega sequence alignment. A prototypic virus from each genus (labelled 
in blue) is shown (strain is given in parentheses).  
 
 
Vaccinia, like all members of the poxvirus family, is a double stranded DNA virus that 
undergoes its entire replication cycle in the cytoplasm of the host cell, unlike other large 
DNA viruses such as herpes or adenovirus, which replicate in the host nucleus (Tolonen 
et al., 2001). Following the eradication of smallpox, the study of vaccinia virus and 
other members of the Orthopoxviridae has remained a key research tool in unravelling 
many host-cell mechanisms due to their complex manipulation of the host-cell 
machinery. Vaccinia is genetically tractable and easy to visualize, making it an ideal 
tool to study cellular processes. Vaccinia has been at the forefront of immunotherapy 
and viral oncolytics, in part due to the amenability of the viral genome to accept up to 
25 kbp of foreign DNA, in addition to a long track record of safety as a vaccine 
(Albelda and Thorne, 2014; Thorne, 2008).  Lastly, the study of vaccinia virulence 
remains high on the agenda amidst renewed concerns of the use of smallpox in 
biological warfare. Only two officially stored stocks of variola virus exist at WHO 
collaborating laboratories at the CDC (Georgia, USA) and VECTOR (Koltsovo, Russia) 
(Mayr, 2003). Debate continues as to whether these stocks should be destroyed to 
prevent future outbreaks or misuse, or whether they should continue to be stored for 
future research (Agwunobi, 2007; Hammond, 2007).  
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1.1.2 Genome and Gene Expression 
The vaccinia virus genome consists of 195 kbp encoding around 260 proteins, including 
its own replication and transcription machinery (Boone and Moss, 1978; Goebel et al., 
1990; Hruby et al., 1979; Moss, 1990; Paoletti and Grady, 1977). This allows the virus 
to undergo its entire replicative cycle in a perinuclear compartment in the cytoplasm of 
the host cell (Dahl and Kates, 1970; Pennington, 1974; Prescott et al., 1971; Roberts 
and Smith, 2008; Smith et al., 2002). The viral genome can be viewed as a self-
complementary circular strand of DNA due to the presence of 12-kb inverted terminal 
repeats at the either end of its genome (Figure 1.2 A) (Baroudy and Moss, 1982; Goebel 
et al., 1990). Nomenclature of genes is derived from the distribution of 15 HindIII 
restriction sites throughout the genome. HindIII digestion results in 16 fragments 
designated A to P according to decreasing size (DeFilippes, 1982). Open reading frames 
within a HindIII fragment are numbered left to right, denoting the order based on the 
position of the first in-frame start codon.  As both DNA strands are transcribed, genes 
are additionally denoted with a ‘L’ or ‘R’ indicating the direction of transcription 
(Figure 1.2 A) (Goebel et al., 1990).  
 
Viral transcriptional promoters, found approximately 30 bp upstream of the initiating 
methionine, tightly control viral gene expression throughout infection (Condit and Niles, 
2002). Viral genes are therefore additionally characterised by their expression kinetics 
during replication (Figure 1.2 B). The mRNA’s encoding early, intermediate, or late 
genes can be detected respectively from 20, 100, and 140 minutes post infection in 
HeLa cells (Assarsson et al., 2008; Broyles, 2003; Joklik and Becker, 1964).  
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Figure 1.2 The vaccinia virus genome 
A The vaccinia virus genome is a self-complementary circular strand of DNA containing a 
hairpin loop of 101 nucleotides at each terminus. The 12-kbp inverted terminal repeats (ITRs) 
are underlined. The 16 fragments that arise from HindIII digest are labeled ‘A-P’ (indicted by 
dashed lines). The ‘E’ HindIII fragment consists of 11 genes represented by green or blue 
arrows. The direction of the arrows indicates the direction of transcription (L or R). B The 
temporal gene expression cascade that occurs during the course of vaccinia infection. 
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1.1.3 Viral entry  
Vaccinia virus particles are approximately 350 x 270 x 250 nm and were the first virus 
to be visualized by light microscopy due to their large size (Condit et al., 2006; Cyrklaff 
et al., 2005; Roos et al., 1996). Vaccinia belongs to a class of over 20 diverse viruses 
that actively trigger their internalization (Grove and Marsh, 2011; Mercer and Helenius, 
2009). Two infectious forms of the virus exist, intracellular mature virions (IMVs) and 
extracellular enveloped virions (EEVs) that must both breach the plasma membrane in 
order to initiate infection (Figure 1.3 – 1) (Roberts and Smith, 2008). EEVs are wrapped 
in an additional host derived membrane compared to IMV, and therefore these virions 
contain no common surface proteins and are structurally and antigenically distinct from 
one another (Boulter and Appleyard, 1973). IMVs and EEVs therefore utilise distinct 
clathrin-independent mechanisms of entry (Mercer and Helenius, 2008; Schmidt et al., 
2011; Schmidt and Mercer, 2012).  
 
During IMV entry, several outer viral membrane proteins are able to bind a range of 
host glycosaminglycans (GAGs) at the plasma membrane. These include A27 and H3 to 
heparin sulphate, A26 to laminin, and D8 to chondroitin sulphate (Chiu et al., 2007; 
Chung et al., 1998; Hsiao et al., 1999; Lin et al., 2000). Although IMV particles can 
enter the cell via direct fusion of the viral and host membrane in a pH-independent 
manner, the primary entry route of IMV, is thought to be via the induction of endocytic 
and macropinocytic uptake (Mercer and Helenius, 2008; Mercer et al., 2010; Sandgren 
et al., 2010; Schmidt et al., 2011; Townsley et al., 2006). Upon contact with the plasma 
membrane large actin-dependent blebs are induced by phosphatidylserine in the viral 
membrane to facilitate uptake into the cell, in a manner mimicking the clearance of 
apoptotic bodies (Hoffmann et al., 2001; Mercer and Helenius, 2009; Mercer et al., 
2010). Tyrosine kinases, protein kinase C (PKC), p21-activated kinase 1 (PAK), myosin 
and a host of other cellular triggers act in concert to mediate the large actin 
rearrangements required for macropinosome formation (Locker et al., 2000; Mercer and 
Helenius, 2008; Mercer et al., 2010). Following uptake, IMVs utilise a macromolecular 
viral entry fusion complex (EFC), which is activated upon acidification of 
macropinosomes. This facilitates fusion with the macropinosomal membrane and 
subsequent release the genomic viral core (Laliberte et al., 2011). 
  Chapter 1. Introduction 
 
 20 
The entry of EEV is not yet entirely understood at a molecular level, due to the intrinsic 
instability of the additional host derived membrane. No EEV specific cellular 
attachment factors have been uncovered thus far, and it is a widely supported hypothesis 
that the EEV outer membrane is disrupted prior to fusion, thus revealing the IMV fusion 
machinery (Law et al., 2006; Schmidt et al., 2011; Senkevich et al., 2004). It addition it 
has now been established that EEV actively induce their macropinocytic uptake in a 
mechanism similar to that of IMVs (Laliberte and Moss, 2009; Mercer and Helenius, 
2008; Sandgren et al., 2010; Schmidt et al., 2011). Like IMV, EEVs appear to require 
the acidification of the endosome in order to disrupt the outer EEV membrane, after 
which the viral core can be released via endosomal fusion in an IMV-like manner 
(Schmidt et al., 2011; Schmidt et al., 2013; Townsley and Moss, 2007). 
The specific method of viral entry is likely to be strain dependent, with some vaccinia 
strains (e.g. IHD-W and MVA) shown to invade preferentially via direct membrane 
fusion (Chang et al., 2010; Mercer et al., 2010). Viral entry is also likely to be cell type 
specific, altogether resulting in multiple modes of entry (Mercer et al., 2010; Norbury, 
2006). 
1.1.4 Viral Replication and Assembly  
Following entry into the host cell viral cores accumulate in the perinuclear region of the 
cell via an unknown microtubule-dependent mechanism and/or by vaccinia-induced cell 
contraction (Figure 1.3 – 2) (Carter et al., 2003; Schramm et al., 2006). Viral RNA 
polymerase and early transcription factors are pre-assembled on early viral promoters 
and initiate early viral gene expression immediately after core release (Yang and Moss, 
2009). Early genes make up approximately half of the 260 genes encoded by vaccinia. 
Early genes are primarily responsible for encoding the viral DNA replication machinery, 
subverting the host immune system and preventing host cell apoptosis (Broyles, 2003; 
Postigo and Ferrer, 2009). There are fewer intermediate genes, which primarily function 
to regulate the expression of late genes (Assarsson et al., 2008). Late genes are largely 
required for the assembly of new virions including the production of structural proteins 
and those required for viral egress and spread (Rosel and Moss, 1985). These initial 
sites of early DNA replication can be detected and grow over time to form a large 
DNA-rich viral factory that is anchored at the microtubule-organising centre (Domi and 
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Beaud, 2000; Ploubidou et al., 2000; Schepis et al., 2006). The complex morphogenesis 
of vaccinia results in the production of distinct forms of the virus (Leite and Way, 2015; 
Roberts and Smith, 2008). The first discernible viral structures observed at the viral 
factory are crescent membranes (Dales and Mosbach, 1968; Hollinshead et al., 1999; 
Risco et al., 2002). Crescent-shaped lipid structures composed of a single lipid bilayer, 
which are thought to be derived from ER-Golgi compartments, grow to enclose newly 
synthesised viral cores to form the immature virion (IV) (Figure 1.3 – 3) (Husain et al., 
2006; Rodriguez et al., 1985; Sodeik et al., 1993; Sodeik and Krijnse-Locker, 2002; 
Zhang and Moss, 1992). Proteolytic cleavage of several viral core and membrane 
proteins results in the maturation of IVs into the first infectious form of the virus, the 
intracellular mature virus (IMV) (Figure 1.3. – 4) (Condit et al., 1983). IMVs make up 
around 80% of infectious particles and form dense, brick shaped virions that are only 
released from the cell upon lysis (Dubochet et al., 1994; Roos et al., 1996; Roper et al., 
1996).  
 
A subset of IMVs is transported in a microtubule dependent manner away from the viral 
factory to the trans-Golgi network (TGN) or the endosomal network whereby they 
become wrapped in an additional membrane cisternae (Figure 1.3 – 5) (Earley et al., 
2008; Payne and Kristenson, 1979; Sanderson et al., 2000; Schmelz et al., 1994; Tooze 
et al., 1993). The mechanisms defining how IMVs are sorted into those to be wrapped, 
and how IMVs are transported to the TGN are at present unknown. Prior to wrapping of 
IMVs, the TGN-derived membrane is preloaded with a number of viral proteins that are 
crucial for the wrapping process such as B5 and F13, that mediate wrapping via 
interactions with the IMV specific surface protein, A27 (Duncan and Smith, 1992; 
Husain et al., 2007; Rodriguez and Smith, 1990). The integral membrane proteins A33, 
A34, A36, A56, B5, K2, E2, F12, along with membrane-associated F13, are unique to 
the intracellular enveloped virus (IEV) membrane and play crucial roles during IEV 
transport and release (Figure 1.4). A36 and F12 are solely associated with the outer IEV 
membrane, and are therefore absent from EEV following release from the plasma 
membrane (van Eijl et al., 2002; van Eijl et al., 2000).  
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Figure 1.3 The vaccinia replication cycle 
IV = immature virion, IMV = intracellular mature virion, IEV = intracellular enveloped virion, 
CEV = cell-associated enveloped virion, EEV = extracellular enveloped virion.  
 
1. IMV and EEV attach to the cell, stimulate macropinocytosis, and breach the host membrane. 
2. The viral core is released into the cytosol following fusion of the outer viral membrane with 
endosomal membranes (Schmidt et al., 2011). Viral cores are transported in a microtubule 
dependent manner to the perinuclear region. 3. Early transcription of mRNAs commences, 
crescents form, and immature virions (IV) are assembled. 4. IVs are processed to form 
intracellular mature virions (IMVs). 5. IMVs are transported to the TGN where they are 
wrapped by a double membrane cisternae. 6. IEVs are transported to the cell periphery in a 
microtubule dependent manner by kinesin-1. 7. IEVs breach the cortical actin beneath the 
plasma membrane with which they then fuse. 8. Outside-in activation of Src/Abl family kinases 
stimulates the formation of the actin tails (shown in red) by CEVs on the plasma membrane. 9. 
CEVs either directly infect a neighboring cell, or can be released into the extracellular space as 
EEV. 
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Figure 1.4 Topology of IEV specific proteins  
Arrows indicate interactions between the IEV proteins. Domains are drawn to size aside from 
that of F13, which is a large membrane associated IEV protein, tethered to the membrane by a 
lipid anchor. The outer IEV membrane fuses with the host plasma membrane during EEV 
release (bottom). The EEV remain enveloped by the inner IEV-derived membrane lacking F12 
and A36 (top).  
 
 
 
Wrapped IMVs, termed intracellular enveloped virions (IEVs), are subsequently 
transported to the cell periphery in a microtubule-dependent manner by kinesin-1 
(Figure 1.3 – 6) (Dodding et al., 2009; Geada et al., 2001; Moss and Ward, 2001; 
Rietdorf et al., 2001). Kinesin-1 is recruited to IEVs via binding of the kinesin-light 
chain (KLC) tetratricopeptide repeat (TPR) to IEV specific A36 (Rottger et al., 1999; 
van Eijl et al., 2000; Ward and Moss, 2004). Deletion of A36 leads to accumulation of 
IEV in the perinuclear region, and consequently reduces the cell-to-cell spread of 
vaccinia (Moss and Ward, 2001; Parkinson and Smith, 1994; Rietdorf et al., 2001; 
Wolffe et al., 1998). A combination of GST pull-down assays and yeast two hybrid 
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screens together revealed that A36 could directly bind kinesin-1 via two conserved 
tryptophan motifs in the cytoplasmic domain of A36 (Dodding et al., 2011; Dodding et 
al., 2009; Konecna et al., 2006; Morgan et al., 2010). The A36 WE and WD motifs are 
conserved kinesin-1 binding motifs that are found in mammalian Calsyntenin-1 and γ-
BAR (also known as Gadkin) (Araki et al., 2007; Dodding et al., 2011; Schmidt et al., 
2009). Mutation of both of these motifs significantly reduces the spread of IEV to the 
plasma membrane and also results in defective cell-to-cell spread of the virus, as is 
observed following infection with vaccinia lacking A36 expression entirely (∆A36R) 
(Dodding et al., 2011; Wolffe et al., 1998). 
 
In addition to A36, the IEV proteins F12 and E2 have been implicated in microtubule-
transport of IEVs (Carpentier et al., 2015; Morgan et al., 2010; van Eijl et al., 2002). 
Deletion of either F12 (∆F12L) or E2 (∆E2L) also led to a reduction in cell-to-cell 
spread (Dodding et al., 2009; Johnston and Ward, 2009; Zhang et al., 2000). Like A36, 
F12 contains a potential kinesin-1 binding WD motif, however, in isolation F12 is 
unable to mediate binding to kinesin-1 (Carpentier et al., 2015; Morgan et al., 2010). 
F12 in complex with E2, however, is able to associate with kinesin-1 (KLC isoform 2) 
(Carpentier et al., 2015). Interestingly, overexpression of a F12 mutant lacking the WD 
motif during infection with ∆F12L is unable to rescue IEV spread or kinesin-1 
recruitment, suggesting that the WD motifs are clearly important for the functional role 
of F12 (Morgan et al., 2010). Whether A36 and the F12/E2 complex function together 
to mediate IEV transport is yet to be elucidated (Dodding et al., 2009; Johnston and 
Ward, 2009). Live cell imaging and ultrastructural analysis following infection with 
∆F12L, suggest that F12, rather than acting as an essential component of viral transport, 
is essential for the formation of IEVs (Dodding et al., 2009). Curiously, it has been 
shown that IMV of the IHD-W strain of vaccinia are able to reach the cell periphery of 
infected cells in an microtubule-independent manner, although little is known about 
how this process is mediated and whether this occurs in other viral strains (Schepis et al., 
2006; Tsutsui, 1983; Tsutsui et al., 1983). 
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1.1.5 Viral Egress and Spread  
Once IEV reach the cell periphery, the outermost IEV membrane fuses with the plasma 
membrane, resulting in the presentation of the cell-associated enveloped virion (CEV) 
on the cell surface (Figure 1.3 – 8) (Arakawa et al., 2007; Blasco and Moss, 1992; 
Cudmore et al., 1995). During this process of fusion, kinesin-1 dissociates, and the 
largely cytoplasmic A36 localizes to the base of the virion (Figure 1.4) (Newsome et al., 
2004; van Eijl et al., 2000). A36 is subsequently phosphorylated in a Src/Abl family 
kinase-dependent manner, initiating a complex signalling cascade which results in the 
recruitment of Arp2/3 and the assembly of actin structures, termed actin tails (Figure 
1.3 – 9) (Blasco and Moss, 1992; Cudmore et al., 1995; Frischknecht et al., 1999a; 
Moreau et al., 2000; Newsome et al., 2004; Scaplehorn et al., 2002; Stokes, 1976; 
Zhang et al., 2000).  
 
CEVs are propelled on the plasma membrane via these actin protrusions and mediate 
the direct cell-to-cell spread of vaccinia (Wolffe et al., 1998). While a proportion of 
CEVs (approximately 15-20 % in the case of vaccinia WR strain) are released as EEV, 
the majority of virions are retained as CEV on the surface of infected cells. CEV are 
largely responsible for the formation of viral plaques (Blasco and Moss, 1992). 
Vaccinia is able to spread directly via cell-to-cell contacts in distinct processes that are 
both dependent and independent on the formation of actin tails beneath the CEV. This 
may suggest that mechanisms of direct cell-to-cell spread via CEV are highly context 
dependent.  
 
Actin polymerisation beneath CEV has been postulated to directly aid egress of the 
virus from the host membrane (Horsington et al., 2013). The driving force generated by 
actin polymerisation is thought to disrupt crucial luminal interactions of the IEV 
proteins that span the CEV membrane and the plasma membrane, and thus disrupt 
association with the cell itself, facilitating the release of EEV (Figure 1.5) (Horsington 
et al., 2013). The viral proteins B5, A33 and A34 all contain signification luminal 
domains thought to mediate adhesion with one another and therefore to the host plasma 
membrane (Figure 1.4) (Duncan and Smith, 1992; Isaacs et al., 1992; Roper et al., 
1996). In support of this, a C terminal deletion in A33, and point mutations in B5 
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(P189S) and A34 (K151E) that disrupt luminal interactions, all led to an increase in 
EEV release (Blasco et al., 1993; Katz et al., 2003; Katz et al., 2002).  
 
 
 
 
 
Figure 1.5 Mechanisms promoting vaccinia egress 
A proposed mechanism in which actin polymerisation beneath the CEV clusters IEV proteins 
beneath the virion and provides the driving force to disrupt luminal interactions of the IEV 
proteins tethering the CEV to the plasma membrane. A virus that cannot induce actin tails, A36 
YdF, was shown by EM to be trapped in invaginated pits in the membrane, tethered by multiple 
luminal interactions of the IEV proteins shown in Figure 1.4 (indicated by pink lines above). 
(Horsington et al., 2013). 
 
 
Despite only representing a fraction of infectious virions, the spread of vaccinia through 
tissue is predominantly mediated by EEV (Payne, 1980). EEV are resistant to 
neutralizing antibodies and the immune complement, providing a huge biological 
advantage over IMV mediated spread in vivo (Law et al., 2002; Law and Smith, 2001; 
Smith et al., 2002; Vanderplasschen et al., 1998). Extracellular enveloped virions 
(EEVs) are formed once the CEVs are released from the plasma membrane, and are able 
to infect adjacent cells in addition to facilitating the long-range spread of infection via 
the release of free EEVs into the blood stream of an infected organism (Payne, 1980; 
Roberts and Smith, 2008). 
 
More recently, however, it has been found that released EEVs may also play a role in 
long-range actin tail mediated spread of infection in order to enhance viral spread 
(Condit, 2010; Doceul et al., 2012; Doceul et al., 2010). The kinetics of viral spread 
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through a monolayer of cells were found to be four-fold faster than expected given the 
temporal dynamics of the viral replication cycle (Figure 1.3).  Reinfection of infected 
cells is inhibited by the presence of A56-K2 dimers at the plasma membrane following 
infection (Turner and Moyer, 2008; Wagenaar and Moss, 2009). The A56-K2 complex 
engages with the entry fusion complex (EFC) on incoming viral particles to prevent 
reinfection (Wagenaar and Moss, 2007; Wagenaar et al., 2008). The transmission of 
vaccinia through a monolayer can, however, be enhanced by the presence of the IEV 
proteins A36 and A33 at the plasma membrane of recently infected cells (Doceul et al., 
2010). A36 and A33 are expressed early following infection and are crucial for the 
formation of actin tails. Prior to the production of infectious particles from recently 
infected cells (Figure 1.6 A), released EEV can arrive at the plasma membrane, and 
although inhibited from reinfection, can utilise A36 and A33 at the membrane (Figure 
1.6 B) to propel the EEV along the cell surface, until an uninfected cell is reached 
(Figure 1.6 C) (Doceul et al., 2012; Doceul et al., 2010). This model of rapid 
transmission of EEV would ensure that infected cells are able to promote viral spread 
even prior to the production of infectious particles. These ‘secondary’ actin tails 
induced by A36 and A33 upon contact with EEVs therefore enhances the rate of viral 
spread through a monolayer (Condit, 2010; Doceul et al., 2012; Doceul et al., 2010). 
 
Lastly, in addition to direct viral spread mediated by the dissemination of CEV and 
EEV, vaccinia infection may also be enhanced via viral-induced cell motility. 
Following infection, the expression of early viral genes appear to be responsible for 
dramatic cellular morphological changes that lead to cellular contraction, re-spreading, 
migration, and cytopathic effect (CPE) (Bablanian et al., 1978; Sanderson and Smith, 
1998; Schepis et al., 2006; Schramm et al., 2006). The precise mechanism and 
requirement of viral-induced cell motility remains to be elucidated at this point, 
however the induction of cell migration upon infection enhances the ability of vaccinia 
to come into contact with uninfected cells and therefore disseminate rapidly through 
cells and tissues.  
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Figure 1.6 The super-repulsion hypothesis  
A Infection is initiated on a neighbouring cell mediated by CEV or EEV particles released after 
6-8 hours of infection. B EEVs arrive on an adjacent recently infected cell that is undergoing 
the early stages of viral infection. A36 and A33 are expressed early following infection and are 
therefore present on the plasma membrane. C The presence of A36 and A33 is sufficient to 
induce a secondary actin tail beneath the EEV and propel the EEV even further in order to 
infect distal, uninfected cells (Doceul et al., 2010). Adapted from Pickup, 2010.  
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1.2 The Actin Cytoskeleton and N-WASP in pathogen spread  
1.2.1 Actin polymerisation 
During infection, vaccinia virus hijacks the actin cytoskeleton to facilitate both 
macropinosomal entry and actin tail mediated egress and spread (Doceul et al., 2010; 
Horsington et al., 2013; Mercer and Helenius, 2009). Actin is highly conserved 
throughout evolution and is one of the most abundant proteins in eukaryotic cells 
(Erickson, 2007; Firat-Karalar and Welch, 2011). Therefore, it comes as no surprise that 
a number of pathogens utilise actin-dependent processes to facilitate entry or spread. 
 
The ability of actin to self-polymerise plays an essential role in a large number of 
cellular structures and processes that are fundamental to cell function. At a cellular level 
polymerisation of actin at the leading edge drives cell migration as well as the formation 
of lamellipodia and filopodia protrusions (Panner and Honig, 1967; Ridley, 2011; 
Woodrum et al., 1975). Furthermore, at a subcellular level actin plays a key role to 
facilitate and regulate membrane trafficking and endocytic events (Anitei and Hoflack, 
2012; Mooren et al., 2012). Actin is able to cycle from monomeric 42 kDa globular G-
actin, to filamentous F-actin. F-actin has polarised ends, comprising a pointed and a 
barbed end, derived from the appearance of actin filaments in electron micrographs 
(Huxley, 1963; Woodrum et al., 1975). The initial assembly of three G-actin monomers 
forms a stable ‘seed’ which nucleate filament growth (Gilbert and Frieden, 1983; 
Nishida and Sakai, 1983). Following this nucleation phase, rapid filament elongation 
can proceed. During elongation G-actin can be added to both ends of the filament, 
however, more rapid polymerization occurs at the barbed end (Goley and Welch, 2006; 
Pollard and Borisy, 2003; Woodrum et al., 1975).   
 
Despite high cellular concentration of actin, in vitro the establishment of trimeric G-
actin nuclei is extremely thermodynamically unfavorable, with the dissociation 
equilibrium constant in the Molar range (Pollard and Cooper, 1986; Pollard and Weeds, 
1984). Several cellular actin nucleators, have evolved to overcome this kinetically 
unfavorable process (Campellone and Welch, 2010). The Arp2/3 complex was the first 
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actin nucleator to be discovered, and plays a vital role during vaccinia induced actin 
polymerization. 
1.2.2 The Arp2/3 Complex 
The Arp2/3 complex is composed of seven highly evolutionarily conserved subunits 
forming a large 220 kDa complex (Goley and Welch, 2006; Machesky et al., 1994). The 
Arp2/3 core consists of Arp2 and Arp3 (actin-related proteins 2 and 3) that associate 
with the additional Arp subunits C1-C5 (Goley and Welch, 2006; Pollard, 2007). 
Highly conserved from yeast to man, the Arp2/3 complex is crucial for nucleation of 
new actin filaments, and cross-linking of actin filaments into the characteristic 70 
degree, Y-branches first observed in electron micrographs (Blanchoin and Pollard, 
2002; Mullins et al., 1998). The core Arp2 and Arp3 subunits have 47% and 40% 
identity to actin respectively and are brought into close proximity in the active state of 
the complex, mimicking dimeric actin (Kelleher et al., 1995; Robinson et al., 2001). 
This overcomes the kinetic barrier preventing spontaneous actin nucleation and 
provides a template from which filament elongation can proceed. Activated Arp2/3 can 
bind to the side of a pre-existing mother filament, thus promoting the nucleation of a 
nascent daughter filament (Amann and Pollard, 2001; Blanchoin et al., 2000; Mullins et 
al., 1998). The ability of the Arp2/3 complex to induce networks of branched actin 
filaments provides a key driving force in formation of lammellipodia, invadopodia, and 
pathogen induced actin structures (Bailly et al., 2001; Welch and Way, 2013; 
Yamaguchi et al., 2005). 
 
In order to bring the Arp2 and Arp3 subunits into close proximity to promote Arp2/3 
activation in vivo, several key regulators have been identified (Bonder et al., 1983; 
Pollard and Borisy, 2003; Wang, 1985). In vitro reconstitution of the actin-based 
motility of the bacterium Listeria monocytogenes identified a bacterial protein, ActA 
that was able to promote the actin nucleating ability of Arp2/3 and stimulate bacterial 
motility (Loisel et al., 1999; Welch et al., 1997; Welch et al., 1998; Welch and Way, 
2013).  Several cellular proteins that perform the analogous function in vivo have now 
been uncovered. These are known as nucleation-promoting factors or NPFs 
(Campellone and Welch, 2010; Le Clainche and Carlier, 2008).  
  Chapter 1. Introduction 
 
 31 
The NPFs are subdivided into two distinct classes. Class I NPFs make up the largest 
group of NPFs and are characterised by the presence of a conserved C-terminal WCA 
domain (WASP-homology2-Central-Acidic) that bind G-actin and the Arp2/3 complex. 
In vitro, this domain is sufficient to mediate activation of Arp2/3 (Goley and Welch, 
2006). Class II NPFs lack the G-actin binding WH2 domain, and instead contain a F-
actin binding domain (FAB) that has been shown to be essential for Arp2/3 activation 
(Goode et al., 2001; Uruno et al., 2001; Weaver et al., 2001). The binding of NPFs to 
Arp2/3, acts to enhance Arp2/3 activity in a temporal and spatial manner (Ma et al., 
1998; Mullins et al., 1998; Rohatgi et al., 1999; Welch et al., 1998). A number of NPFs 
have been identified including WASP (Winter et al., 1999; Yarar et al., 1999), N-WASP 
(Rohatgi et al., 1999), ActA (Welch et al., 1998), WAVE (Machesky et al., 1999), yeast 
Abp1p (Duncan et al., 2001), and yeast Pan1p (Duncan et al., 2001) to name a few. The 
diversity of the NPF family of proteins reflects the wide variety of actin dependent 
processes that they mediate, including pathogen spread (Welch and Way, 2013). 
Vaccinia hijacks both Arp2/3 and its well-characterized nucleation-promoting factor, N-
WASP to induce the formation of actin tails (Cudmore et al., 1995; Moreau et al., 2000). 
1.2.3 N-WASP function and regulation 
The Class I NPF, N-WASP is expressed in most cell types and is highly conserved 
amongst eukaryotes (Miki et al., 1996; Snapper et al., 2001). N-WASP plays a vital role 
in multiple host cell processes such as phagocytosis, endocytosis, the formation of 
invadopodia and filopodia, as well as pathogen induced actin polymerisation (Dart et al., 
2012; Miki et al., 1998; Qualmann et al., 2000; Snapper et al., 2001; Yamaguchi et al., 
2005). N-WASP is composed of a N-terminal WH1 (WASP homology 1) domain, 
followed by a basic region (B), GTPase binding domain (GBD), a proline-rich domain 
(PRD), and C-terminal WCA domain crucial for the activation of Arp2/3 (Figure 1.7). 
The WCA domain consists of a WH2 region (W), and a central region (C) and a 
terminal acidic region (A). The CA region directly interacts with multiple subunits in 
the Arp2/3 complex (Rodal et al., 2005; Weaver et al., 2002; Zalevsky et al., 2001). 
Multiple structural studies supports the role of CA binding in order to induce a large 
conformational change to bring the Arp2 and Arp3 subunits into close proximity, thus 
activating the Arp2/3 complex (Chereau et al., 2005; Marchand et al., 2001; Panchal et 
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al., 2003). The WH2 domain recruits G-actin, delivering actin to the Arp2/3 complex, 
together mimicking the G-actin trimer ‘seed’ required to nucleate filament growth.  
 
N-WASP is itself tightly regulated in order to facilitate the correct spatial and temporal 
activation of Arp2/3 mediated actin polymerisation (Miki et al., 1996; Snapper et al., 
2001). N-WASP together with WIP (WASP-interacting protein) and the SH3 containing 
proteins Nck and Grb2 cooperate to mediate Arp2/3-dependent vaccinia induced actin 
polymerisation (Figure 1.8) (Moreau et al., 2000; Zettl and Way, 2002). N-WASP exists 
in an autoinhibited conformation and requires activation to facilitate binding of Arp2/3 
and actin (Kim et al., 2000; Miki et al., 1998; Prehoda et al., 2000; Rohatgi et al., 2000).  
 
In its inactive conformation the N-WASP GTP-binding domain (GBD) is bound to its 
WCA domain, preventing Arp2/3 recruitment (Kim et al., 2000; Miki et al., 1998; 
Rohatgi et al., 2000). One of the first characterised activators of N-WASP was the Rho-
family GTPase, Cdc42 (Miki et al., 1998). Rho GTPases are small 20-25 kDa proteins 
that act as molecular switches due to their ability to cycle from a GTP-bound active 
state to a GDP-bound inactive state (Hall, 2012). Guanine nucleotide exchange factors 
(GEFs), GTPase activation proteins (GAPs) and guanine-nucleotide-dissociation 
inhibitors (GDIs) regulate the conversion between these two states. The majority of 
Rho-family GTPases, including Cdc42 are post-translationally modified at their C-
terminus by the addition of an isoprenoid lipid, which plays an essential role in their 
localisation to cellular membranes (Boulter and Garcia-Mata, 2012). In order to activate 
N-WASP, active (GTP-bound) Cdc42 binds the N-WASP GBD (Kim et al., 2000). The 
GBD cannot interact with both Cdc42 and the WCA domain, therefore binding of 
Cdc42 to the GDB induces a large conformation change that releases autoinhibition of 
N-WASP and frees the WCA domain, allowing it to engage with the Arp2/3 complex 
(Figure 1.7 A, B) (Kim et al., 2000; Miki et al., 1998; Torres and Rosen, 2006). 
 
In addition, the proline-rich domain (PRD) that links the GBD and the WCA domain 
can interact with several SH3-domain containing N-WASP binding partners. These 
include Nck, Grb2, Toca-1, Abi1, syndapin and Abp1 (Carlier et al., 2000; Ho et al., 
2004; Innocenti et al., 2005; Kessels and Qualmann, 2004; Rohatgi et al., 2001). 
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Although interactions of the SH3 domains with the PRD do not directly disrupt GBD-
WCA autoinhibition, they help to promote and maintain the formation of the active 
‘open’ state of N-WASP. Nck and Grb2 have both been shown to synergize with 
PI(4,5)P2 and Cdc42 respectively to enhance activation of N-WASP (Carlier et al., 
2000; Rohatgi et al., 2001). The combination of Cdc42-mediated activation and binding 
of the SH3-containing proteins together maintains N-WASP in its open conformation 
and promotes Arp2/3-dependent actin polymerization (Figure 1.7 A).  
 
Oligomerization of N-WASP has been identified as a key mechanism in the regulation 
of N-WASP function (Padrick et al., 2008; Padrick et al., 2011). The Arp2/3 complex 
contains two WCA binding sites, and it has been show that dimerization of two N-
WASP WCA domains enhances the ability of the Arp2/3 complex to polymerise actin 
100-200 fold (Figure 1.7 B) (Higgs and Pollard, 2000; Padrick et al., 2011; Ti and 
Pollard, 2011). Supporting this, antibody-mediated clustering of Nck, led to the 
induction of N-WASP and Arp2/3 dependent actin comets from which the relative 
ratios of Arp2/3 and N-WASP were able to be determined (Ditlev et al., 2012). This 
reported a 2:1 ratio of N-WASP to Arp2/3, consistent with the earlier observations that 
two WCA domains are required to interact with each Arp2/3 complex (Figure 1.7 C).  
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Figure 1.7 N-WASP regulation  
A N-WASP is autoinhibited via intramolecular interactions between the GBD and the WCA 
domains (left). Active conformation and binding sites of N-WASP interacting proteins (right) 
(Campellone and Welch, 2010). B The activation of N-WASP. Activator binding releases the 
WCA domain, and promotes binding of the Arp2/3 complex. Dimerisation results in higher 
affinity binding of the WCA domain to Arp2/3 (adapted from Padrick et al., 2008). C Antibody-
mediated clustering of the SH3 domains of Nck proposed a ratio of two N-WASP molecules to 
one Arp2/3 complex, consistent with the presence of two WCA binding sites in Arp2/3 (adapted 
from Ditlev et al., 2012). 
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1.2.4 Vaccinia actin tail formation 
The hijacking of the actin polymerisation machinery by pathogens has led to numerous 
insights about the regulation of actin polymerisation in vivo (Welch and Way, 2013). In 
a mechanism that is conserved among the poxviruses, vaccinia virus assembles actin 
structures to facilitate egress and mediate cell-to-cell spread (Dodding and Way, 2009).  
 
During vaccinia egress, following fusion of the virus with the plasma membrane, the 
outer IEV membrane is incorporated into the plasma membrane. The virus induces 
outside-in signalling to locally activate Src and Abl family kinases in a process 
dependent on B5 (Frischknecht et al., 1999b; Newsome et al., 2004; Newsome et al., 
2006). Activated Src phosphorylates A36 at tyrosine 112 and 132, in a manner 
mimicking receptor tyrosine kinase signalling. Phosphotyrosines 112 and 132 can 
recruit the SH3-adaptor proteins, Nck and Grb2 respectively (Frischknecht et al., 1999a; 
Newsome et al., 2004; Scaplehorn et al., 2002). Nck directly interacts with WIP in order 
to recruit the WIP:N-WASP complex (Figure 1.8) (Donnelly et al., 2013; Weisswange 
et al., 2009). This results in the local activation of the Arp2/3 complex beneath the CEV, 
and the induction of actin tails (Frischknecht et al., 1999b; Moreau et al., 2000). The N-
WASP PRD also interacts with Grb2 downstream of phosphotyrosine 132 (Donnelly et 
al., 2013; Frischknecht et al., 1999b; Moreau et al., 2000; Snapper et al., 2001; Zettl and 
Way, 2002). Grb2 although not essential for actin tail formation, functions as a 
secondary adaptor (Scaplehorn et al., 2002; Weisswange et al., 2009). FRAP 
experiments revealed that Grb2, Nck, and WIP all exhibit rapid rates of exchange 
beneath the virus, 3.5 times faster than N-WASP turnover (Weisswange et al., 2009). 
Loss of Grb2 led to even higher turnover of Nck and WIP, suggesting that the primary 
role of Grb2 is to stabilise the vaccinia actin-signalling complex (Weisswange et al., 
2009).  
 
In addition, Cdc42 has been found to regulate the activity of N-WASP to stimulate 
Arp2/3 dependent actin tails (Humphries et al., 2014). Expression of a N-WASP mutant 
(N-WASP H208D) that is unable to bind Cdc42, leads to a decrease in the ability of the 
virus to nucleate actin tails, and inhibition of viral spread (Humphries et al., 2014; Miki 
et al., 1998). Cdc42 acts cooperatively with Nck and Grb2 to stabilise N-WASP beneath 
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the virus. Furthermore, the RhoGEF intersectin-1 is recruited to the virus prior to actin 
tail formation via an unknown mechanism, and thought to locally activate Cdc42 upon 
its binding to N-WASP (Figure 1.8) (Humphries and Way, 2013; Hussain et al., 2001). 
Mediated by multiple interactions with WIP, Nck, Grb2, and Cdc42, N-WASP can 
stably recruit actin and the Arp2/3 complex, facilitating actin polymerisation beneath 
the CEV, thus enhancing viral spread (Frischknecht et al., 1999a; Snapper et al., 2001; 
Weisswange et al., 2009). 
 
 
 
 
Figure 1.8 The vaccinia actin-signalling network 
The actin-signaling network mediated by phosphorylation of A36 Y112 and Y132. Bold lines 
indicate experimentally confirmed interactions between components of the vaccinia-signaling 
complex. Dashed lines indicate interactions between components of this actin signaling 
complex determined in another systems, which may also occur in the case of viral induction of 
actin tails. Domains are annotated: SH2 (Src homology 2), SH3 (Src homology 3), WBD 
(WASP binding domain), PRD (Polyproline-rich domain), WH1 (WASP homology 1), GBD 
(GTPase binding domain) and WCA (WH2, central and acidic region), EH (Eps15-homology 
domain), DH (Dbl-homology domain), PH (Pleckstrin-homology domain), C2 (Membrane 
targeting motif).  
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1.2.5 Actin-based motility of pathogens  
A number of bacterial pathogens also utilise the host actin polymerisation machinery to 
promote infection such as EPEC, Listeria, and Shigella, (Bernardini et al., 1989; 
Heinzen et al., 1993; Tilney and Portnoy, 1989). Both enteropathogenic Escherichia 
coli (EPEC) and vaccinia virus recruit N-WASP and Arp2/3 in mechanism analogous to 
tyrosine phosphorylation dependent signalling {Frischknecht, 1999 #79}{Frischknecht, 
2001 #156}{Welch, 2013 #768}. Upon contact of EPEC with the host cell, a type III 
secretion system inserts the bacterial effector protein Tir (translocated intimin receptor) 
into the host plasma membrane (Kenny et al., 1997). Tir is tyrosine phosphorylated by 
Src, resulting in Nck recruitment mediated by phosphotyrosine 474 (Kenny, 1999; 
Phillips et al., 2004; Swimm et al., 2004). Nck binding mediates the recruitment of N-
WASP and Arp2/3, stimulating the polymerisation of actin beneath the bacterium 
(Gruenheid et al., 2001). This forms highly dynamic actin pedestals that promote 
efficient bacterium colonization (Kenny et al., 1997). 
 
 Shigella flexneri and Listeria monocytogenes both induce actin-rich structures that 
propel them through the cytoplasm. The Shigella protein IcsA is the sole mediator of 
actin-based motility during infection, and acts to both recruit and activate N-WASP 
beneath the bacterium (Bernardini et al., 1989; Egile et al., 1999; Goldberg and Theriot, 
1995; Kocks et al., 1995; Moreau et al., 2000). Listeria ActA, was the first NPF to be 
identified and like both A36 and IcsA is the sole component of Listeria required to 
mediate actin polymerisation (Cameron et al., 1999; Domann et al., 1992; Kocks et al., 
1992; Smith et al., 1995; Welch et al., 1998). ActA is a class I NPF that mimics the N-
WASP WCA domain and is able to directly recruit and activate the Arp2/3 complex 
(Egile et al., 1999; Tilney and Portnoy, 1989; Welch et al., 1997; Welch et al., 1998). 
 
The host actin polymerisation machinery is not alone in being hijacked by pathogens in 
order to enhance the spread of infection. The endocytic clathrin machinery forms 
another system of highly conserved proteins that are manipulated during pathogen entry 
and spread. 
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1.2.6 A Clathrin-dependent step 
Clathrin is most commonly associated with endocytosis at the plasma membrane, 
however during vaccinia infection, it instead appears to facilitate the formation of actin 
tails during viral egress (Humphries et al., 2012). Following the fusion of the viral 
particle with the plasma membrane, clathrin and its adaptor, AP-2, are recruited. Live 
cell imaging showed that AP-2 and clathrin are transiently recruited following the loss 
of kinesin-1, and dissociate upon actin tail formation. Super-resolution imaging also 
revealed that AP-2 plays a role to cluster A36 and N-WASP beneath the CEV (Figure 
1.10) (Humphries et al., 2012). In this regard, clathrin machinery appears to mimic the 
early stages of endocytosis, which begins by selective sequestration of cargo. While the 
actin-signalling network can function in the absence of clathrin, the loss of clathrin-
mediated A36 and N-WASP polarisation leads to a less robust actin-signalling platform 
and delayed actin tail nucleation (Humphries et al., 2012). Once formed, actin tails are 
significantly longer and fewer in number. It is hypothesised that the clustering of A36 
and N-WASP facilitates the oligomerization of N-WASP, which is known to enhance 
the activation of the Arp2/3 complex (Figure 1.7). Precisely how AP-2 and clathrin 
recruitment results in this altered actin tail behaviour is yet to be elucidated. To similar 
effect, in vitro motility assays have demonstrated that the density of N-WASP or its 
WCA domain determines Arp2/3-dependent bead or vesicle motility (Bernheim-
Groswasser et al., 2002; Delatour et al., 2008; Wiesner et al., 2003). Once an actin tail 
is formed, the viral particle is propelled away from the AP-2 and clathrin-rich 
membrane, and AP-2 and clathrin dissociate.  
 
The cytoplasmic domain of A36 (residues 24-221) was shown to associate with AP-2. 
Earlier studies identified that the IEV protein, F13, is also able to associate with AP-2 
(Husain and Moss, 2003). Several potential adaptor-binding motifs exist within the IEV 
proteins that may be responsible for AP-2 or clathrin recruitment (Figure 1.9). The 
molecular basis of AP-2 and clathrin recruitment could therefore involve a combination 
of weak interactions mediated by multiple IEV proteins. It has been shown that actin 
nucleation itself promotes the polarization of A36 beneath the virus and disrupts 
luminal interactions of IEV proteins that tether the virus to the plasma membrane 
(Figure 1.5) (Horsington et al., 2013). Clathrin-mediated clustering of A36 beneath the 
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virion may therefore aid EEV release by contributing to the disruption of IEV tethering 
to the plasma membrane. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Vaccinia IEV proteins and their potential adaptor binding motifs 
The amino acid sequences of the IEV specific proteins, A36, F13, B5, A33 and A34. The 
predicted transmembrane domains are highlighted in green. Sequences exposed within the 
cytoplasm are in black and those that are outside of the cell following the fusion of IEV with the 
plasma membrane are in grey. Potential clathrin adaptor binding sites are indicated in red.  
 
 
  Chapter 1. Introduction 
 
 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10 Model of clathrin function during vaccinia virus egress 
During IEV egress the outer viral membrane (blue) fuses directly with the plasma membrane 
and viral IEV proteins, including A36, become incorporated. In this model proposed by 
Humphries et al 2012, AP-2 together with clathrin cluster A36 beneath the virus particle. This 
creates a stable protein platform to which N-WASP and other components of the actin-signaling 
network can be recruited. 
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1.2.7 Subversion of endocytic machinery by pathogens   
The plasma membrane barrier is the first obstacle pathogens face during infection of a 
host cell. To facilitate internalisation, a number of endocytic pathways are hijacked to 
overcome the plasma membrane, among them, macropinocytosis and phagocytosis 
(Cossart and Sansonetti, 2004; Gruenberg, 2009; Marsh and Helenius, 2006; Mercer et 
al., 2010; Pelkmans and Helenius, 2003; Schelhaas, 2010). Typically clathrin-coated 
vesicles range in size from 30 nm – 150 nm, however in many instances clathrin 
facilitates the uptake of far larger objects. This was first demonstrated to be the case 
during internalisation of vesicular stomach virus (VSV). VSV, which is 200 nm in 
diameter, is able to enter cells in a clathrin-dependent manner, hijacking the actin 
cytoskeleton in order to breach the host cell membrane (Cureton et al., 2009; Cureton et 
al., 2010; Johannsdottir et al., 2009).  
 
Retroviruses despite the small complement of proteins they encode, have also found 
unique ways to hijack the endocytic machinery during entry and budding from the host. 
It has been shown the HIV-1 Gag protein recruits clathrin adaptors, AP-2 and AP-1 in 
order to promote trafficking of viral proteins and budding at the membrane (Batonick et 
al., 2005; Camus et al., 2007). The HIV-1 glycoprotein (gp41) plays a crucial role in 
facilitating fusion between viral and target cell membranes upon viral entry. Following 
contact with a target cell, the gp41 N-terminus is inserted into the host plasma 
membrane. Work has uncovered that the HIV-1 gp41 core specifically binds the Asn-
Pro-Phe (NPF) repeats in the early endocytic protein, epsin (Huang et al., 2006; Huang 
et al., 2008) A peptide mimicking the epsin NPF motifs (470-499) causes a block in 
HIV-1 entry (Huang et al., 2008). Furthermore, the overexpression of dominant 
negative Eps15 which is recruited downstream of epsin also results in a 95% decrease in 
viral entry, suggesting that the entire early endocytic pathway is required for HIV-1 
uptake (Nakashima et al., 1999).  
 
Clathrin is also recruited to EPEC induced actin pedestals described in 1.2.5. EPEC 
induced pedestal formation is an AP-2 independent process, and instead the endocytic 
adaptor protein Dab2 along with the early endocytic proteins, epsin and Eps15 are 
responsible for clathrin recruitment (Lin et al., 2011; Maurer and Cooper, 2006). The 
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role of clathrin at the EPEC pedestal is yet to be fully elucidated, however it has been 
shown that the phosphorylation of clathrin heavy chain is triggered upon infection, 
which leads to the formation of a robust signalling platform and subsequent actin 
polymerization (Bonazzi et al., 2011).  
 
1.3 Clathrin Mediated Endocytosis 
Clathrin was first isolated by Barbara Pearse in 1976, and has been intimately linked to 
the process of vesicle trafficking, endocytosis, and recycling (Pearse, 1976). The first 
observations of what were later found to be clathrin-coated pits were reported during 
the study of yolk-protein uptake in mosquito oocytes in 1964 (Roth and Porter, 1964). 
This revealed coated baskets of triskelia at the plasma membrane around 30 nm in 
length. The observation of coated pits, vesicles, and fused granules led to an initial 
description of pinching, uncoating, and fusion that we now understand as characterising 
classical clathrin-mediated endocytosis (McMahon and Boucrot, 2011; Roth and Porter, 
1964). More recently newly emerging roles of clathrin have become more apparent. 
Clathrin has crucial functions in the regulation of signal transduction, neuronal 
development, cell division, and of course during pathogenesis (Cossart and Veiga, 
2008; Cureton et al., 2009; Veiga and Cossart, 2005; Warner et al., 2006). Several viral 
and bacterial pathogens described thus far, have been shown to hijack the clathrin 
machinery at the plasma membrane in order to force entry into the host cell (Cossart 
and Veiga, 2008; Cureton et al., 2009; Gruenberg, 2009; Marsh and Helenius, 2006; 
Mercer et al., 2010; Pizarro-Cerda et al., 2010; Veiga and Cossart, 2005). In the case of 
vaccinia, clathrin appears to have a unique role to support actin dynamics and enhance 
viral spread (Figure 1.10) (Humphries et al., 2012; Humphries and Way, 2013).  
1.3.1 Clathrin  
It is the unique structure of clathrin observed by electron microscopy (EM) in 1976 that 
led to the discovery of its role in the formation of vesicles at the plasma membrane. The 
characteristic triskelia organisation of clathrin, results from the trimerisation of three 
identical clathrin heavy chains (CHC - 180 kDa) via the central ‘hub’ (Kirchhausen et 
al., 1987; Liu et al., 1995). Each heavy chain associates with one clathrin light chain 
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(CLC – 33-36 kDa) via the CHC proximal leg domain (Figure 1.11 A) (Kirchhausen 
and Harrison, 1981; Ungewickell and Branton, 1981). Self-assembly of clathrin triskelia 
forms the polyhedral lattice structure first observed by EM (Roth and Porter, 1964). It is 
this unique self-assembly property of clathrin that mediates its function at the plasma 
membrane. Like actin, the CHC is conserved in all eukaryotes (Wakeham et al., 2005). 
Regulation of clathrin lattice formation and assembly is mediated by a combination of 
clathrin light chain binding, adaptor binding, phosphorylation and the isoform diversity 
of the clathrin itself (Brodsky, 2012; Delom and Fessart, 2011; Di Pietro et al., 2010; 
Reider and Wendland, 2011; Wang et al., 2013; Ybe et al., 1998). The clathrin heavy 
and light chains are encoded by two genes; CHC17/CHC22 and CLCa/CLCb 
respectively (Jackson et al., 1987; Kirchhausen et al., 1987). CHC17 is ubiquitously 
expressed in all tissues (Brodsky, 2012). In contrast CHC22, despite 85% sequence 
homology to CHC17, appears to have a more specialised role, and is most highly 
expressed in muscle tissue (Vassilopoulos et al., 2009). CHC22 can associate with the 
adaptors AP-1 and AP-3 but not AP-2, however is able to rescue CHC17 function in 
CHC17 depleted cells, suggesting a degree of redundancy between the heavy chain 
isoforms (Hood and Royle, 2009; Liu et al., 2001; Vassilopoulos et al., 2009). While 
both CLC isoforms associate with CHC17, neither can bind CHC22, again alluding to 
the more distinct role of CHC22 (Liu et al., 1995).  
 
The hub of the CHC is composed of a central trimerization domain, proximal leg 
extension, and knee joint, followed by the distal leg domain (Figure 1.11 A) (Smith and 
Pearse, 1999). A flexible linker region connects the hub to the ankle region altogether 
terminating in the N-terminal domain (TD). The CLC contains three key tryptophan 
residues that mediate binding to the CHC (Ybe et al., 1998). The rearrangement of the 
N-terminus of the CLC in relation to the heavy chain facilitates a bent knee 
conformation, compatible with the formation of the clathrin lattice (Wilbur et al., 2010). 
In addition to CLC, other clathrin binding proteins are able to bind the TD region in 
order to induce clathrin assembly (Drake et al., 2000; Miele et al., 2004; ter Haar et al., 
1998).  
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Figure 1.11 Domain and subunit organisation of clathrin and AP-2  
A The domain organisation of clathrin light and heavy chains and their organisation in the 
triskelia. Top panel - Inset depicts quick-freeze deep-etch images of clathrin-coated vesicles 
budding from the plasma membrane (with thanks to John Heuser) Bottom panel - vaccinia 
recruiting clathrin during viral egress. B AP-2 is composed of four subunits. Common accessory 
proteins that bind the appendages are shown to the right. Adapted from (Kirchhausen et al., 
2014; Ohno, 2006). 
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1.3.2 Clathrin Adaptors 
The term adaptor was first coined in 1981, as it was clear that there must be a family of 
proteins to link clathrin, which itself lacks membrane binding activity, to its designated 
cargo (Dannhauser and Ungewickell, 2012; Kirchhausen, 1999; Pearse and Bretscher, 
1981; Robinson, 2004). Currently over 20 endocytic accessory proteins have been 
described (excluding splice variants) (Owen et al., 2004). Although diverse in function, 
clathrin adaptors share many common characteristics. Firstly, most adaptors contain 
modular cargo-binding domains (Kalthoff et al., 2002; Merrifield and Kaksonen, 2014; 
Traub, 2009). Secondly, the clathrin adaptors also contain short, highly conserved linear 
motifs often followed by largely unstructured linker regions that mediate binding to the 
N-terminal domain (TD) in the large CHC (Figure 1.11 B).  
 
The ‘AP’ family of clathrin adaptors were first identified following the observation that 
clathrin in isolation could only form cages in physiological conditions upon the addition 
of cytosolic extract (Keen et al., 1979; Pearse and Bretscher, 1981). These assembly 
polypeptide (AP) complexes consist of four subunits: two large ~ 100 kDa subunits (β 
and α/δ/γ/ε), a medium ~ 50 kDa subunit (µ), and a small 17 kDa subunit (σ) (Ahle et al., 
1988; Keen et al., 1987; Matsui et al., 1990). The large subunits are themselves split 
into three domains that together with the µ and σ subunit make up the adaptor core 
(Figure 1.11 B). The large subunits α/δ/γ/ε and β consist of N-terminal HEAT repeats, 
followed by a flexible hinge region linking to the C-terminal appendage. The large β 
subunit is responsible for direct interaction with clathrin via the highly conserved 
clathrin box motif, LΦxΦ[D/E] (where Φ represents a bulky hydrophobic residue), with 
the β appendage providing an additional site of clathrin binding (Dell'Angelica et al., 
1998; Gallusser and Kirchhausen, 1993; ter Haar et al., 2000). The appendages can also 
function to mediate binding to a host of accessory factors required to mediate specificity 
and function to the adaptor proteins in vivo (Figure 1.11 B).  
 
Vertebrate genomes encode five adaptors: AP-1 – AP-5 (Hirst et al., 2013; Kirchhausen, 
1999; Robinson and Bonifacino, 2001). AP-1 and AP-3 function during intracellular 
clathrin-dependent events between endosomes and the TGN (Klumperman et al., 1993; 
Meyer et al., 2000; Peden et al., 2002). AP-4 and AP-5 are the most recently 
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characterised adaptor proteins and have been linked to neuronal specific endosomal 
trafficking (Dell'Angelica et al., 1998; Hirst et al., 2011; Hirst et al., 2013). AP-2 
mediates protein sorting and endocytic events specific to the plasma membrane and is 
responsible for clathrin recruitment to vaccinia prior to actin tail formation (Ahle et al., 
1988; Humphries et al., 2012; Kirchhausen et al., 1997; Robinson, 1987). 
 
AP-2, described in 1984, is one of the best-characterised clathrin adaptors and is 
conserved amongst all eukaryotes. After clathrin, AP-2 is the most abundant protein 
found in the vesicle (Brodsky et al., 2001; Pearse and Robinson, 1984). Loss of AP-2 in 
mice results in embryonic lethality, highlighting its essential role in cellular homeostasis 
(Mitsunari et al., 2005; Zizioli et al., 1999). Interestingly, in Saccharomyces cerevisiae, 
AP-2 depletion does not affect clathrin function to the same extent, and is not lethal 
(Carroll et al., 2009; Huang et al., 1999; Yeung et al., 1995). AP-2 is specific to the 
plasma membrane and is able to bind both PI(4,5)P2 and cargo destined for 
internalisation. The large subunits (α and β2) mediate targeting to the plasma membrane 
and clathrin recruitment, while the µ2 subunit specifically interacts with common cargo 
internalisation motifs (Ohno et al., 1995; Owen and Evans, 1998). The majority of AP-2, 
however, exists in the cytoplasm in a locked, inactive state (Collins et al., 2002; Jackson 
et al., 2010; Rapoport et al., 1997). In this locked state, cargo binding sites are buried 
and AP-2 must undergo a large conformation change mediated by PI(4,5)P2 binding to 
reveal cargo binding motifs (Jackson et al., 2010). Phosphorylation of the µ2 subunit of 
AP-2 enhances the affinity of AP-2 to PI(4,5)P2 and thus facilitates cargo recruitment 
(Fingerhut et al., 2001; Honing et al., 2005; Ricotta et al., 2002). 
 
The role of AP-2 is well characterised; however, the essential requirement for AP-2 
during clathrin-mediated endocytosis remains a subject of fierce debate. Several studies 
were able to show that clathrin-mediated internalisation could still occur following AP-
2 depletion (Hinrichsen et al., 2003; Keyel et al., 2006; Lakadamyali et al., 2006; 
Maurer and Cooper, 2006; Motley et al., 2003). This suggests that additional accessory 
proteins may be required to mediate binding between the plasma membrane, cargo, and 
clathrin. Several endocytic proteins with the right properties exist and may act alone or 
in complex with AP-2 to recruit clathrin in a cargo-specific manner. Epsin1/2, ARH, 
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NUMB, Dab2 and β-arrestin have all been proposed to function in this regard (Maurer 
and Cooper, 2006; Traub and Bonifacino, 2013). Even so, AP-2 depletion results in a 
~12-fold reduction in the formation of clathrin-coated pits, and it has been suggested 
that incomplete RNAi mediated depletion of AP-2 is responsible for the detection of 
clathrin dependent endocytic events in the aforementioned studies (Kelly et al., 2014). 
By and large it has been accepted that AP-2 is the dominant adaptor required for 
initiation of clathrin-coated pits (Cocucci et al., 2012). 
 
Protein-protein interactions facilitating endocytic events are low affinity and commonly 
mediated by highly conserved short linear motifs. The most well characterised AP-2 
binding motifs consist of tyrosine (YxxΦ) and dileucine ([D/E}xxxL[L/I/M]) motifs 
which designate cargo for AP-2 mediated internalisation (Doray et al., 2007; Kelly et al., 
2008; Owen et al., 2004). Via multiple low affinity interactions with sorting signals, 
AP-2 coordinates high avidity endocytic structures that are highly transient in their 
nature. Other cofactors implicated as cargo-specific adaptor proteins, acting either in 
conjunction or independently of the role of AP-2, also utilise short conserved linear 
stretches to recognise cargo (Table 1.1).  
Table 1.1 Common endocytic motifs and their binding adaptor proteins  
 
Motifs denoted according to PROSITE annotation. Φ denotes a bulky hydrophobic residue (L, 
M, I, F, V), x - any amino acid. When known the subunit mediating binding is given in 
parenthesis. Adapted from (Traub, 2009). 
Motif: Adaptor: Corresponding cargo protein: 
YxxΦ AP-2 (µ2) Tranferrin receptor 
[DE]xxxL[LI] AP-2 ( α-σ2 ) CD4 / LIMP4 / Nef 
[FY]xNPx[YF] DAB2 (PTB domain) 
NUMB 
ARH  
LDL receptor / LRP1/2 
II AP-2 K+ channel Kir2.3 
Phosphate group β-arrestin1 
β-arrestin2 
GPCRs 
Acidic cluster AP-2 (putative)  Furin / CD-M6PR 
Ubiquitin Epsin (UIM) 
Eps15 (UIM) 
EGFR / MHC class 1  
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1.3.3 The Endocytic pathway 
The mechanism of clathrin-mediated endocytosis at the plasma membrane is well 
established and requires the recruitment of several adaptors and cofactors at distinct 
temporal stages (McMahon and Boucrot, 2011). During endocytosis, nucleation, cargo 
selection, coat assembly, scission, and uncoating of the vesicle all occur in a highly 
coordinated manner (Engqvist-Goldstein and Drubin, 2003; Geli and Riezman, 1998; 
McMahon and Boucrot, 2011; Sorkin, 2004; Toret and Drubin, 2006). PI(4,5)P2 is 
essential for the initiation of the endocytic clathrin-coated pit, and also plays a key role 
in the regulation of pit size and stability (Antonescu et al., 2011).  
 
Recent single molecule imaging was able to reveal that the simultaneous recruitment of 
two AP-2 complexes with one clathrin triskelion is responsible and essential for the 
initiation of clathrin-coated pits (Figure 1.12 A) (Cocucci et al., 2012). The RIM 
complex is subsequently recruited following initiation of the clathrin-coated pit. This 
complex comprises of the F-BAR domain containing protein, FCHo1/2 which binds to 
PI(4,5)P2-rich sites of the plasma membrane, along with epsin, Eps15 and intersectin-1 
(Henne et al., 2010; Reider et al., 2009; Stimpson et al., 2009). Together this complex 
specifically localises to the edge of the growing pit and plays a crucial role to enhance 
membrane curvature, thus promoting vesicle formation (Henne et al., 2010; Reider et al., 
2009; Saffarian et al., 2009; Tebar et al., 1996). These accessory proteins form multiple 
low affinity interactions with one another and AP-2, and the depletion of any one of 
these components results in defective vesicle formation (Loerke et al., 2009; Mettlen et 
al., 2009).  
 
Upon recruitment to PI(4,5)P2 at the plasma membrane AP-2 autoinhibition is released, 
to reveal dileucine and tyrosine cargo binding sites (Collins et al., 2002; Jackson et al., 
2010; Page and Robinson, 1995). Polymerization of the clathrin triskelia acts to 
facilitate the maturation of the growing pit by promoting curvature of the membrane 
(Hinrichsen et al., 2003). Finally, membrane scission of the nascent vesicle from the 
plasma membrane occurs via the GTPase dynamin. Dynamin oligomerises into 
tetramers that form tubules of approximately 26 dynamin molecules around the neck of 
the vesicle (Baba et al., 1995; Grassart et al., 2014; Hinshaw, 2000; Kosaka and Ikeda, 
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1983). Once the mature vesicle buds off from the plasma membrane, uncoating of 
clathrin is initiated in an HSC70 and auxillin dependent manner (Massol et al., 2006; 
Taylor et al., 2011). Auxillin is recruited after budding and localizes to the hub of the 
clathrin triskelia via binding to the terminal domains and ankle region (Fotin et al., 
2004; Scheele et al., 2001). HSC70 is then recruited by auxillin, allowing internalization 
and sorting of the vesicle to proceed (Schlossman et al., 1984; Ungewickell et al., 1995).  
 
 
 
 
Figure 1.12 Mammalian clathrin-mediated endocytosis 
A The progression of protein internalisation during clathrin-mediated endocytosis. The site of 
nucleation is defined by the coordinated arrival of two AP-2 molecules and one clathrin 
triskelia. Vesicle progression and cargo incorporation is then reliant on the recruitment of 
additional accessory proteins, prior to vesicle maturation and scission from the plasma 
membrane by dynamin. B Proteins that coordinate actin polymerization during clathrin-
mediated endocytosis. Adapted from Humphries, 2012.  
  Chapter 1. Introduction 
 
 50 
1.3.4 The role of actin during Clathrin-Mediated Endocytosis  
Actin polymerisation and endocytic events are two complex and highly regulated 
processes; moreover the role of actin is intimately coupled with the process of 
endocytosis in several instances (Engqvist-Goldstein and Drubin, 2003; Merrifield, 
2004; Yarar et al., 2005). Genetic studies in yeast were the first to uncover a link 
between actin polymerisation and endocytosis whereby disruption of genes required for 
either process, was shown to inhibit the other (Ayscough, 2000; Engqvist-Goldstein et 
al., 2004; Kaksonen et al., 2006; Wendland et al., 1998). This relationship, however, is 
not so clear in mammalian cells. Chemical inhibition of actin polymerisation with 
latrunculin A revealed that actin plays a supporting rather than essential role in 
endocytic events in mammalian cells (Fujimoto et al., 2000; Gottlieb et al., 1993; 
Lamaze et al., 1997). In contrast, more recent evidence from electron microscopy and 
live cell imaging has revealed a crucial role for actin polymerisation during vesicle 
pinching off from the plasma membrane, and the subsequent internalisation of cargo 
(Boulant et al., 2011; Taunton, 2001).  
 
Analogous to the role of vaccinia-induced actin tails, actin polymerisation has been 
detected on vesicles and macropinosomes propelling them into the cytoplasm from their 
site of generation at the plasma membrane (Figure 1.12 B) (Frischknecht et al., 1999b; 
Kaksonen et al., 2000; Merrifield et al., 1999; Yarar et al., 2005). Like many actin 
dependent processes, endosomal motility is thought to require the presence of both 
Arp2/3 and N-WASP (Merrifield, 2004; Merrifield et al., 2002). Overexpression of 
WASP/N-WASP inhibits endosome motility, and the efficiency of endocytic events is 
significantly reduced in WASP null lymphocytes (Benesch et al., 2005; Rozelle et al., 
2000; Zhang et al., 1999). N-WASP can bind several endocytic proteins, such as 
intersectin-1 and endophilin A, however the precise mechanism of N-WASP 
recruitment during endocytosis remains elusive (Hussain et al., 2001; McGavin et al., 
2001; Otsuki et al., 2003).  
 
Aside from the well-characterised role of dynamin in vesicle neck scission, dynamin 
may provide a key link between the actin and clathrin machinery during vesicle 
transport (Danino and Hinshaw, 2001; Lee and De Camilli, 2002; Orth et al., 2002). 
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Overexpression of dynamin mutants inhibits both the formation of actin stress fibres 
and actin-dependent vesicle motility (Lee and De Camilli, 2002; McNiven et al., 2000; 
Orth et al., 2002). Dynamin can interact indirectly with N-WASP (via intersectin-1 and 
endophilin A), but can also directly bind the class II NPF, cortactin and profilin, a key 
regulator of actin dynamics (Le Clainche et al., 2007; McNiven et al., 2000; Merrifield, 
2004; Qualmann and Kelly, 2000; Roos and Kelly, 1998). 
 
Mammalian adaptors Hip1 and Hip1R also act to mediate the actin and clathrin 
networks. Found at the site of clathrin-coated pits, Hip1R is able to directly bind actin, 
clathrin and the plasma membrane (Brett et al., 2006; Engqvist-Goldstein et al., 1999; 
Engqvist-Goldstein et al., 2001; Hyun et al., 2004; Legendre-Guillemin et al., 2005; 
McCann and Craig, 1997; Wilbur et al., 2008). Abolishing the interaction between 
Hip1R and clathrin, or depletion of Hip1R, results in actin accumulation at the site of 
vesicle formation, leading to the suggestion that the Hip1R-clathrin interaction is crucial 
for regulation of actin dynamics during endocytic events (Boettner et al., 2011). A key 
component of the early endocytic RIM complex, epsin has also been reported to play a 
role to mediate Hip1R function during endocytosis (Messa et al., 2014). Mouse 
knockout cell lines lacking all three isoforms of epsin could still make clathrin coats pits, 
however these vesicles were unable to mature and failed to internalize (Messa et al., 
2014). Interestingly, Hip1R is no longer recruited at these clathrin-rich sites in cells 
lacking epsin, which once again results in aberrant actin accumulation at these sites 
(Engqvist-Goldstein et al., 2004; Messa et al., 2014).  
 
This link between the clathrin and actin machinery also appears to play a crucial role in 
the formation of non-classical clathrin structures. Recent studies have linked the roles of 
clathrin and actin during the formation and maintenance of long-lived clathrin structures 
at the plasma membrane, termed clathrin plaques (Saffarian et al., 2009). These clathrin 
plaques form a flat extended lattice on the plasma membrane and are enriched at the 
adherent surface of cells. These plaques appear to be composed of a unique hexagonal 
array of clathrin that is dependent on the presence of actin (Saffarian et al., 2009). These 
structures are rich in both Hip1R and epsin, which are localised throughout these flat 
lattices, unlike their distinct localisation at the nascent vesicle edge during canonical 
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clathrin-mediated endocytosis (Boulant et al., 2011). The extent to which actin is 
required during endocytic events is still under a degree of discussion, with evidence 
pointing to a greater requirement for actin under conditions of stress, such as high 
turgor pressure, high membrane tension, or the presence of large cargo 
(Aghamohammadzadeh and Ayscough, 2009; Batchelder and Yarar, 2010; Boulant et 
al., 2011; Cureton et al., 2010; Liu et al., 2009). 
 
1.4 Eps15 Homology family proteins 
1.4.1 Discovery and members 
The RhoGEF intersectin-1 is recruited to vaccinia during its egress where it is thought 
to locally activate Cdc42. In addition intersectin-1 is a component of the cellular 
endocytic machinery and contains conserved EH domains described in more detail 
below. 
 
The Eps15 Homology (EH) domains were as their name suggests, originally identified 
as a conserved domain present in three copies in the N-terminus of Epidermal growth 
factor receptor substrate 15 (Eps15) (Fazioli et al., 1993). The EH domains are around 
100 residues in length, and are highly conserved from yeast to man (Fazioli et al., 1993; 
Wong et al., 1994; Wong et al., 1995). The EH domains of a number of proteins have 
been structurally determined, and are characterised by the presence of two EF-hand 
domains linked by an anti-parallel beta-sheet (de Beer et al., 1998). While EF-hand 
motifs are usually calcium binding, not all EH domains contain the required residues to 
facilitate the interaction with calcium (Enmon et al., 2000; Heizmann and Hunziker, 
1991; Lewit-Bentley and Rety, 2000; Strynadka and James, 1989). Since their initial 
discovery by DiFiore and colleges in 1991, the SMART database currently lists 35 
human proteins containing 60 EH domains in total. In mammals the EH domain 
proteins can be grouped into five distinct families: Eps15, intersectin, Reps, synergin, 
and EH domain containing proteins 1-4 (EHD 1-4). EH domain containing proteins are 
typically associated with endocytic events at the plasma membrane as well as 
trafficking of endosomes to the TGN (Chen et al., 1998; Fernandez-Chacon et al., 2000). 
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To date, the best characterised EH domain containing proteins are mammalian Eps15, 
intersectin-1, and their yeast homologues, End3p and Pan1p, all which have been 
implicated in early endocytic events (Benedetti et al., 1994; Wendland et al., 1998).  
 
A number of approaches have been used to determine EH domain-binding targets, and 
thus far, three classes of highly conserved motifs have been identified. The majority of 
EH domains bind class 1 peptides, containing the NPF motif (Asn-Pro-Phe) (Paoluzi et 
al., 1998; Salcini et al., 1997). Class II peptides contain WW (Trp-Trp), FW (Phe-Trp), 
or SWG (Ser-Trp-Gly) that mediate recruitment to the third EH domain of Eps15, and 
first EH domain of yeast YBL47c. The first EH domain of yeast End3p was also shown 
to bind a third class of peptides, containing a H(S/T)F (His-Ser/Thr-Phe) motif (Salcini 
et al., 1997) (Table 1.2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.2 Binding specificity of EH domains 
 
Experimentally determined binding specificity of the best studied EH domain containing 
proteins. * - The ITSN2 EH domains lack comprehensive experimental evidence determining 
specific binding to NPF motifs, however this is presumed due to its similarity to ITSN1, and the 
ITSN2 binding partners identified thus far. (Kay et al., 2004; Paoluzi et al., 1998; Yamabhai et 
al., 1998). 
Name EH domain Binding Specificity 
Eps15 EH1 NPF 
EH2 NPF 
EH3 FW 
Eps15R EH1 NPF(R) 
EH2 NPR 
EH3 NPF(R) 
ITSN1 EH1 NPF 
EH2 (S)xNPF 
ITSN2* EH1 NPF 
 EH2 NPF 
YBL047Cp EH1 (S)FW(R) 
EH2 NPF / WW 
EH3 NPF(R) 
End3p EH1 HTF 
Pan1p EH2 (S)xNPF 
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Structural determination of EH domain-NPF binding reveals that NPF-containing 
peptides bind a hydrophobic pocket in the EH domain mediated by highly conserved 
leucine and tryptophan residues (Figure 1.13 B) (Enmon et al., 2000; Paoluzi et al., 
1998; Rumpf et al., 2008; Salcini et al., 1997). Mutation of these key residues abolishes 
binding to NPF containing peptides (Rumpf et al., 2008). It has been noted that around 
50% of NPF containing ligands contain a conserved serine or threonine (S/T) at 
positions -1, and -2, suggesting that there is potential for additional regulation of EH 
domain binding via phosphorylation (Paoluzi et al., 1998). Confirmed NPF-containing 
ligands include epsin, stonin2, Numb, CALM, synaptojanin, and Hrb (Chen et al., 1998; 
Doria et al., 1999; Haffner et al., 2000; Legendre-Guillemin et al., 2005; Morgan et al., 
2003; Smith et al., 2004).  
 
EH domain binding proteins were found to have no conserved sequence similarity aside 
from the presence of the NPF motif repeats (Salcini et al., 1997). These proteins 
typically contain multiple, equally spaced NPF motifs that mediate weak binding to EH 
domains in the range of 103-104 M-1 (de Beer et al., 1998; Paoluzi et al., 1998; 
Yamauchi et al., 2004). How EH domains determine binding specificity between 
multiple NPF motifs is still unclear. Interestingly, the crystal structure of the second EH 
domain of Eps15 (EH2) bound to stonin2 revealed a unique mechanism to enhance 
binding affinity. Eps15-EH2 was able to bind stonin2 via interactions with both of its 
NPF motifs (Figure 1.13 C) (Rumpf et al., 2008). Multiple contacts resulted in a binding 
affinity in the order of 106 M-1, far higher than typically observed (Rumpf et al., 2008). 
All other EH domain structures determined thus far have only been shown to bind 
single NPF motifs, however the Eps15 EH2-stonin2 model may be indicative of the 
ability of EH domains to coordinate multiple NPF containing ligands in vivo.  
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Figure 1.13 Domain and subunit organisation of Eps15 and intersectin-1 
A Domain organisation of Eps15 and intersectin-1. B Sequence alignment of the three EH 
domains of Eps15/R with the two EH domains found in intersectin-1/2. Sequence similarity is 
highlighted in blue and residues required to mediate NPF recruitment are shown above the 
sequence in pink. C NMR solution structure of the Eps15 EH2 domain (blue) in complex with a 
peptide containing two NPF motifs found in Stonin2 (pink). PDB=2JXC. One EH domain is 
sufficient to mediate binding to both NPF motifs simultaneously. Cyan patches annotate NPF 
binding residues. The NPF motif is highlighted in yellow. (Rumpf et al., 2008) 
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1.4.2 Epidermal growth factor receptor substrate 15 – Eps15  
Eps15 was originally identified on the basis of its rapid phosphorylation on tyrosine 850 
by EGFR upon ligand binding (Fazioli et al., 1993). While Eps15 had been found to be 
a key regulatory component of clathrin mediated endocytic machinery, it is becoming 
more apparent that the EH domain family of proteins plays a more diverse role during 
intracellular signalling and regulation of the actin cytoskeleton.  
 
Eps15 is composed of a globular head region containing three N-terminal EH domains, 
a central coiled-coil stalk domain and 15 Asp-Pro-Phe (DPF) repeats. These DPF 
repeats mediate direct binding to the α-appendage of AP-2 (Benmerah et al., 1996; 
Iannolo et al., 1997). The central coiled-coil region is thought to mediate both homo- 
and hetero-oligomerisation with other EH domain proteins such as Eps15R and the 
intersectin family (Figure 1.13 A) (Coda et al., 1998; Sengar et al., 1999). 
Ultrastructural studies using EM have confirmed that Eps15 can form homo-dimers in 
parallel and homo-tetramers in antiparallel, via the central coiled-coil region (Cupers et 
al., 1997).  Gel filtration experiments have also revealed that Eps15 within the cell is 
primarily contained in large macromolecular complexes, primarily in complex with AP-
2 (Tebar et al., 1997; Tebar et al., 1996). As a component of the RIM complex, Eps15 is 
known to play an essential role during the early initiation of endocytosis (Carbone et al., 
1997; Suzuki et al., 2012). Eps15 specifically localises to the rim of the growing coated 
pit, unlike AP-2 that is found on the vesicle at all stages of endocytosis (Figure 1.12 
A)(Ehrlich et al., 2004; Saffarian et al., 2009; Tebar et al., 1996). In vitro analysis 
reveals that Eps15 binding to AP-2 is disrupted upon the recruitment of clathrin to AP-2, 
suggesting that Eps15 is mutually exclusive to clathrin polymerisation (Cupers et al., 
1998).  
 
Eps15R (Eps15-related protein) has 63% identity and only differs in 33 positions to 
Eps15 and was identified largely due to its high sequence similarity with Eps15 
(Paoluzi et al., 1998). Eps15R is found in complex with Eps15 at the rim of the growing 
pit (Coda et al., 1998). However, it also has distinct localisation to that of Eps15. 
Whereas Eps15 contains a C-terminal nuclear export signal within the last 25 C 
terminal residues, due to the absence of this domain in Eps15R, it is able to maintain 
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nuclear localisation (Offenhauser et al., 2000; Poupon et al., 2002). In addition, Eps15R 
lacks tyrosine 850, which is present in Eps15 and phosphorylated specifically upon 
EGRF internalisation, once again suggesting these proteins may have unique roles 
(Confalonieri et al., 2000). Aside from their distinct cellular localisations, the binding 
specificity of the Eps15 family EH domains also differs. While the third Eps15 EH 
domain (EH3) preferentially binds FW containing peptides, the EH3 domain of Eps15R 
has significantly higher binding specificity to NPF motifs with an arginine residue at the 
+1 position (NPFR) (Table 1.2) (Paoluzi et al., 1998).  
1.4.3 The Intersectin family 
Intersectin is encoded by two mammalian isoforms, Intersectin-1 and Intersectin-2 (also 
known as Ese-1/Ese-2 in mice) (Sengar et al., 1999; Yamabhai et al., 1998). Intersectin-
1 was originally identified during a cDNA screen in Xenopus Laevis with an SH3 
peptide ligand (Yamabhai et al., 1998). Like Eps15, Intersectin-1 contains two N-
terminal EH domains and a central coiled-coil region required to mediate 
oligomerisation (Wong et al., 2012; Yamabhai et al., 1998). The C-terminus differs 
vastly from that of Eps15, and contains five C-terminal SH3 domains (Yamabhai et al., 
1998). In addition, the long splice variant contains DH, PH, and C2 domains (Fig 1.13 
A) (Guipponi et al., 1998; Hussain et al., 1999; Sengar et al., 1999). Like Eps15, the 
function of intersectin-1 is intimately coupled to endocytic events, where it is thought to 
acts as a scaffold to maintain the specific localisation of endocytic proteins (Koh et al., 
2004; Marie et al., 2004; Wong et al., 2012). 
 
Intersectin-1 co-localises with clathrin during endocytosis and is constitutively 
associated to Eps15 and Eps15R via their coiled-coil domains (Hussain et al., 1999; 
Sengar et al., 1999; Yamabhai et al., 1998). Yeast 2-hybrid screens have also found that 
intersectin-1 can interact with itself and intersectin-2, suggesting that like Eps15, 
intersectin-1 may homo- and heteroligmerize in vivo (Wong et al., 2012). Together with 
Eps15, intersectin-1 associates with FCHo1/2 during early nucleation and initiation of 
clathrin-coated pits (Henne et al., 2010). As is typical of many early endocytic proteins 
described thus far, overexpression of intersectin-1 has also been shown to block 
endocytosis (Sengar et al., 1999).  
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In fact, intersectin-1 may play a more direct role during endocytosis than previously 
appreciated. The linker region between SH3A-SH3B has been shown to directly 
associate with both the α- and β- appendages of AP-2 (Pechstein et al., 2010). This 
stretch of intersectin-1 does not contain consensus AP-2 binding motifs. It does, 
however, contain two aromatic patches consisting of the WADF and WDxW motifs 
that are sufficient to facilitate AP-2 recruitment (Pechstein et al., 2010). These motifs 
are capable of binding both α- and β- appendages, although in vitro intersectin-1 
preferentially binds β- (490 nM) over α- (5 µM) appendages of AP-2 (Pechstein et al., 
2010). These tryptophan motifs are also found within the intersectin-2 SH3A-SH3B 
linker region, suggesting that both isoforms are equally capable of direct AP-2 binding 
(Pechstein et al., 2010).  
 
Screening of potential binding partners of the intersectin-1 EH domains reveals that 
both EH1 and EH2 typically bind class I NPF motifs, with EH1 in general mediating 
higher affinity binding that EH2 (Wong et al., 2012; Yamabhai et al., 1998). In addition, 
it was found that the binding affinity to C-terminal NPF motifs (e.g. NPF-COOH) is 
200 times higher than that of internal NPF motifs. This suggests that the tertiary 
structure of NPF plays a crucial role in influencing specificity and affinity of 
intersectin-1 EH domain binding, which may be a common feature among other EH 
domain containing proteins (Yamabhai et al., 1998). 
1.4.4 Interplay between intersectin-1 and actin 
Eps15 and intersectin-1 are the two best studied EH domain containing proteins and 
share several similar features. Both have the ability to bind one another, epsin, NPF 
motifs and AP-2 directly. The ability of Eps15 and intersectin-1 to form homo- and 
hetero-oligomers, and the multiple protein-protein interaction domains they contain, 
suggests that they act as a molecular scaffolds during endocytic events at the plasma 
membrane (Hussain et al., 1999; Okamoto et al., 1999; Roos and Kelly, 1998; Sengar et 
al., 1999; Yamabhai et al., 1998). Although the regulation of the EH domain containing 
proteins is yet to be fully elucidated, clear evidence points towards a functional 
interaction between Eps15 and intersectin-1. Intersectin-1 affects the localisation of 
Eps15, mirroring observations from their yeast homologues, End3p and Pan1p, in which 
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End3p mediates the localisation of Pan1p (Benedetti et al., 1994; Raths et al., 1993; 
Tang et al., 1997; Toshima et al., 2007; Wendland et al., 1998). In addition earlier 
studies determined a role for the End3p/Pan1p complex for the correct localization of 
endocytic components and the correct formation of the actin cytoskeleton in yeast. 
(Benedetti et al., 1994; Suzuki et al., 2012; Tang et al., 1997). 
 
Intersectin-1, unlike Eps15, contains five SH3 domains, a Dbl homology (DH) domain, 
and a Pleckstrin homology (PH) domain (Figure 1.13 A). Intersectin-1 recruits GDP-
bound Cdc42 via the DH-PH domains, which is thought to facilitate intersectin-1 
binding to N-WASP. The interaction of intersectin-1 and N-WASP is direct and 
mediated by the intersectin-1 SH3 domains (Hussain et al., 2001; Zamanian and Kelly, 
2003). Binding of N-WASP to intersectin-1 also stimulates its GEF activity towards 
GDP-bound Cdc42, which is then exchanged to GTP-Cdc42. In turn, GTP-bound 
Cdc42 can then directly bind N-WASP, activating its ability to bind Arp2/3. This feed-
forward loop appears conserved between isoforms, as similarly intersectin-2 is able to 
interact with both N-WASP and activate Cdc42 in the context of T-cell antigen receptor 
endocytosis (McGavin et al., 2001). Analysis of rat brain extracts have shown that 
intersectin-1, N-WASP, and actin are all components of purified clathrin-coated 
vesicles (Hussain et al., 2001). Interestingly, the intersectin-1 N-WASP signalling 
pathway does not appear to be exclusive to endocytic events and is also activated during 
both exocytosis and phagocytosis (Gasman et al., 2004; Humphries et al., 2014).   
 
More recently a link between intersectin-1 and the N-WASP binding protein, WIP, has 
been uncovered (Anton et al., 2007; Gryaznova et al., 2015; Martinez-Quiles et al., 
2001; Moreau et al., 2000). WIP is a component of a multitude of actin-based structures, 
directly recruiting N-WASP to podosomes, invadopodia, and vaccinia-induced actin 
tails (Donnelly et al., 2013; Garcia et al., 2012; Garcia et al., 2014; Martinez-Quiles et 
al., 2001; Moreau et al., 2000; Yamaguchi et al., 2005). The SH3 domains A, C and E 
of both intersectin-1 and intersectin-2 have been shown to directly mediate binding to 
WIP in vitro, enabling the formation of an intersectin:WIP:N-WASP complex 
(Gryaznova et al., 2015; Wong et al., 2012). In addition to the localisation of 
intersectin-1 to clathrin-coated pits, intersectin-1 has also been shown to localise in vivo 
  Chapter 1. Introduction 
 
 60 
to invadopodia in a WIP dependent manner (Gryaznova et al., 2015). Taken together, it 
appears that intersectin-1 acts as a crucial link between the endocytic and actin 
machinery during a number of cellular events. 
 
1.5 Aims of this thesis 
Decades of research have elegantly dissected how vaccinia and other viruses cleverly 
hijack host machinery to facilitate their spread. Determining exactly how viruses use 
and regulate host machinery during their egress promises to provide novel insights into 
mechanisms of host cell and pathogen biology. In spite of initial characterisation of the 
roles of AP-2 and clathrin during vaccinia infection, we still lack an understanding of 
how they are recruited to the virus. My studies were aimed at understanding the 
molecular basis for the recruitment of AP-2 to vaccinia during viral egress. In addition, 
I aimed to further investigate the interplay between endocytic machinery and actin 
dependent processes, which can cooperate together in cellular host processes and during 
pathogen spread (Humphries and Way, 2013).   
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Chapter 2. Materials & Methods 
2.1 General buffers and culture media  
The in house Cell Services facility at London Research Institute provided general 
buffers and culture media, with details listed below. Specific reagents will be described 
in the relevant section. 
2.1.1 General Buffers 
Phosphate Buffered Saline A (PBSA) 
 
 
Reagents were dissolved in distilled water, and pH adjusted to 7.2, to a total volume of 
1 L. Solutions were autoclaved prior to use.  
2.1.2 Cell Culture Media 
Trypsin Solution: 0.25% in Tris Saline 
 
Tris Saline (TS) 
8.00 g  NaCl 
2.00 ml  19% (w/v) KCl solution 
0.10 g  Na2H2PO4 
1.00 g  D-Glucose 
3.00 g Trizma Base 
1.50 ml 1% (w/v) Phenol red solution 
0.06 g Penicillin 
0.10 g Streptomycin 
 
 
8.00 g  NaCl 
0.25 g  KCl 
1.43 g  Na2HPO4 
0.25 g  KH2PO4 
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Versene Solution 
8.00 g  NaCl 
0.20 g  KCl 
1.15 g  Na2HPO4 
0.20 g  KH2PO4 
0.20 g EDTA 
1.50 ml 1% (w/v) Phenol red solution 
 
0.05% Trypsin working stock  
0.25% trypsin was diluted 1:5 in versene and filter sterilised through a 0.22 µm filter 
prior to use. 
 
Minimal Essential Medium (MEM) 
9.68 g  MEM powder 
3.70 g NaHCO3 
 
The reagents above were dissolved in 10 L of distilled water and pH adjusted to 7.0. 
MEM solution was sterilised through a 0.22 µm filter and stored at 4ºC until use.  
 
2.1.3 Bacteriological Media 
Luria-Bertani (LB) Medium 
10 g  Bacto-tryptone 
5 g  Bacto-yeast extract 
10 g  NaCl 
 
LB Agar 
15 g of Bacto-agar was dissolved in 1 L of LB medium and autoclaved prior to use. 
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2.2 Cell Culture 
All cell lines used in this thesis along with their culture conditions are listed in Table 
2.1.  
 
Table 2.1 Cell lines and culture conditions 
Cell Line Species Medium Source 
HeLa Human 
MEM, 10% FCS3, Pen/Strep4, 
2 mM Glutamine 
Dr Sally Cudmore 
(EMBL) 
HeLa LifeAct-Cherry Human 
MEM, 10% FCS3, Pen/Strep4, 
2 mM Glutamine, 1 µg/ml 
puromycin 
Dr Charlotte Durkin 
(LRI) 
HeLa GFP-N-WASP Human 
MEM, 10% FCS3, Pen/Strep4, 
2 mM Glutamine 
Dr Ina Weisswange 
(LRI) 
BS-C-1 Monkey 
DMEM1, 10% FCS3, 
Pen/Strep4, 2 mM Glutamine 
ATCC 
A549 Human 
MEM, 10% FCS3, Pen/Strep4,  
2 mM Glutamine 
ATCC 
N-WASP -/- MEFs Mouse 
DMEM2, 10% FCS3, 
Pen/Strep4, 2 mM Glutamine 
Dr Scott Snapper 
(MGH) 
N-WASP -/- 
GFP-N-WASP 
(WT & H208D) 
Mouse 
DMEM2, 10% FCS3, 
Pen/Strep4, 2 mM Glutamine, 
1 µg/ml puromycin 
Dr Ashley Humphries  
(LRI) 
 
 
1 Dulbecco’s Modified Eagle Medium 1000 mg/l glucose (Sigma D-6046) 
2 Dulbecco’s Modified Eagle Medium 4500 mg/l glucose (Sigma D-6429) 
3 Fetal Calf Serum (PAA laboratories A15-101) 
4 Penicillin G sodium/streptomycin sulphate 100x stock (Invitrogen 1540-122) 
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2.2.1 Culturing stocks 
Cells were cultured at 37ºC in 5% CO2 and maintained at a confluency of ~70% by 
passage every 2-3 days. To passage cells, media was removed and cells were washed 
once with PBSA and 2 ml of 0.05% trypsin was added to cells per 10 cm dish. After 
brief incubation at 37ºC, detached cells were resuspended in complete media and 
passaged to the desired confluency. When required, cells were counted using the 
Scepter 2.0 Cell Counter (Merke Millipore). 
2.2.2 Freezing stocks 
To generate cell stocks for storage in liquid nitrogen, 70% confluent cells were 
trypsinised as above and collected by centrifugation at 100 g for 5 minutes. Cells were 
resuspended in 1 ml FCS with 10% DMSO per 10 cm dish, aliquoted, and transferred to 
-80ºC prior to long term storage in liquid nitrogen. To recover frozen stocks, aliquots 
stored in liquid nitrogen were rapidly thawed and resuspended in warm complete MEM 
(10% FCS) into a 10 cm dish. Following cell adhesion, media was refreshed to remove 
storage DMSO. 
 
2.2.3 Transfection 
Effectene 
Effectene (Qiagen) was used in all transfection assays, unless otherwise stated. Cells 
were plated to 70% confluency the day prior to transfection. In a 6 well dish, 400 ng of 
DNA was diluted in 100 µl EC buffer. 3.2 µl of enhancer was then added and the 
solution was vortexed and incubated for 5 mins at room temperature. Next 5 µl of 
effectene was added and the mixture vortexed and incubated for an additional 10 mins 
at room temperature. The transfection mix was added dropwise directly to cells in fresh 
MEM. In a 10 cm plate the following volumes were used; 2 µg DNA, 300 µl EC buffer, 
16 µl Enhancer and 30 µl effectene. The protocol was followed as above.  
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HiPerFect 
HiPerFect (Qiagen) was used for RNAi transfection of HeLa cells, using the following 
standard fast-forward protocol. For a 6 well dish, 2 µl siRNA (20 µM) was diluted in 
100 µl MEM, with the addition of 12 µl HiPerFect. The mixture was vortexed and 
incubated at room temperature for 5 mins. This transfection mix was added to 2 ml of 
freshly seeded HeLa cells (0.5x105 per ml). Media was refreshed after 24 hrs, and cells 
were analysed 48 hrs post transfection. In a 10 cm plate the following volumes were 
used; 8 µg siRNA, 300 µl MEM, and 40 µl Hiperfect added to 5 x 105 freshly seeded 
HeLa cells. The protocol was followed as above. 
 
Lipofectamine 2000 
Lipofectamine 2000 transfection reagent (Qiagen) was used for the transfection of 
vaccinia targeting vectors during the generation of recombinant viruses. Cells were 
plated to 80% confluency the day prior to transfection in a 10 cm plate. Prior to 
transfection cells were infected with ∆A36R at an MOI=0.1. 10 µl of Lipofectamine 
2000 was diluted in 250 µl Opti-MEM (Invitrogen 31985), while 4 µg DNA was diluted 
in 250 µl Opti-MEM. After a 5 minute incubation, DNA and Lipofectamine solution 
were mixed and incubated at room temperature for a further 20 mins. At 1 hpi the 
Lipofectamine transfection mix was added dropwise to cells. After 24 hpi cells were 
harvested for the generation of recombinants.  
 
Table 2.2 siRNA target sequences 
Gene Target sequence Source 
Intersectin-1 GAUAUCAGAUGUCGAUUGA GGCCAUAACUGUAGAGGAA 
Dharmacon D-008365-03 
and 04 
Intersectin-2 AAACUCAGCUGGCUACUAU Sigma Aldrich 
Eps15 ATGCTGTAGGTTGAACCATTA Sigma Aldrich 
Eps15R GCACTTGGATCGAGATGAG Sigma Aldrich 
AP-2 alpha subunit 
AP-2 mu2 subunit 
AGAGCAUGUGCACGCUGGC 
GCGAGAGGGUAUCAAGUAU 
Motley et al., 2003 
Dharmacon J-004233-06 
CHC GAAAGAAUCUGUAGAGAAA UGACAAAGGUGGAUAAAUU 
Dharmacon D-004001-01 
and 03 
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2.3 Molecular Biology  
10 x DNA Loading Buffer 
0.25% (w/v)     Bromophenol Blue 
30% (v/v)         Glycerol 
Diluted in 5 x TBE 
  
5 x TBE 
445 mM   Tris Base 
445 mM Boric Acid 
10 mM EDTA 
Made up to a final volume of 1 L with distilled water 
2.3.1 Expression vectors  
Four different expression vectors were used in this thesis. The pE/L vector contains a 
synthetic vaccinia early/late promoter and was used to drive expression during the 
course of infection in mammalian cells (Chakrabarti et al., 1997). The pMW172 vector 
contains a leaky T7 promoter and was used to for bacterial expression of recombinant 
proteins (Way et al., 1990). Both of these vectors contained a GFP or GST tag at the N-
terminus of the protein of interest. The pBlueScript SKII vector and the pJS4 vector 
were used for the expression of targeting constructs during the generation of viral 
recombinants (Chakrabarti et al., 1997). Constructs used throughout this thesis are listed 
in Table 2.3. 
 
Table 2.3 Expression vectors 
Vector Figure Generated by 
pEL-GFP-stop 
3.2, 3.3, 3.4, 
4.1, 5.13, 6.2 
Rietdörf et al., 2001 
pEL-GFP-A36 24-211 
3.2, 3.3, 3.4, 
4.1, 5.13, 6.2 
I. Weisswange 
pEL-GFP-A36 WE/AA 3.2 Dodding et al., 2009 
pEL-GFP-A36 WD/AA 3.2 Dodding et al., 2009 
pEL-GFP-A36 WEWD/AAAA 3.2 Dodding et al., 2009 
pEL-GST-stop 3.3 Rietdörf et al., 2001 
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pEL-GST-A36 24-221 3.3, 6.2 I. Weisswange 
pEL-GST-A36 (24-118, 24-155, 24-169, 24-186, 
24-197, 24-210) 
3.3 I. Weisswange 
pEL-GST-A36 (35-221, 55-221, 82-221, 118-
221, 155-221, 186-221, 197-221) 
3.3 X. Snetkov 
pEL-GST-A36 120-155 6.2 I. Weisswange 
pEL-GFP-A36 (24-197, 24-186, 155-221, 186-
221) 
3.3 X. Snetkov 
pEL-GFP-A36 (88-155, 88-141, 88-133, 120-155, 
120-141, 120-133, 24-120, 35-120, 55-120, 88-
120) 
6.2 X. Snetkov 
pEL-GFP-A36 24-221 
∆NPF1, ∆NPF2, ∆NPF3, ∆NPF1-3 
3.4 X. Snetkov 
pEL-GFP-Intersectin-1L 3.4 A. Humphries 
pEL-GFP-Intersectin-1L ∆EH 3.4 X. Snetkov 
pMW172-GST-Intersectin-1L-EH1-2 3.6 X. Snetkov 
pMW172-GST-Eps15-EH1-3 3.6 X Snetkov 
pMW172-GST-Intersectin-1L-EH1 3.6 X. Snetkov 
pMW172-GST-Intersectin-1L-EH2 3.6 X. Snetkov 
BS SKII-LA-A36R-RA 
Targeting vector 
4.4, 4.5 X. Snetkov 
BS SKII-LA-A36R ∆NPF1-RA 
Targeting vector 
4.4, 4.5 X. Snetkov 
BS SKII-LA-A36R ∆NPF2-RA 
Targeting vector 
4.4, 4.5 X. Snetkov 
BS SKII-LA-A36R ∆NPF3-RA 
Targeting vector 
4.4, 4.5 X. Snetkov 
BS SKII-LA-A36R ∆NPF1-3-RA 
Targeting vector 
4.5 X. Snetkov 
BS SKII –LA-RFP-A3-RA 
Targeting vector 
4.5 S. Schleich 
BS SKII-LA-A36R-YdF-∆NPF1-3-RA 
Targeting vector 
5.13 X. Snetkov 
pEL-GFP-Nck 4.11 Frischknecht et al., 1999 
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pEL-GFP-Grb2 4.11 N. Scaplehorn 
pEL-GFP-WIP 4.11 M. Zettl 
pEL-GFP-N-WASP 4.11, 5.9, 5.10 Frischknecht et al., 1999 
pEL-GFP-N-WASP H208D 5.7, 5.10 Moreau et al., 2000 
pEL-GFP-A36-YdF 5.13 Frischknecht et al., 1999 
JS4-4b-A36R Targeting vector 5.5 X. Snetkov 
JS4-4b-A36R ∆NPF1-3 Targeting vector 5.5 X. Snetkov 
pEL-GST-Cdc42 5.10 J. Cordiero 
pEL-GFP-Cdc42 5.9 Moreau et al., 2000 
 
2.3.2 Polymerase Chain Reaction 
PCR was used to amplify plasmid DNA and to insert suitable restriction sites for sub-
cloning. A typical 100 µl PCR reaction contained 100 ng of template DNA, 1 µM of 
forward and reverse primer, 1 x Phusion HF buffer, 1 µM dNTP mix (0.25 µM of each 
nucleotide), and 2 units of Phusion High Fidelity DNA polymerase (NEB). PCR 
reactions were performed using an Applied Biosystems GeneAmp PCR machine under 
the following conditions: 
 
1. 95°C 1 minute  
 
2. 
 
95°C 
 
15 seconds 
 55°C 
 
72°C 
30 seconds 
 
30 seconds / kb of product length 
 
 
25 cycles 
 
3. 
 
72°C 
 
10 minutes 
 
 
The PCR reaction was resolved on a 1% agarose gel (made in 1 x TBE) containing 
1:10,000 SYBR safe DNA gel stain (Invitrogen). The PCR product was visualised at 
470 nm using a Safe Imager (Invitrogen). The desired PCR product was cut from the gel 
and purified using the Qiagen QIAquick gel extraction kit. The PCR product was eluted 
35 µl of distilled water to be used for subsequent subcloning. 
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2.3.3 Overlap PCR 
This method was used to generate A36 ∆NPF mutants used throughout this thesis. Two 
sets of internal primers were designed containing the necessary mutations. Mutations 
were designed in the center of the complementary sequence, flanked by 20 bp of 
complementary sequence on either side (Table 2.4). Two initial PCR reactions were 
carried out to amplify the segments of the gene containing the point mutations. These 
PCR products were gel purified and final PCR reaction was carried out using a 1:1 
mixture of these products as a template. Forward and reverse primers containing the N 
and C-terminal restriction sites were used in the final PCR reaction and the resulting 
product was cloned into the desired vector. 
For each reaction the following PCR mix was prepared containing: 100 ng DNA, 10 
pmol of each primer, 1x Phusion HF buffer, 1 µM dNTP mix (0.25 µM of each 
nucleotide) and 2 units of Phusion High Fidelity DNA polymerase (NEB) in 100 µl total 
volume. The PCR reaction was carried out under the following conditions: 
 
1. 95°C 5 minute  
 
2. 
 
95°C 
 
30 seconds 
 55°C 
 
72°C 
30 seconds 
 
1 minutes             25 cycles 
 
 
 
3. 
 
72°C 
 
7 minutes 
 
 
Table 2.4. Primers used for mutagenesis 
Construct Primer sequence 
A36 ∆NPF1 For 
                    Rev 
GAATCCTAACTATTCATCCGCCGCCGCCGTAAATTATAATAAAAC 
GTTTTATTATAATTTACGGCGGCGGCGGATGAATAGTTAGGATTC 
A36 ∆NPF2 For 
                    Rev 
GTATTTGTAGCAAGTCAGCCGCCGCCATTACAGAACTCAAC 
GTTGAGTTCTGTAATGGCGGCGGCTGACTTGCTACAAATAC 
A36 ∆NPF3 For 
                    Rev 
CAATAAATTTAGTGAGAATGCCGCCGCCAGACGAGCACATAGC 
GCTATGTGCTCGTCTGGCGGCGGCATTCTCACTAAATTTATTG 
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2.3.4 Sub-cloning 
Insert and vector DNA was digested in a 20 µl reaction volume containing 10U of 
restriction enzyme (NEB) and the corresponding NEB buffer. The digestion mix was 
incubated at 37°C for 2 hrs. The digestion reaction was resolved on a 1% (w/v) agarose 
gel and the desired products purified using the Qiagen QIAquick gel extraction kit and 
eluted in 35 µl of distilled water as described above. Ligation reaction were performed 
at a 3:1 insert to vector ratio. Ligation reactions contained 1 x T4 ligase buffer and 
200U T4 ligase (NEB) and were incubated for 1 hr at room temperature. The ligation 
reactions were subsequently transformed into chemically competent XL-10 E.coli cells.  
 
2.3.5 Bacterial transformation  
To transform competent bacteria, 50 ng of plasmid DNA (or total ligation reaction) was 
incubated with 25 µl of chemically competent XL-10 cells on ice for 15 min. Bacteria 
and DNA were heat shocked at 42°C for 45 seconds and placed on ice for a further 5 
min. 100 µl of LB was added to the transformation mix, and incubated shaking at 
37°C for 30 min. The bacterial culture was spread on LB-agar plates containing the 
appropriate antibiotics and incubated at 37°C overnight.  
 
2.3.6 Colony screening by PCR 
To identify XL-10 colonies containing the insert of interest, colony screening by PCR 
was performed following the transformation of cloning ligation reactions. Bacterial 
colonies were picked and transferred into a 25µl PCR reaction composed of: 1x PCR 
buffer, 1.5 mM MgCl2, 0.5 µM of each primer, 1 mM dNTP mix (0.25 mM each 
nucleotide) and 5 U/µl Taq DNA Polymerase (Invitrogen). The PCR reaction was 
carried out under the following conditions: 
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1. 95°C 10 minute  
 
2. 
 
95°C 
 
30 seconds 
 55°C 
 
72°C 
30 seconds 
 
1 minutes             30 cycles 
 
 
 
3. 
 
72°C 
 
10 minutes 
 
2.3.7 Preparation of chemically competent bacteria 
To prepare chemically competent XL-10 cells a 5 ml starter culture was incubated at 
37°C overnight. 500 ml of LB media was inoculated with 2 ml of starter culture and 
incubated at 37°C until the bacteria reached the exponential growth phase at an OD600 = 
0.5. The bacterial culture was then incubated on ice for 30 min, prior to centrifugation at 
2500 rpm for 12 min. The bacterial pellet was resuspended in RF1 buffer, and incubated 
on ice for 15 min and centrifuged at 2500 rpm for 10 min. The pellet was placed on ice 
and resuspended in 7 ml of RF2 buffer. Resuspended cells were snap frozen in liquid 
nitrogen, aliquoted and stored at -80°C. 
 
RF1 Buffer 
12 g   Rubidium chloride 
9 g Manganese chloride 
2.94 g  Potassium acetate 
150 g Glycerol 
The reagents above were dissolved in 900 ml distilled water, and pH adjusted to 5.8 to a 
final volume of 1 L. RF1 was filtered through a 0.45 µm filter and stored at 4°C. 
 
RF2 Buffer 
2.09 g MOPS 
1.2 g   Rubidium chloride 
11 g Calcium chloride 
150 g Glycerol 
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The reagents above were dissolved in 900 ml distilled water, and pH adjusted to 6.8 to a 
final volume of 1 L. RF2 was filtered through a 0.45 µm filter and stored at 4°C. 
2.3.8 Plasmid DNA preparation 
XL-10 cultures from a single bacterial colony were grown in LB containing the 
appropriate antibiotic (typically 100 µg/ml ampicillin) shaking overnight at 37°C. 
Plasmid DNA was purified from XL-10 overnight cultures using Qiagen Miniprep kit 
according to manufacturers instructions.  
2.3.9 DNA sequencing 
To confirm the correct sequence of newly generated constructs, primers were designed 
flanking the region interest. The sequencing PCR reaction contained: 200 ng of plasmid 
DNA, 3.2 pmol primer, and 8 µl BDTv3.1 reaction mix (Big Dye Terminator Cycle 
sequencing kit), and the following cycling conditions were carried out: 
 
1. 95°C 1 minute  
 
2. 
 
95°C 
 
10 seconds 
 55°C 
 
60°C 
5 seconds 
 
4 minutes             25 cycles 
 
 
3. 12°C ∞  
 
The PCR product was then purified using DyeEx columns (Qiagen) and vacuum dried. 
Sequencing was performed by the LRI equipment park facility. 
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2.4 Vaccinia Virus 
Throughout this thesis the wild-type vaccinia strain used is the Western Reserve strain 
(WR). Recombinant viruses are listed in Table 2.5. 
 
Table 2.5. Recombinant viruses used in this thesis 
Virus Source 
∆A36R Geoffrey Smith (Parkinson and Smith, 1994) 
A36 WEWD-AAAA Dr Mark Dodding (LRI) 
A36 YdF Anna Holmström (Rietdörf et al., 2001) 
A36 1-155 stop Dr Ina Weisswange (LRI) 
∆A36R YLDV-126L Dr Mark Dodding (LRI) 
A36 ∆NPF1 X.Snetkov 
A36 ∆NPF2 X.Snetkov 
A36 ∆NPF3 X.Snetkov 
A36 ∆NPF 1-3 X.Snetkov 
A36late  X.Snetkov 
A36 ∆NPF1-3late X.Snetkov 
A36 YdF-∆NPF X.Snetkov 
 
2.4.1 General buffers for virology 
Tris buffer 
10mM Tris-HCl pH 9 
2mM  MgCl2 
Made up in distilled water and filter sterilised using a 0.22µm filter. 
 
Sucrose cushion: 35% sucrose (w/v) in Tris buffer 
 
Crystal violet 
0.1%  Crystal violet (w/v) 
20% Ethanol 
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Viral lysis buffer 
10mM Tris-HCl pH 9 
10mM  KCl 
3mM  Mg(CH3COO)2 
Made up in distilled water and filter sterilised using a 0.22 µm filter. 
2.4.2 Sucrose Purification of vaccinia virus 
HeLa cells were grown in 15 cm2 culture dishes to a confluency of 90%. Cells were 
infected with vaccinia virus at a multiplicity of infection (MOI) = 0.1 for 48-72 hours 
until all cells displayed clear cytopathic effect (CPE). Media was removed and cells 
were harvested in 7 ml of PBSA. Infected cells were centrifuged for 7 minutes at 
1,700rpm and were washed once in PBSA. The infected cell pellet was re-suspended in 
7mls of Tris Buffer and cells sheared by 20 strokes of a 7ml Dounce homogenizer 
(Wheaton). The resulting solution was centrifuged at 1,700rpm for 7 minutes, to remove 
nuclei and cell debris, and the viral supernatant was stored at -20ºC. Viral supernatant 
was thawed at roomed temperature and was carefully layered onto an 8 ml 35% sucrose 
cushion in Beckman SV40 ultracentrifuge tubes, and made to a total volume of 30 ml 
with Tris buffer. The viral supernatant was centrifuged at 24,000 rpm for 30 mins in a 
Beckman Optima L-100 XP ultracentrifuge. The viral pellet was re-suspended in Tris 
buffer and stored in 100µl aliquots at -80°C. 
2.4.3 Plaque Assay 
Plaque assays were used in the generation of recombinant viruses, to determine the titer 
of viral stocks, to assess cell-to-cell spread, and to quantify EEV release.  BS-C-1 cells 
were plated at 2 x 105 in 6 well dishes, forming a confluent monolayer after 24 hours. 
Viral preparations were sonicated and serially diluted 1:10 in 1ml of serum free MEM. 
The culture media was removed from the BS-C-1 cells and replaced with 10-5, 10-6 and 
10-7 dilutions of virus. After 1 hour of viral adsorbsion, serum free MEM was removed 
and replaced with a semi-solid overlay of 1 x MEM, 2% FCS and 1.5% carboxy-methyl 
cellulose. After 48 hours, the overlay was removed, cells were washed thoroughly with 
PBSA and fixed with 2% paraformaldehyde (PFA) in PBSA for 1 hour. Plaques were 
visualized with crystal violet staining for 30 mins. The plaque forming unit per ml 
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(PFU/ml) was determined by counting the number of cell cleared viral plaques per 
dilution, where plaques are both discernible and isolated.  
Plaque assays performed in N-WASP null cell lines were performed as above.  
2.4.4 Infection 
The multiplicity of infection (MOI) was calculated from the PFU of the viral stock and 
the number of cells per experiment. A MOI of 2 was used to infect cells for 
immunofluorescence and live-cell imaging. Prior to infection, viral aliquots were 
sonicated in a water bath for 30 seconds. Cells were washed and the appropriate volume 
of virus was added to cells in serum free MEM. 1 hour post infection serum free MEM 
was removed and was replaced for complete MEM. Cells were incubated at 37°C and 
fixed or imaged 8 hours post infection. 
2.4.5 EEV release assays 
To quantify EEV release, BS-C-1 cells were seeded at a density of a 1 x 105 in a 12 well 
dish, forming a confluent monolayer after 24 hrs. Cells were infected in triplicate at an 
MOI = 0.1 in all experiments. At 1 hour post infection, serum free MEM was removed 
and cells were washed twice with fresh serum free MEM. Complete media was added to 
cells and infection was allowed to proceed at 37°C. After 16 hours of infection, 
complete MEM was carefully harvested and the viral titer was immediately determined 
by plaque assay on pre-plated confluent BS-C-1 dishes as in 2.5.3. BS-C-1 cells were 
infected in duplicate with 10-1 or 10-2 dilutions of viral media, and EEV release 
quantified in PFU/ml.  
2.4.6 Single step growth curve 
Single step growth curves were carried out to determine replication dynamics of newly 
generated recombinant viruses. BS-C-1 cells in a 6 well dish were infected in duplicate 
at an MOI = 10. The inoculum was removed 1 hour post infection and cells washed 
twice with complete MEM. At 0, 4, 8, 12, and 24 hpi, the supernatant was removed and 
infected cells were collected. To collect the cell associated virus fractions, 2 ml of fresh 
complete MEM was added to cells and cells were thoroughly scraped into the media. 
Cell associated virus fractions were freeze/thawed three times in liquid nitrogen/37°C 
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incubator. Samples were sonicated and each time point was titrated by plaque assay as 
in 2.5.3. Each time point was titrated in triplicate. 
2.4.7 Drug treatments during infection 
HeLa cells and N-WASP MEF cell lines were treated with inhibitors at the indicated 
time prior to infection and maintain throughout infection, at the following 
concentrations: 
 
Table 2.6 List of inhibitors 
Compound Concentration Incubation time Source 
AraC 50 µM 1 hr prior to infection  
ZCL128 50 µM 1 hr prior to infection  Tocris 
 (Friesland et al., 2013) 
 
2.4.8 Amplification of vaccinia DNA 
Touch-down PCR 
 
Touch down PCR was used to amplify DNA from vaccinia genomic DNA from an 
aliquot of sucrose-purified WR virus. Approximately 1µl of vaccinia genomic DNA 
was added to a standard PCR mix (2.4.2) and the following PCR reaction was 
performed: 
1. 95°C 1 minute  
 
2. 
 
95°C 
 
20 seconds 
 65°C 
 
72°C 
20 seconds    - 1°C / cycle     
 
1 minute  
 
 
10 cycles 
 
3. 
 
    95°C 
 
        20 seconds 
 
 55°C 
 
    72°C 
20 seconds 
 
        1 minute  
 
25 cycles 
 
4. 
 
72°C 
 
10 minutes 
 
  Chapter 2. Materials & Methods 
 
 77 
2.4.9 Recombinant viruses 
During this thesis two approaches were used to generate recombinant viruses. The first 
approach used was the insertion of the A36R gene containing ∆NPF mutations into the 
WR-∆A36R locus via homologous recombination. The second approach was the 
introduction of the 4b-A36R / 4b-A36R-∆NPF gene into the thymidine kinase (TK) 
locus of the WR-∆A36R genome. This virus was used to study the role of early A36R 
expression during actin tail formation. Targeting vectors were cloned into pBlueScript / 
pJS4 vectors (Table 2.3). In both cases, the A36R gene was flanked on either side by 
300bp of genomic DNA, homologous to the left and right regions flanking the targeting 
locus of the virus (Figure 4.5, 5.5). 
 
To generate recombinants, HeLa cells were infected with ∆A36R at a MOI of 0.1. At 2 
hpi cells were transfected with the 4 µg of targeting vector using Lipofectamine 2000 
(Qiagen), according to the manufacturer’s protocol (2.3.3). 24 hours post 
infection/transfection, media was removed and cells were scraped into 500 µl of viral 
lysis buffer. The infected cell lysate was freeze/thawed three times in liquid 
nitrogen/37°C incubator. Confluent monolayers of BS-C-1 cells in 6 well dishes were 
infected with 1:10 serial dilutions of the infected cell lysate in serum free MEM, and 
overlaid with carboxy-methyl cellulose (2.5.3). After 24 hours, plaques were identified 
in BS-C-1 monolayers on a widefield microscope using phase contrast to search for 
isolated cell clearance. To obtain recombinants, cells were stained with a neutral red to 
reveal plaques. A36R-recombinants resulted in a rescue of plaque size compared to 
those induced by ∆A36R. This allowed the selection of the virus of interest based on 
size. Plaques were transferred with a p1000 pipette tip into 250 µl viral lysis buffer, and 
freeze/thawed as before. For subsequent rounds of plaque purification 50 µl of the 
picked plaque solution was used to infect BS-C-1 monolayers as before. Recombinant 
virus purity was confirmed by analytical PCR using primers pairs that amplified the 
target locus and distinguished between parental and recombinant virus, by size of the 
PCR product (2.5.10). Positive plaques were than used to infect confluent monolayers 
of BS-C-1 cells for a repeated round of plaque assays. Following four rounds of 
purification two positive plaques were amplified in 15 cm dishes of HeLa cells and 
sucrose purified to obtain a pure viral stock (2.5.2). 
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2.4.10 Analytical PCR from plaque picks 
In order to assess correct insertion during viral homologous recombination plaques 
selected during the generation of recombinant viruses were re-suspended in 250 µl Tris 
buffer and freeze/thawed three times. A digestion mix containing 16 µl of viral 
suspension, 2 µl of 10µg/ml Proteinase K (Fluka), and 3 µl of 10x Taq PCR buffer 
(Invitrogen), made up to a 25 µl volume was incubated for 20 minutes at 56°C followed 
by 10 minutes at 85°C. The mixture was then supplemented with 1mM dNTPs, 0.5 µM 
of each primer, 1.5mM MgCl2 and 5 U/µl Taq DNA Polymerase (Invitrogen). The 
PCR reaction was performed as using the following conditions and the reaction product 
analysed on a 1% agarose gel as before. 
 
1. 95°C 5 minute  
 
2. 
 
95°C 
 
20 seconds 
 50°C 
 
72°C 
30 seconds     
 
2 minute           30 cycles 
 
 
 
4. 
 
72°C 
 
10 minutes 
 
 
2.5 Biochemistry 
2 x Final sample buffer (FSB) 
125mM Tris HCl pH6.8 
4%  SDS 
20%  Glycerol 
10% B-mercaptoethanol 
+ Bromophenol blue 
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2.5.1 SDS-PAGE 
To determine A36 expression during infection or to assess the efficiency of siRNA 
knockdown, cells were lysed directly into 2 x FSB and samples boiled for 10 minutes at 
95ºC. Samples were loaded onto 4-12% Bis-Tris or 8% Tris-acetate NuPAGE pre cast 
gels (Invitrogen), and resolved for 1 hour at 175 V. SeeBluePlus2 protein standards 
(Invitrogen) were used as reference. 
2.5.2 Immunoblot Analysis 
Proteins resolved by SDS-PAGE were transferred onto nitrocellulose membranes using 
the iBlot semi-dry transfer system (Invitrogen) at 23V for 7 minutes or 20V for 10 
minutes for large proteins. Membranes were incubated in blocking buffer (5% Milk in 
PBS-T (Phospho-buffered saline + 0.1% Tween20) for 30 minutes prior to overnight 
incubation with primary antibody in blocking buffer at 4ºC (Table 2.7). Membranes 
were washed three times with PBS-T, and then incubated with HRP-conjugated 
secondary antibody (Jackson ImmunoResearch) diluted 1:5000 in blocking buffer for 30 
minutes at room temperature. Membranes were washed three times with PBS-T, and 
incubated with ECL reagent (Amersham Biosciences) for 5 minutes. The membrane 
was exposed on Hyperfilm-ECL (Amersham Biosciences). Immunoblots were 
developed using an IGP compact automated developer (IPG limited). 
 
Table 2.7 Antibodies used for immunoblot analysis 
Primary Antibody Species Dilution Source 
GST Rabbit 1:2500 Sigma 
GFP (3E12) Mouse 1:2500 CRUK  
AP-2 – alpha Adaptin (M11)  Mouse 1:1000 Thermo Scientific 
Intersectin-1 Mouse 1:1000 BD Biosciences 
Intersectin-2 Rabbit 1:1000 Peter McPherson (McGill) 
Eps15 Rabbit 1:1000 BD Biosciences 
Eps15R Mouse 1:1000 Abcam 
A36 Rabbit 1:2500 Dr S.Cudmore (Way Lab) 
Vincullin Mouse 1:1000 Cell Signalling  
Grb2 Mouse 1:1000 Cell Signalling  
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Secondary Antibody Species Dilution Source 
HRP-Rabbit Goat 1:5000 Jackson Immunoresearch 
HRP-Mouse Goat 1:5000 Jackson Immunoresearch 
HRP-Rat Goat 1:5000 Jackson Immunoresearch 
 
2.5.3 GST pull-down assay 
HeLa cells at 80% confluency in 10 cm dishes were infected with vaccinia virus 
(typically ∆A36R) in serum free MEM. 1 hour post infection the media was changed, 
and the relevant pE/L-GST-tagged constructs were transfected into cells using Effectene 
(2.3.1). 16 hours post infection/transfection, media was removed and the cells were 
washed 1 x with PBSA on ice.  PBSA was subsequently removed and 300 µl of GST 
lysis buffer added. Cells were scraped into the lysis buffer, transferred to an eppendorf, 
and rotated at 4°C for 10 mins. Cell lysates were clarified at 13,000 rpm at 4°C for 5 
mins and the supernatant retained. 30 µl of the lysate was retained as an input sample, to 
which 30 µl of FSB was added. 20 µl of pre-washed glutathione sepharose beads 
(Amersham biosciences) were added to cell lysates and the mixture rotated for 2 hrs at 
4°C. Glutathione beads were then washed 3x with ice-cold wash buffer, and finally 
resuspended in 30 µl of FSB. Glutathione beads and input samples were boiled at 95°C 
for 10 mins and samples resolved by SDS-PAGE (2.6.1). 
 
GST Lysis buffer 
50 mM  Tris.HCl, pH7.5 
150 mM  NaCl 
0.5 mM  EDTA 
0.5%  NP-40 
0.5%  Triton-X 
1 x Protease Inhibitor 
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GST Wash buffer 
50 mM  Tris.HCl, pH7.5 
150 mM  NaCl 
0.5 mM  EDTA 
1 x  Protease Inhibitor 
2.5.4 GFP-Trap 
HeLa cells at 80% confluency in 10 cm dishes were infected with vaccinia virus 
(typically ∆A36R) in serum free MEM. 1 hour post infection the media was changed, 
and the relevant pE/L-GFP-tagged constructs were transfected into cells using Effectene 
(2.3.1). 16 hours post infection/transfection, media was removed and the cells were 
washed 1 x with PBSA on ice. PBSA was subsequently removed and 300 µl of GFP 
lysis buffer added. Cells were scraped into the lysis buffer, transferred to an eppendorf, 
and rotated at 4°C for 10 mins. Cell lysates were clarified at 13,000 rpm at 4°C for 5 
mins and the supernatant retained. Lysates were diluted with the addition of 500 µl of 
wash buffer. 30µl of the diluted lysate was retained as an input sample, to which 30 µl 
of FSB was added. 20 µl of pre-washed GFP-Trap beads (Chromotek) were added to 
cell lysates and the mixture rotated for 2 hrs at 4°C. GFP-Trap beads were then washed 
3 x with ice-cold wash buffer, and finally resuspended in 30 µl of FSB. GFP-Trap beads 
and input samples were boiled at 95°C for 10 mins and samples resolved by SDS-PAGE 
(2.6.1). 
 
GFP-Trap Lysis buffer 
10 mM  Tris.HCl, pH7.5 
150 mM  NaCl 
0.5 mM  EDTA 
0.5%  NP-40 
1 x  Protease Inhibitor 
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GFP-Trap Wash buffer 
10 mM  Tris.HCl, pH7.5 
150 mM  NaCl 
0.5 mM  EDTA 
1 x Protease Inhibitor 
2.5.5 Immunoprecipitation 
Intersectin-1 immunoprecipitation was carried out using the ESE-1 antibody (BD 
Biosciences). For each condition a 10 cm dish of HeLa cells was infected with ∆A36R 
and transfected with GFP-A36 (2.3.1). At 16 hpi cells were lysed in 1 ml of GFP-Trap 
lysis buffer, and centrifuged for 10 mins at 13,000rpm. Clarified cell lysates were 
incubated with 30 µl prewashed Protein-G resin (Pierce) for 1 hr at 4°C. Resin was 
pelleted at 2000 rpm and cell lysates were transferred to a fresh tube. 30 µl of lysate was 
retained as input fraction. 5 µg of ESE-1 antibody was added to lysates and incubated 
rotating at 4°C overnight. 30 µl of prewashed Protein-G resin was added to cell lysates 
and incubated with each sample for 1 hr at 4°C. Resin was pelleted at 2000 rpm and 
washed 3 x with GFP-Trap wash buffer. Resin was boiled for 10 mins in FSB and 
analyzed by SDS-PAGE and immunoblot (2.6.1, 2.6.2).  
2.5.6 Expression and purification of GST-EH domains  
GST Binding buffer 
50 mM  Tris-HCl pH 7.5 
250 mM NaCl 
2 mM  DDT 
2 mM  CaCl2 
1 x  Protease Inhibitor 
 
GST Elution buffer 
GST Binding buffer + 10 mM glutathione 
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2.5.6.1 Leaky Protein Expression  
BL21 (DE3) Rosetta E.coli were transformed with pMW172-GST-intersectin-1 EH1-2 
or pMW172-GST-Eps15 EH1-3. A single colony was used to inoculate a 5ml starter 
culture (LB-ampicillin). This was grown for 5 hrs at 37°C with vigorous shaking. 1 ml 
of starter culture was used to inoculate a 1 L culture (LB-ampicillin), and this was 
grown overnight shaking at 30°C. Bacteria was harvested at 5000 rpm for 15 minutes 
at 4°C and the resulting bacterial pellet snap frozen in liquid nitrogen. The bacterial 
pellet was thawed on ice and resuspended in 10 ml of GST binding buffer with the 
addition of 10 µl DNase. The bacterial total lysate was lysed by sonication. Lysates 
were clarified at 10,000 rpm for 30 mins at 4°C. GST-tagged recombinants were 
subsequently purified from the resulting bacterial soluble fraction. 
2.5.6.2 Purification of GST-EH domains 
GST sepharose resin (GE Amershem) was pre-equilibrated with 3 x washes with GST 
binding buffer. GST resin was added to the bacterial soluble fraction and incubated for 
3 hours rotating at 4°C. Following binding, the unbound fraction was removed and 
GST resin was washed with 3 x GST buffer. GST-EH domains were eluted in 2 ml 
fractions of GST elution buffer overnight at 4°C. Protein purity in wash fractions and 
elution fractions was assessed by SDS-PAGE analysis and coomassie staining (2.6.1).  
Protein concentrations were measured by spectrophotometry (absorbance at 280 nm) 
using a NanoDrop spectrophotometer (Thermo Scientific).  
2.5.7 Peptide pull-down assays 
The A36158-197 peptides used in Figure 3.6 were obtained from the peptide synthesis 
facility and synthesised with an N-terminal Biotin tag. Streptavidin beads (M-280 
Dynabeads – ThermoFisher Scientific) were washed 4 x with PBSA. Peptides in PBSA 
were coupled to beads for 30 minutes, rotating at room temperature. 20 mg of peptide 
was used per pull-down. Uncoupled peptide was removed by 3 x washes with PBSA. 
Peptide loaded Streptavidin beads were resuspended in 500 µl of GST binding buffer 
and 5 µg of purified GST-EH domains was added per pull-down. Streptavidin coupled 
peptides were incubated with recombinant protein for 3 hours rotating at 4°C. Unbound 
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recombinant protein was removed and Stretavidin beads were subsequently washed 4 
x in GST binding buffer. Beads were resuspended in 30 µl of FSB and boiled for 
10mins. Binding of recombinant protein to Streptavidin coupled beads was assessed 
by SDS-PAGE (2.6.1). Gels were stained with coomasie to visualise bound protein. 
2.5.8 Probing peptide arrays 
The A36 peptide arrays used in Figure 3.2 were generated by the peptide synthesis 
laboratory at Cancer Research UK. Arrays comprised of 15-mer peptides that were 
synthesised and spotting onto a nitrocellulose membrane. Adjacent peptides were 
shifted by 1 amino acid each time. To carry out far western analysis, dried peptide 
arrays were pre-rinsed in 100% ethanol and subsequently washed 3 times in PBSA for 
10 minutes each time. The array was blocked with blocking buffer (5% milk in PBS-T) 
for 1 hour. Peptide arrays were probed with cell lysates treated with AllStar or AP-2 
siRNA for 48 hours prior to incubation. Total protein concentration of lysates was 
equalized prior to incubation with peptide arrays. Peptide arrays and cell lysates were 
incubated for 2 hours at 4°C. Peptide arrays were then washed thoroughly 4 x 10 min 
with blocking buffer and incubated with mouse anti-AP-2 antibody (1:5000) for 1 
hour at room temperature. Primary antibody was removed and arrays were incubated 
and peptide arrays washed thoroughly 3 x 10 min with blocking buffer, followed by 
incubation with goat anti-mouse HRP conjugated secondary antibody (1:10000) for 45 
mins. This was followed by 4 x 10 min washes with PBS-T and 1 x 10 min wash with 
PBS-T + 500 mM NaCl to reduce non-specific binding. Peptide arrays were 
developed using ECL as described in 2.6.2. 
2.6 Imaging 
2.6.1 General reagents 
1 x Cytoskeletal buffer (CB) 
10 mM  MES, pH 6.1 
150 mM NaCl 
5 mM  EGTA 
5 mM  MgCl2 
5 mM  Glucose 
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Blocking buffer 
1%  BSA 
2%  FCS 
These reagents were dissolved in 1x CB, filtered through a 0.45 µm filter and stored 
in aliquots at -20°C. 
 
Mowoil 
2.4 g Mowoil 
6 g  Glycerol 
12 ml  
 
200 mM Tris.HCl, pH 8.5 
Mowoil and glycerol were added to 6 ml of distilled water. The mixture was then 
incubated stirring at room temperature, before the addition of Tris.HCl. This solution 
was then stirred for 10 mins at 60°C, and subsequently centrifugated at 5000 rpm for 5 
mins. Mowoil was stored in aliquots at -20°C. 
 
10% and 4% paraformaldehyde (PFA) 
10% stocks of PFA were made by dilution of 50 g of PFA in 500 ml of warm PBSA. 
The solution gently stirred and 1 M NaOH tablets were added until PFA had dissolved. 
After cooling at room temperature, the pH was adjusted to 7.5, and the solution filtered 
through a 0.45 µm filter and stored in aliquots at -20°C. 10% aliquots were thawed and 
freshly diluted to 4% with PBSA prior to use. 
2.6.2 Fixation 
For PFA fixation, cells were incubated with 4% PFA in PBSA for 15 mins and 
subsequently washed 1 x with PBSA.  
2.6.3 Immunofluorescence 
Coverslips were incubated with blocking buffer for 10 mins, prior to incubation with 
antibody. For extracellular virus labelling, the B5 antibody was added prior to 
permeabilisation of cells. In all other cases, cells were permeabilised for 45 seconds 
with 0.1% Triton-X in PBSA. Coverslips were washed 3 x with PBSA. Cells were 
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incubated with primary antibody in blocking buffer for 1 hr, before washing 3 x with 
PBSA. Secondary antibodies diluted 1:500 in blocking buffer were then added for 30 
mins. F-actin was stained using Phalloidin, which was diluted 1:1000 in blocking buffer, 
and was added at the same time as secondary antibody. Secondary antibodies were 
removed and cells incubated with DAPI (300 nM in PBS) for 2 mins.  Cells were finally 
washed 3 x with PBSA, 1 x with distilled water, and mounted using Mowoil on 
microscopy slides.  
 
Table 2.8 Primary antibodies used for immunofluorescence  
Antibody Species Dilution Source 
B5 Rat 1:1000 Gerhardt Hiller 
CHC Rabbit 1:500 Abcam 
AP-2 alpha Adaptin  Mouse 1:500 Abcam 
Intersectin-1 Mouse 1:500 BD Biosciences 
Intersectin-2 Rabbit 1:500 Peter McPherson (McGill) 
Eps15 Rabbit 1:500 BD Biosciences 
Eps15R Rabbit 1:500 Abcam 
A36 Rabbit 1:250 Dr S.Cudmore (Way Lab) 
Phalloidin   1:1000 Molecular probes 
 
2.6.4 Antibody staining of viral plaques 
Plaques in A549 and N-WASP cell lines were additionally visualized using the B5 
antibody. After fixation of infected 6 well dishes, cells were permeabilised for 2 mins 
with 0.1% Triton-X in PBSA. Cells were washed 3 x with PBSA and incubated with B5 
antibody in blocking buffer at a dilution of 1:1000 for 1 hour with gentle rocking, 
before washing 3 x with PBSA. Cells were next incubated with anti-rat HRP conjugated 
secondary antibody diluted 1:1000 in blocking buffer for 45 mins with gentle rocking. 
Cells were washed 3 x with PBSA and 0.5 ml of TMB peroxidase substrate (Sigma) 
was then added to each well, and left to develop for 5-15 mins with gentle rocking. 
Once plaques were visible, the substrate was removed, cells were washed with distilled 
water, and the plate left to dry. 
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2.6.5 Microscopes 
Zeiss Axioplan Upright 
For imaging of fixed samples, a Zeiss Axioplan2 microscope equipped with a 
Photometrics Cool Snap HQ cooled CCD camera, external Prior Scientific filter wheels 
(DAPI; FITC; Texas Red; Cy5) and a 63x / 1.4 Plan Achromat objective was used. The 
system was purchased from Zeiss and Universal Imaging Corporation Limited and was 
controlled with MetaMorph 6.3r7 software. Images were analysed using the MetaMorph 
software and were processed with the Adobe software package. 
 
Zeiss Inverted 
To view and select plaques during generation of recombinant viruses a Zeiss Axiovert 
200 equipped with a Photometrics Cool Snap HQcooled CCD camera, a Photometrics 
Cascade II camera, external Prior Scientific filter wheels (GFP, RFP) and a 10x/0.25 
Ph1 objective was used. The system was purchased from Zeiss and Universal Imaging 
Corporation Ltd. The system was controlled by the MetaMorph 6.3r7 software.  
 
Spinning-disk confocal 
Live-cell imaging of actin tails was carried out on a Zeiss Axio Observer microscope 
equipped with a Plan Achromat 63x / 1.4 Ph3 M27 oil lens, an Evolve 512 camera and a 
Yokagawa CSUX spinning disk. The system was purchased from 3i Intelligent Imaging 
Innovations and was controlled by Slidebook 5.0. Movies were analysed using either 
the Slidebook or MetaMorph software. 
2.7 Statistical Analysis 
Data in all graphs are presented as the standard error of the mean, unless otherwise 
stated. Prism 5.0 (GraphPad) was used to perform standard statistical analysis of data 
sets. A Student’s T-test was performed to compare two data sets. To compare multiple 
data sets a One Way Anova analysis was performed, followed by a Tukey Multiple 
Comparison to compare all pairs of samples. A p value of <0.05, <0.01 and <0.001 is 
represented as *, ** and ***, respectively. A P value > 0.05 was not considered 
statistically significant, and in this event the data was labelled, n.s., for not significant.
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Chapter 3. The C-terminus of A36 is essential for AP-2 
binding 
3.1 Introduction 
During vaccinia virus egress, the plasma membrane adaptor AP-2 and clathrin are 
recruited to cell-associated enveloped virions (CEV) following their fusion with the 
plasma membrane. The role that AP-2 and clathrin play during egress is yet to be fully 
elucidated. Thus far it has been shown that AP-2 and clathrin act to polarise A36 
beneath the virus (Humphries et al., 2012). This results in a clustered A36 signalling 
platform that stabilises N-WASP recruitment, to promote efficient Arp2/3 dependent 
actin polymerisation beneath the virion. The molecular mechanism governing AP-2 and 
clathrin recruitment to vaccinia, however, is still unknown. Earlier work from live cell 
imaging and indirect biochemical assays has shown that AP-2 is able to associate with 
A36 (Humphries et al., 2012). The observation that a C-terminal truncation of A36 
resulted in a similar long actin tail phenotype as cells depleted of AP-2 led to 
investigation of the requirement of the A36 C-terminus during AP-2 and clathrin 
recruitment.  
3.2 Results 
3.2.1 The C-terminus of A36 is essential for AP-2 binding 
Vaccinia A36 is a 221-residue integral membrane protein, which is predicted to be 
largely disordered, and almost entirely cytoplasmic in orientation (Rottger et al., 1999; 
van Eijl et al., 2000). Alongside pull-down data indicating that A36 can associate with 
AP-2, A36 may contain several potential AP-2 binding motifs mimicking the canonical 
YxxΦ, DExxxL[L/I], or DxF motifs (Figure 3.1 A) (Humphries et al., 2012; Kelly and 
Owen, 2011; Pond et al., 1995). This suggests that A36 may either directly recruit AP-2 
or conversely may require the presence of additional host factors to mediate clathrin 
recruitment. Other IEV proteins, such as F13 and B5, also containing potential adaptor 
binding motifs and may act in complex with A36 to mediate adaptor binding.  
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AP-2 and clathrin depletion both lead to an increase in actin tail length, a similar 
phenotype observed during infection with a recombinant virus expressing A36 truncated 
from residue 155 onwards (Humphries et al., 2012; Weisswange, 2008). To address the 
mechanism governing AP-2 recruitment, the initial characterisation of the role of A36 
was carried out. 
 
As a preliminary screen to identify AP-2 binding motifs present in A36, I utilised a far 
western approach. This method has been highly successful in the past to identify short 
interaction motifs following incubation with recombinant target proteins (Chen et al., 
2014; Donnelly et al., 2013; Postigo et al., 2006). In addition, far western peptide arrays 
have been utilised to identify novel AP-1 binding motifs (Maritzen et al., 2010). AP-2 is 
a large tetrameric complex composed of four subunits, thus purification and 
reconstitution is a challenge. In addition, it was unknown whether the association of 
A36 and AP-2 is direct or indirect, therefore as an initial approach, a far western screen 
of overlapping A36 peptides was probed with endogenous AP-2 complexes from HeLa 
cell extracts.  
 
An overlapping peptide array composed of 15-mer peptides spanning the sequence of 
A36, and shifted one residue per spot, was synthesised on a nitrocellulose membrane 
(schematic shown in Figure 3.1 B). This A36 peptide array was probed with cell lysates 
from HeLa cells that were treated with AP-2 or AllStar control (CTRL) siRNA in order 
to identify specific AP-2 binding sites (Figure 3.1 C). Successful AP-2 knock down was 
confirmed by immunoblot analysis prior to incubation with the membrane (Figure 3.2 
A). Finally, peptide arrays were subjected to immunoblot analysis using an anti-AP-2 
antibody. Two peptide spots were positive for AP-2 association and were absent from 
the A36 peptide array when cells were treated with AP-2 siRNA (Figure 3.2 A). These 
peptides corresponded to WEDHCSAMEQNNDVD and LIWDNESNVMAPSTE 
respectively. Interestingly these peptides contain the kinesin-1 binding WE and WD 
motifs (underlined) (Figure 3.2 B) (Dodding et al., 2011). Although not classical 
adaptor binding motifs, there have been reports of tryptophan-based motifs required to 
mediate both kinesin-1 recruitment and adaptor binding (Maritzen et al., 2010; Schmidt 
et al., 2009). Gadkin (also termed γ-BAR), is a key regulator of endosomal vesicle 
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recycling, and uses the WENDF motif as a novel link between the binding of the 
clathrin adaptor AP-1 and recruitment of kinesin-1 (Maritzen et al., 2010; Schmidt et al., 
2009). Immunofluorescence imaging of fixed HeLa cells infected with vaccinia WR 
(wild type Western Reserve strain) has shown that AP-2 only localizes to CEV after 
fusion with plasma membrane and is not present on particles positive for kinesin-1, 
suggesting that binding is mutually exclusive (Humphries et al., 2012). The mechanism 
for the dissociation of kinesin-1 from A36 is unknown, and it may be the case that the 
displacement of kinesin-1 is the direct result of competitive AP-2 recruitment.  
 
To examine the requirement of the A36 WE and WD motifs for AP-2 binding, a GFP-
Trap pull-down assay was carried out. HeLa cells were infected with the WR-∆A36R 
virus, in which the A36 coding region is deleted. Cells were then transiently transfected 
to express the cytoplasmic domain of A36 (residues 24-221), as well as the WE/AA, 
WD/AA, and WEWD/AAAA A36 mutants in which the respective tryptophan kinesin 
binding motifs are substituted with alanine residues. While GFP-A3624-221 was able to 
associate with AP-2 as previously reported, abrogating either of the WE/WD motifs 
alone or in combination did not affect the association of AP-2 to A3624-221 (Figure 3.2 
C).  
 
Previous work has shown that RNAi depletion of AP-2 during WR infection results in 
the production of significantly longer actin tails compared to control RNAi treatment 
(Humphries et al., 2012). As another assay to address whether or not the WE/WD 
motifs of A36 were required for AP-2 recruitment, the length of virus induced actin tails 
were measured following infection with WR or a virus expressing the full length A36 
WEWD/AAAA mutant under the endogenous A36 promotor. If the WE/WD motifs of 
A36 were required to mediate AP-2 recruitment it would be expected that abolishing 
these motifs would phenocopy AP-2 depletion and result in an increase in actin tail 
length. WR and the A36 WEWD/AAAA virus both, however, induced actin tails that 
were on average the same length (2.20 ± 0.03 µm and 2.14 ± 0.03 µm respectively) 
(Figure 3.2 D). Taken together these results suggest that the A36 WE/WD motifs do not 
play a functional role in the recruitment of AP-2 to the virus at the plasma membrane. 
Binding of the A36 peptides containing the WE/WD motifs to AP-2 may be an artifact 
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of high peptide density spotted on the far western array and/or the hydrophobic 
properties of tryptophan inducing non-specific binding to AP-2 and/or an intermediate 
binding partner. In addition, peptides adjacent to the WE and WD positive peptide spots 
identified, differ by one residue and therefore also contain these motifs, yet were unable 
to mediate AP-2 binding. Density and accessibility of A36 motifs required for AP-2 
binding on the CEV or affinity purified on GFP-Trap beads is likely to differ from 
peptides spotted on a far western array, and therefore may be more indicative of in vivo 
AP-2 and clathrin recruitment during vaccinia egress.  
          
Figure 3.1 A far western approach used to identify AP-2 binding to A36  
A Sequence of full-length vaccinia A36. The transmembrane domain is shown in green. 
Potential adapter binding sites are shown in red. B Overlapping peptides corresponding to the 
full-length sequence of A36 were spotted onto a nitrocellulose membrane. Peptides were 15 
amino acids in length and adjacent peptides shifted by 1 amino acid. C Peptide arrays were 
incubated with HeLa cell lysates and probed for AP-2 binding with an anti-AP-2 antibody 
(pink) followed by detection with a HRP-conjugated secondary antibody (purple).  
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Figure 3.2 A36 WE and WD motifs do not mediate AP-2 binding 
A Two distinct peptide spots were positive for AP-2 binding. Depletion of the α-adaptin subunit 
of AP-2 was confirmed by immunoblot analysis. Grb2 was used as a cellular loading control. B 
Vaccinia A36 sequence. The two positive peptide spots contain the WE (1) and WD (2) kinesin-
binding motifs of A36 (highlighted in red and blue respectively). Transmembrane domain is 
shown in green C Immunoblot following GFP-Trap pull-down assays determined that alanine 
substitution of the A36 WE and WD motifs individually or together, did not affect AP-2 binding 
to GFP-A3624-221. D Representative immunofluorescence images showing actin tails (red) 
induced by the A36 WEWD/AAAA virus additionally (green) remained the same as those 
induced by wild type A36 (green) 10 hours post infection (hpi). Quantification of actin tail 
length from N=300 tails over 3 independent experiments. ns indicates a p value > 0.05. 
α 
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In order to determine which region of A36 was therefore required to mediate AP-2 
binding, a series of C-terminally truncated constructs were generated by PCR from the 
largely disordered cytoplasmic domain of A36 (A3624-221) (Figure 3.3 A). A GST-alone 
control, GST-A3624-221, and a panel of GST-A36 C-terminal deletions were expressed 
under the exogenous viral pE/L promoter in ∆A36R infected HeLa cells. A glutathione 
pull-down assay was subsequently carried out on infected cell lysates to investigate the 
association of A36 with endogenous AP-2. Curiously, the GST-A36 construct that 
lacked the last 35 C-terminal residues (A3624-186) was unable to associate with AP-2 
(Figure 3.3 B). Conversely longer A36 constructs, A3624-197, A3624-210 and full length 
cytoplasmic A3624-221 could all bind AP-2 from cell lysates (Figure 3.3 B). 
 
To determine the boundaries required to mediate AP-2 binding, N-terminal truncations 
of cytoplasmic A36 were generated and expressed in the same manner as described 
above. In this case, residues 155-221 (A36155-221) were sufficient for AP-2 binding 
(Figure 3.3 C). AP-2 binding was abolished entirely from shorter constructs, A36186-221 
and A36197-221 (Figure 3.3 C).  Taken together this suggests that A36 residues 155-197 
are important for binding of AP-2. To confirm, pull-down assays were repeated using 
an alternative affinity tag. A36 deletion constructs were fused to GFP. GFP-alone, GFP- 
A3624-197, -A3624-186, -A36155-221, and -A36186-221 were transiently expressed in ∆A36R 
infected HeLa cells (Figure 3.3 D). In agreement with previous experiments, GFP-Trap 
pull-downs confirm that residues 186-197 and 155-186 were required for AP-2 binding, 
altogether suggesting that A36 residues 155-197 are required to mediate AP-2 binding 
to the virus during egress.  
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Figure 3.3 A36 residues 155-197 mediate AP-2 binding 
A Secondary structure of A36 showing alpha helices (red) and beta sheets (blue arrows) 
predicted using the JPred server (Drozdetskiy et al., 2015). The cytoplasmic domain of A36 is 
largely composed of disordered coiled regions. Highlighted in bold are the residues at which C-
terminal and N-terminal truncations were designed. Transmembrane domain is shown in green. 
B GST pull-down assays were carried out from HeLa cell lysates transfected with C-terminally 
truncated GST-A36. Immunoblot analysis shows that AP-2 binding requires residues 186-197 
of A36. A36 schematic below illustrating constructs which can mediate AP-2 binding (black) or 
are unable to bind AP-2 (red). C Immunoblot analysis from GST-pull-downs on N-terminally 
truncated GST-A36 constructs. A36, residues 155-197, are required to mediate AP-2 binding 
from cell lysates. Schematic of A36 binding below as in B. D Immunoblot analysis confirms 
AP-2 binding shown in B and C. GFP-Trap pull-downs from GFP-A36 transfected cell lysates. 
Dashed box depicts the region of A36 (155-197) required to mediate AP-2 binding.  
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3.2.2 Three Asn-Pro-Phe (NPF) motifs mediate AP-2 binding 
Closer examination of A36 residues 155-197, does not reveal the presence of a typical 
AP-2 binding motif, however, it does contain three highly conserved endocytic motifs. 
A36 155-197 contains three Asn-Pro-Phe (NPF) residues at positions 161-3, 176-8, and 
190-2 (Figure 3.4 A). NPF motifs are commonly found in early endocytic adaptor 
proteins including epsin, synaptojanin, stonin, and AP180 (Chen et al., 1998; Haffner et 
al., 2000; Martina et al., 2001; McMahon, 1999). The vaccinia A36 NPF motifs are the 
first viral NPF motifs to be identified to date. During clathrin-mediated endocytosis 
NPF motifs directly bind Epsin-15 homology (EH) domain containing proteins at the 
plasma membrane facilitating the recruitment of AP-2 and clathrin. To date the best 
characterised EH domain containing proteins are intersectin-1 and Eps15. Intersectin-1 
and Eps15 are modular proteins that contain two and three EH domains respectively, 
and are therefore attractive candidates for direct binding to the A36 NPF motifs (Figure 
3.4 B). In addition, earlier work has shown that intersectin-1 is recruited to CEV at the 
plasma membrane during egress, where it is thought to activate Cdc42 via its intrinsic 
GEF activity to mediate the interaction between Cdc42 and N-WASP beneath the virus 
(Humphries et al., 2014).  
 
To confirm whether the three A36 NPF motifs are indeed required to mediate binding to 
AP-2, NPF mutants were generated in the cytoplasmic domain of A36. Individual 
motifs (∆NPF1, ∆NPF2, and ∆NPF3) and all three NPF motifs together (∆NPF 1-3) 
were substituted with a tri-alanine (AAA) sequence to ascertain the role and 
contribution of each NPF motif to AP-2 binding. The GFP-tagged A36 NPF mutants 
were expressed under the viral pE/L promoter during the course of ∆A36R infection in 
HeLa cells. Alanine substitution of the individual NPF motifs was sufficient to abolish 
the interaction between the A36 cytoplasmic domain and AP-2 (Figure 3.4 C). 
Mirroring the A36:AP-2 interaction, mutation of any one of the three NPF motifs is also 
sufficient to abolish binding of A36 to intersectin-1 and Eps15 (Figure 3.4 C). This 
suggests that an intermediate EH domain containing protein is responsible for adaptor 
binding, as the NPF motifs are crucial requirement for A36 mediated binding of AP-2. 
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To confirm the requirement of the A36 NPF motifs, HeLa cells infected with the 
∆A36R virus were transiently transfected with GFP-A36 or the GFP-A36 ∆NPF 
mutants. Endogenous intersectin-1 was immunoprecipitated from cell lysates and the 
interaction with GFP-A36 and endogenous AP-2 was investigated by immunoblot 
analysis. In agreement with previous results, intersectin-1 was able to associate with 
wild type GFP-A36 but was unable to associate with any of the A36 ∆NPF mutants 
(Figure 3.4 D). As expected, intersectin-1 is able to co-immunoprecipitate AP-2 from 
cell lysates in all cases (Figure 3.4 D). 
 
To determine whether the A36 and intersectin-1 interaction was mediated by the 
intersectin-1 EH domains as would be predicted, a GFP-tagged intersectin-1 (ITSN1) 
construct was generated by PCR that lacks both N-terminal EH domains (residues 1-
311) (GFP-ITSN1-∆EH). GFP-ITSN1, GFP-ITSN1-∆EH, and GST-A3624-221 were 
expressed in HeLa cells under the pE/L promoter during infection with the ∆A36R virus. 
GFP-Trap pull-downs from cell lysates showed that GFP-ITSN1 ∆EH was unable to 
pull-down wild type GST-A3624-221 (Figure 3.4 E). Wild type GFP-ITSN1 could still 
interact with GST-A3624-221 as previously observed (Figure 3.4 E). Taken altogether this 
confirms that the interaction between A36 and intersectin-1 requires all three A36 NPF 
motifs and is mediated by the intersectin-1 EH domains. The specific requirement of the 
EH domains of Eps15 remains to be elucidated. Intersectin-1 and Eps15 are thought to 
act in complex and are known to oligomerise via their respective coiled-coil domains 
(Wong et al., 2012). As A36 binding from cell lysates is abolished upon the loss of the 
EH domains of intersectin-1, this may suggest that endogenous Eps15 is either unable, 
or not essential to mediate A36 binding in the absence of intersectin-1. 
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Figure 3.4 Intersectin-1 and AP-2 bind A36 via NPF motifs  
A Vaccinia A36 contains three Asn-Pro-Phe (NPF) motifs (in red) within residues 155-197. B 
The domain architecture of intersectin-1 and Eps15, which contain two and three N-terminal EH 
domains respectively (green). C Immunoblot of GFP-Trap pull-down assays reveals that wild 
type GFP-A3624-221 can pull-down AP-2, intersectin-1, and Eps15. A36 ∆NPF mutants are 
unable to mediate binding to AP-2, intersectin-1, and Eps15. D Immunoprecipitation (IP) of 
endogenous intersectin-1 can pull-down wild type GFP-A3624-221 but not the A36 ∆NPF mutants. 
In all cases intersectin-1 co-IPs with AP-2. E Immunoblot of GFP-Trap pull-downs on GFP-
ITSN1 wild type alongside ITSN1 lacking the N-terminal EH domains within residues 1-311 
(GFP-ITSN1 ∆EH). Wild type GFP-ITSN1 but not GFP-ITSN1 ∆EH can bind GST-A3624-221. 
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3.2.3 Intersectin-1 and Eps15 are recruited to vaccinia virus 
Intersectin-1 and Eps15 form a group of several EH domain proteins linked to AP-2 
recruitment during early endocytic events at the plasma membrane (Carbone et al., 
1997; Cupers et al., 1998; Henne et al., 2010; Koh et al., 2004; Marie et al., 2004; Tebar 
et al., 1996; Yamabhai et al., 1998). Intersectin-1 and Eps15 both have homologous 
isoforms, intersectin-2 and Eps15R (Guipponi et al., 1998; Wong et al., 1995). Full-
length intersectin-1 and intersectin-2 have 61.2% identity, and Eps15 and Eps15R have 
50% sequence identity. There is a high degree of sequence conservation within the N-
terminal EH domains of both families of proteins. The EH domains of Eps15/15R (EH 
1-3) are 59.7% identical and the EH domains of intersectin-1/2 (EH 1-2) are 50.9% 
identical. Intersectin-2 and Eps15R are much less studied but are thought to play 
overlapping roles to their counterparts during endocytic events (Carbone et al., 1997; 
Coda et al., 1998; McGavin et al., 2001; Pucharcos et al., 2000).  
 
In order to determine whether this family of endocytic proteins were recruited to the 
virus during egress, WR infected HeLa cells were fixed at 8 hours post infection (hpi) 
and immunofluorescence imaging was carried out. Immunofluorescence analysis 
revealed that endogenous intersectin-1, intersectin-2, Eps15, and Eps15R all co-localise 
to CEV particles at the plasma membrane (Figure 3.5 A). AP-2 and clathrin are 
mutually exclusive to vaccinia-induced actin tails (Humphries et al., 2012). Intersectin-
1 however, has been shown to remain on the virus following the formation of the actin 
tail (Humphries et al., 2014). I next sought to determine whether this was also the case 
for intersectin-2, Eps15, and Eps15R. Like intersectin-1, all three EH domain proteins 
associate with virions inducing actin tails, in agreement with previous observations 
(Figure 3.5 B) (Humphries et al., 2014). Unlike AP-2 and clathrin, actin polymerisation 
is not sufficient for the dissociation of EH domain proteins from CEV during egress. 
Furthermore, intersectin-1 and Eps15 co-localise with one another on a subset of viral 
particles, suggesting that they may work in complex with one another (Figure 3.5 C). 
This is in keeping with previous observations in the literature that suggest that 
intersectin-1 and Eps15 have similar and/or complementary roles during endocytosis 
(Sengar et al., 1999). 
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Figure 3.5 Co-localisation of EH domain proteins with extracellular virus particles 
A Immunofluorescence staining shows that endogenous intersectin-1, intersectin-2, Eps15, and 
Eps15R can all be recruited to CEV. CEV were visualized by staining with anti-B5 prior to 
permeabilization. Scale bar = 10 µm. B All four EH domain proteins can be found on viruses 
inducing actin tails. Actin was detected with phalloidin staining. Scale bar = 10 µm. C 
Intersectin-1 and Eps15 can co-localise to a subset of CEV particles. Scale bar = 2 µm. White 
arrows indicate co-localisation.  
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3.2.4 The A36 NPF motifs directly bind intersectin-1 and Eps15 
As both intersectin-1 and Eps15 localise to CEV particles at the plasma membrane, I 
next sought to determine whether intersectin-1 or Eps15 could bind directly to the A36 
NPF motifs. To screen for direct binding, the GST-tagged EH domains of intersectin-1 
and Eps15 were expressed in BL21 DE3 (Rosetta) E.coli cells (Figure 3.6 A). 
Recombinant GST-EH domains were subsequently affinity purified from E.coli soluble 
fractions via a glutathione resin. Due to the highly disordered nature of A36, previous 
attempts to express and purify recombinant A36, have resulted in low protein yields and 
significant degradation, therefore a peptide approach was taken. N-terminal biotinylated 
peptides of the NPF containing A36 residues 158-197 (A36158-197) were synthesised in 
house. Wild type A36158-197 containing all three NPF motifs intact was generated in 
addition to a panel of A36158-197 peptides containing one (∆1, ∆2, ∆3), two (∆1+2, ∆1+3, 
∆2+3), or all three (∆1-3) NPF motifs substituted to a tri-alanine motif (Figure 3.6 B).  
 
The A36158-197 wild type, ∆1-3, and a scrambled peptide control (Scr) were bound to 
Streptavidin beads. Peptide loaded Streptavidin beads and an unloaded beads control 
(CTRL) were incubated with equimolar amounts of purified GST-intersectin-1 EH1-2 
or GST-Eps15 EH1-3 (input). Both GST-intersectin-1 EH1-2 and GST-Eps15 EH1-3 
could specifically bind A36158-197 (Figure 3.6 C). This interaction was abolished entirely 
upon alanine substitution of all three NPF motifs (∆1-3) (Figure 3.6 C). Neither GST-
intersectin-1 EH1-2 nor GST-Eps15 EH1-3 could bind the A36158-197 scrambled control 
(Scr) or unloaded Streptavidin beads (CTRL) (Figure 3.6 C). 
 
In order to determine whether both of the intersectin-1 EH domains are required to 
mediate A36 binding, GST-tagged intersectin-1 EH1 and EH2 were expressed and 
purified from BL21 DE3 (Rosetta) E.coli cells. GST-intersectin-1-EH1 and GST-
intersectin-1-EH2 were incubated with Streptavidin beads loaded with A36158-197 wild 
type (WT), ∆1-3, and scrambled (Scr) peptides as above. GST-intersectin-1-EH1 and 
GST-intersectin-1-EH2 could both bind A36158-197 wild type. Once again, there was no 
binding observed to the unloaded beads (CTRL), ∆1-3, or scrambled (Scr) peptides 
(Figure 3.6 D). This suggests that in vitro, both EH domains of intersectin-1 can 
mediate binding to the A36158-197 NPF motifs, although intersectin-1 EH2 appears to 
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have higher binding affinity than EH1, in contrast to observed measurements in 
literature, in which the reverse has been observed (Yamabhai et al., 1998). Whether this 
is the case in vivo, and whether all three Eps15 EH domains can mediate binding to 
A36158-197 in vitro or in vivo remains to be elucidated.  
 
Next the contribution of the individual A36 NPF motifs to EH domain binding was 
determined. Purified GST-intersectin-1 EH1-2 or GST-Eps15 EH1-3 (input) were 
incubated with A36158-197 peptide loaded Streptavidin beads and an unloaded beads 
control (CTRL) as previously described. GST-intersectin-1 EH1-2 and GST-Eps15 
EH1-3, both had similar binding profiles to the panel of A36158-197 peptides (Figure 3.6 
E). Based on coomassie staining alone, A36158-197 binding to GST-Eps15 EH1-3 
appeared to be higher affinity than to GST-intersectin-1 EH1-2  (Figure 3.6 E). A36158-
197 binding to GST-intersectin-1 EH1-2 and GST-Eps15 EH1-3 was greatly reduced in 
the absence of NPF3 (∆3) (Figure 3.6 E). Consistent with this the presence of NPF3 
alone (∆1+2) but not NPF1 (∆2+3) was sufficient to mediate direct binding of both 
GST-intersectin-1 EH1-2 and GST-Eps15 EH1-3 (Figure 3.6 E). The presence of NPF2 
alone (∆1+3) was able to mediate weak binding to both GST-intersectin-1 EH1-2 and 
GST-Eps15 EH1-3 (Figure 3.6 E). Binding of GST-intersectin-1 EH1-2 and GST-Eps15 
EH1-3 to A36158-197 ∆1-3 was entirely abolished in agreement with earlier observations 
(Figure 3.6 C). These in vitro binding assays have determined that A36 NPF3 is the 
most essential motif for both GST-intersectin-1 EH1-2 and GST-Eps15 EH1-3 binding, 
with an additional contribution by NPF2. The A36 NPF1 motif alone does not appear to 
contribute to binding of either the intersectin-1 or Eps15 EH domains in vitro. 
 
In order to investigate whether endogenous intersectin-1 and Eps15 also require A36 
NPF3 to mediate binding, a HeLa cell extract was passed over the Streptavidin coupled 
A36158-197 peptides. In addition to intersectin-1 and Eps15, the binding of intersectin-2, 
Eps15R, and AP-2 to A36158-197 peptides was determined. Immunoblot analysis of 
endogenous intersectin-1/2, Eps15/15R, and AP-2 binding to the A36158-197 peptides 
mirrored direct binding to some extent (Figure 3.6 E, F). Intersectin-1, intersectin-2 and 
Eps15R all exhibited identical binding profiles to the panel of A36158-197 peptides. In 
addition, their binding was identical to that of recombinant GST-intersectin1 EH1-2 and 
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GST-Eps15 EH1-3 (Figure 3.6 E). The loss of A36 NPF3 in A36158-197 (peptides ∆3, 
∆1+3, ∆2+3 and ∆1-3) significantly reduced binding in all cases. A36 NPF1 alone was 
unable to mediate binding of endogenous intersectin-1, intersectin-2 and Eps15R, while 
NPF2 was able to mediate extremely weak association (Figure 3.6 E).  
 
Unlike the other EH domain proteins, endogenous Eps15 was able to bind the A36158-197 
peptide in the absence of the third NPF motif (∆3). This is in contrast to in vitro binding 
observed with recombinant GST-Eps15 EH1-3 (Figure 3.6 E, F). Endogenous AP-2 
mirrors Eps15 binding, and is also able to associate with A36158-197 lacking the NPF3 
(∆3) motif (Figure 3.6 F). Neither Eps15 nor AP-2 can bind A36158-197 peptides 
containing NPF1 alone (∆2+3), confirming once again that A36 NPF1 does not play a 
role in binding to EH domain-containing proteins, or AP-2 (Figure 3.6 F). Conversely, 
NPF2 alone (∆1+3) is sufficient to bind Eps15 and AP-2 in contrast to intersectin-1, 
intersectin-2 and Eps15R (Figure 3.6 F). While the in vitro binding of intersectin-1 
EH1-2 and endogenous intersectin-1 are identical, this is not the case with Eps15 EH1-3. 
Endogenous Eps15 retains the ability to associate with A36 in the absence of NPF3, 
unlike recombinant GST-Eps15 EH1-3. This may allude to an additional host protein 
required to mediate binding to A36 in cell extracts, or may be due to avidity effects of 
Eps15 oligomerization in vivo leading to enhanced binding. GST-Eps15 EH1-3 lacks 
the coiled-coil region required for oligomerization and therefore may exhibit distinct 
binding properties than endogenous Eps15 in vivo. These in vitro binding experiments 
determine that A36 NPF1 does not appear to mediate binding to intersectin-1/2, 
Eps15/15R or AP-2. A36 NPF2 alone is sufficient to bind Eps15 and AP-2, while A36 
NPF3 is crucial for binding of intersectin-1/2 and Eps15R.  
 
As observed following far western on a peptide array of A36, peptide binding does not 
entirely mimic that observed during GFP-Trap assays (Figure 3.4 C). The loss of any 
one of the A36 NPF motifs in GFP-A3624-221 was sufficient to abolish binding of 
endogenous AP-2, intersectin-1 and Eps15. This may be indicative of an essential 
requirement of all three NPF motifs in vivo.  
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Figure 3.6 A36 NPF motifs directly bind EH domains of intersectin-1 and Eps15  
A GST-ITSN1 EH1-2 and GST-Eps15 EH1-3 purified constructs that were used in peptide pull-
down assays. B N-terminally biotinylated peptides of A36158-197 were synthesised containing 
single, two, and all three NPF motifs substituted to a tri-alanine motif (AAA). A scrambled 
A36158-197 peptide was generated to control for non-specific binding (Scr). C GST-EH domains 
were incubated with A36158-197 loaded Streptavidin beads (IN = input protein levels). GST-
ITSN1 EH1-2 and GST-Eps15 EH1-3 can directly bind wild type A36158-197 (WT) but not ∆1-3, 
Scr, or unloaded Streptavidin beads (CTRL). D GST-ITSN1 EH1 and GST-ITSN1 EH2 were 
incubated with A36158-197 loaded Streptavidin beads (WT, 1-3, Scr) and unloaded Streptavidin 
beads (CTRL). Both are able to bind wild type A36158-197 but not ∆1-3. E Direct peptide pull-
downs on the entire panel of A36158-197 NPF-AAA peptides incubated with GST-ITSN1 EH1-2 
and GST-Eps15 EH1-3.  F Indirect peptide pull-downs on a panel of A36158-197 NPF-AAA 
peptides incubated with HeLa cell lysates and probed for binding of endogenous intersectin-1, 
intersectin-2, Eps15, Eps15R and AP-2. 
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3.2.5 NPF motifs are conserved amongst the Orthopoxviruses 
There are numerous examples of mechanisms by which viruses hijack host cell 
processes in order to enhance viral spread, and clearly the endocytic machinery is no 
exception (Humphries and Way, 2013). Several viruses subvert endocytic machinery for 
their entry, however, at this time functional NPF motifs have never been identified in a 
viral protein (Cossart and Veiga, 2008; Gruenberg, 2009; Marsh and Helenius, 2006; 
Mercer et al., 2010). In order to understand the extent of conservation of the NPF motifs 
among the poxvirus family, BLAST analysis was performed on vaccinia A36. A36 is 
highly conserved amongst the Orthopoxvirus genus, and has a vital role in microtubule-
based and actin mediated viral spread (Parkinson and Smith, 1994; Rottger et al., 1999; 
Ward and Moss, 2001; Wolffe et al., 1998). The homologues of vaccinia A36 in variola 
virus, camelpox virus, monkeypox virus, rabbitpox virus, cowpox virus, and taterapox 
virus all contain three NPF motifs (Figure 3.7). Ectromelia virus, a natural pathogen of 
mice expresses a A36 homologue with 97% sequence identity to vaccinia A36, although 
it is truncated from residue 161 onwards, and therefore lacks all NPF motifs (Figure 
3.7) (Esteban and Buller, 2005; Lynn et al., 2012). A previously characterised 
functional orthologue of A36 in yaba-like disease virus, is encoded by the 126R gene, 
also lacks the presence of NPF motifs. The conservation of the A36 NPF motifs 
amongst the Orthopoxviridae is a strong indicator of a selective evolutionary advantage 
of the NPF motifs during infection. 
 
 
Figure 3.7 The A36 NPF motifs are highly conserved among the Orthopoviridae 
Clustal Omega sequence alignment of the C-termini of the following Orthopoxvirus A36 
orthologues (Uniprot Entry in parenthesis). VACV – Vaccinia virus (P68619), VARV – Variola 
virus (Q0N502), CMLX – Camelpox virus (Q912R6), MKPV – Monkeypox virus (Q5IXM7), 
RPXV – Rabbitpox virus (Q6RZE7), COXPX – Cowpox virus (G0XSQ1), TATV – Taterapox 
virus (Q0NP51), YLDV – Yaba-like disease virus (Q9DHI7), ECTV – Ectromelia virus 
(Q912M8). Three conserved NPF motifs are highlighted in red. 
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3.3 Summary  
Work presented in this chapter has identified vaccinia A36 as the first known viral 
protein containing functional EH domain binding Asn-Pro-Phe (NPF) motifs. NPF 
motifs are conserved from yeast to man and are abundant in early endocytic proteins 
(Chen et al., 1998; Fernandez-Chacon et al., 2000; Haffner et al., 1997; Martina et al., 
2001; Salcini et al., 1997). These motifs act as scaffolds for the recruitment of 
additional endocytic components such as intersectin-1, Eps15 and AP-2 during 
endocytosis. A36 can directly recruit intersectin-1 and Eps15 via the NPF motifs in 
vitro, and is essential for binding of AP-2. In vitro A36 NPF3 is essential for the 
recruitment of intersectin-1/2 and Eps15R, with additional contribution mediated by 
NPF2. A36 NPF1 alone, in contrast, is unable to mediate binding of intersectin-1/2, 
Eps15/R, or AP-2. During infection CEV can recruit the EH domain-containing proteins 
intersectin-1, intersectin-2, Eps15, and Eps15R. Furthermore, intersectin-1, intersectin-2, 
Eps15, and Eps15R can remain associated with viral particles following the initiation of 
actin polymerisation. This differs from prior observations of AP-2 and clathrin, which 
are left behind at the plasma membrane upon the formation of actin tails. Moreover, the 
NPF motifs are a conserved feature of the Orthopoxviridae, and may represent a 
common mechanism required during viral egress. Subsequent characterisation of the 
A36 NPF motifs in vivo, will shed light on the functional role that they play during the 
course of infection.  
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Chapter 4. Generation and characterisation of Vaccinia 
A36 ∆NPF 1-3 
4.1 Introduction 
The previous chapter identified the molecular basis for the interaction of the endocytic 
components, intersectin-1 and Eps15 with vaccinia A36. Intersectin-1 and Eps15 have 
both been shown to directly bind AP-2 (Benmerah et al., 1996; Benmerah et al., 1995; 
Iannolo et al., 1997; Pechstein et al., 2010). Intersectin-1 and Eps15 are both recruited 
to the virus during infection and actin tail formation, suggesting that they act to mediate 
the recruitment of AP-2 to CEV via association with A36. In order to test the functional 
importance of intersectin-1 and Eps15 two approaches were carried out. Initially RNAi 
experiments were utilised to determine the effect of intersectin-1 and Eps15 depletion 
on AP-2 binding, actin tail formation, and cell-to-cell spread. Downregulation of 
endocytic adaptors by RNAi is often difficult to achieve due to functional redundancy 
among the components of clathrin-coated pits, including the EH domain containing 
proteins and their interactors. As demonstrated in the previous chapter, several EH 
domain-containing proteins can be recruited via the vaccinia A36 NPF motifs, 
suggesting that they may act together in complex. Furthermore, complete RNAi 
mediated depletion of endocytic proteins may not be achieved, therefore an additional 
approach was utilised.  
 
A panel of recombinant A36 NPF mutant viruses were generated and characterised in 
order to closely examine the role of the A36 NPF motifs during viral infection. 
Recombinant viruses are a key tool to study the interplay between host and viral biology 
(Dodding and Way, 2009). Recombinant viruses are advantageous over RNAi depletion 
in several respects. They can be investigated over long time periods, with great 
reproducibility, and with no host off-target effects. Several vaccinia recombinants are 
not viable due to early defects in viral replication, however this is not the case in 
vaccinia lacking A36 (∆A36R). ∆A36R is not lethal and is able to progress through the 
early viral life cycle. Creating a virus lacking the A36 NPF motifs aims to abolish A36-
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dependent binding of intersectin-1/2 and Eps15/15R in addition to as-of-yet unknown 
EH domain containing proteins that may be recruited by A36. 
4.2 Results 
4.2.1 Intersectin-1 and Eps15 are essential to mediate AP-2 binding to A36 
Vaccinia-induced actin tails in AP-2 depleted cells exhibited increased tail length and 
increased rate of motility (Humphries et al., 2012). FRAP analysis also revealed that N-
WASP recruited to CEV in AP-2 depleted cells had a significantly faster turnover rate, 
consistent with the increased rate of actin-based motility of the virus upon the loss of 
AP-2 (Humphries et al., 2012; Weisswange et al., 2009). As an initial approach to 
determine whether intersectin-1 or Eps15 act in the same pathway as AP-2, RNAi 
depletion of intersectin-1 and Eps15 and a combined knock down of intersectin-1/2 and 
Eps15/15R (EH pool) was carried out in HeLa cells stably expressing LifeAct-Cherry, a 
reporter for filamentous actin. Actin tail length was subsequently measured 8 hours post 
infection (Figure 4.1 A). AllStar (CTRL) and AP-2 siRNA were used as negative and 
positive controls respectively.  
 
The extent of RNAi depletion was determined by immunoblot analysis (Figure 4.1 B). 
To note, depletion of Eps15 also led to the decreased expression of intersectin-1, 
complicating the ability to analyse the role of Eps15 independent to that of intersectin-1. 
Nevertheless, depletion of intersectin-1, Eps15 and the EH pool during WR infection 
resulted in a significant increase in actin tail length compared to control treated cells 
(Figure 4.1 A, B). This increase in actin tail length phenocopies that observed following 
AP-2 depletion as previously observed (Figure 4.1 A, B) (Humphries et al., 2012). 
RNAi depletion of intersectin-1 also resulted in an increase in the velocity of actin tails 
to the same extent as that observed in AP-2 depleted cells (Figure 4.1 C). Loss of Eps15 
however, had a small albeit not significant increase in tail speed (Figure 4.1 C). Taken 
together, this suggests that intersectin-1/Eps15 act in the same vaccinia-signalling 
pathway as AP-2. Depletion of the EH pool also resulted in an increase in actin tail 
speed compared to control treated cells, however, curiously to a lesser extent than 
observed following depletion of AP-2 and intersectin-1 alone. 
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In order to determine whether intersectin-1 or Eps15 mediate the binding of AP-2 to 
A36 in isolation of one another or as a complex, GFP-Trap pull-down experiments were 
performed on lysates from RNAi treated HeLa cells. Cells were treated with AllStar 
control (CTRL), AP-2, Eps15, and intersectin-1 siRNA for 48 hours prior to infection 
with the ∆A36R virus. Infected, RNAi treated cells were subsequently transfected with 
either GFP alone or GFP-A3624-221. In agreement with the earlier observation that the 
depletion of Eps15 also affected intersectin-1 levels, in this case the reverse was also 
true, with the depletion of intersectin-1 resulting in a decrease in Eps15 and vice versa 
(Figure 4.1 B, D). As previously determined, intersectin-1, Eps15 and AP-2, could all 
interact with GFP-A3624-221 in cells treated with AllStar (CTRL) RNAi (Figure 3.4, 4.1 
D). Depletion of AP-2 did not impact on binding of either Eps15 or intersectin-1 to 
GFP-A3624-221 (Figure 4.1 D). In contrast, the RNAi mediated loss of either Eps15 or 
intersectin-1 entirely abolished AP-2 binding to GFP-A3624-221 (Figure 4.1 D). 
Interestingly, while the depletion of intersectin-1 also abolished Eps15 recruitment to 
GFP-A3624-221, following treatment with Eps15 siRNA, residual intersectin-1 could still 
associate with GFP-A3624-221.  
 
This data may suggest a speculative model whereby intersectin-1 is responsible to 
mediate the recruitment of Eps15 to A36, and that intersectin-1 and Eps15 function in 
complex to mediate AP-2 recruitment. In order to confirm that intersectin-1 is upstream 
of AP-2 and clathrin recruitment during infection, RNAi treated cells were fixed 8 hours 
post infection and stained for extracellular virus and intersectin-1. The co-localisation of 
intersectin-1 to CEV was manually quantified in an unbiased manner following 
immunofluorescence imaging (Figure 4.2 A). Compared to AllStar (CTRL), RNAi 
depletion of AP-2 or clathrin did not affect the percentage of CEV that co-localised with 
intersectin-1 (Figure 4.2 B). Depletion of intersectin-1 decreased detected intersectin-1 
to background levels and thus significantly reduced co-localisation to CEV. This 
confirms that intersectin-1 plays a role upstream of AP-2 and clathrin to facilitate their 
recruitment to the virus during egress.    
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Figure 4.1 Intersectin-1 and Eps15 depletion leads to longer actin tails and the loss of AP-2 
binding to A36  
A Representative images of vaccinia-induced actin tails following RNAi depletion in HeLa-
Lifeact Cherry cells. Scale bar = 5 µm. B RNAi depletion of AP-2, ITSN1, Eps15, and a pool of 
ITSN1/2, and Eps15/15R (EH pool) in HeLa-Lifeact Cherry cells results in the formation of 
longer actin tails compared to AllStar (CTRL). N = 300 tails per condition C AP-2, ITSN1 and 
the EH pool also results in faster moving actin tails. N = 75 tails per condition D GFP-Trap 
pull-downs on GFP or GFP-A3624-221 from lysates of HeLa cells depleted of AllStar (CTRL), 
AP-2, Eps15, and ITSN1. Depletion of AP-2 does not affect binding of ITSN1 and Eps15 to 
A36. Conversely depletion of Eps15 and ITSN1 abolishes AP-2 recruitment. Error bars 
represent SEM from 3 independent experiments. A p value of <0.0001 is indicated by ****, 
<0.001 is indicated by ***, <0.01 is indicated by **. ns indicates a p value > 0.05. 
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Figure 4.2 Intersectin-1 recruitment to CEV is independent of AP-2 and clathrin  
A Representative immunofluorescence images of CEV following RNAi depletion in N-WASP -
/- cells. Scale bar = 5 µm. B Depletion of clathrin (CHC) and AP-2 do not effect localisation of 
intersectin-1 on CEV (bottom panel). Intersectin-1 depletion is not absolute and there remains 
residual recruitment to CEV. Error bars represent SEM from N=300 particles counted in 3 
independent experiments. A p value of <0.0001 is indicated by ****, <0.001 is indicated by ***, 
<0.01 is indicated by **. ns indicates a p value > 0.05. 
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The loss of AP-2 has also been shown to result in the reduction of cell-to-cell spread of 
vaccinia through a confluent cell monolayer (Humphries et al., 2012). To investigate the 
role of intersectin-1 during viral spread, the ability of WR to spread through confluent 
monolayers of RNAi treated A549 cells was determined. This experiment was 
performed under a semi-solid overlay of carboxy-methyl cellulose to restrict spread 
solely to that mediated by direct cell-cell transmission. A single plaque is therefore 
derived from a single infected cell. A549 cells were transfected with siRNA for 48 
hours prior to infection with WR. At 48 hours post infection cells were fixed, 
permeabilized and stained for the viral IEV protein B5 in order to visualize viral 
plaques. As expected the virus was unable to spread efficiently in the absence of AP-2 
(Figure 4.3) (Humphries et al., 2012). In addition, intersectin-1 depletion resulted in an 
equal defect in viral spread as that of AP-2, leading to a 40% reduction in viral plaque 
size compared to AllStar (CTRL) treated cells (Figure 4.3). This data further supports 
that intersectin-1 acts upstream of AP-2, and that intersectin-1 is key to enhance viral 
spread.   
 
 
 
 
 
Figure 4.3 Loss of AP-2 and intersectin-1 reduces the cell-to-cell spread of WR  
Depletion of AP-2 and intersectin-1 (ITSN1) in a confluent monolayer of A549 cells leads to 
the formation of smaller plaques following infection with WR than in AllStar control (CTRL) 
treated cells. Cells were permeabilized, and plaques were stained with anti-B5 and visualised 
with TMB peroxidase. Error bars represent SEM from N=100 plaques measured from 3 
independent experiments. A p value of <0.001 is indicated by ***. 
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4.2.2 Loss of a single NPF motifs leads to longer actin tails  
The length of actin tails was used as a functional read out to determine whether NPF 
motifs affect actin tail morphology to the same extent as the loss of AP-2 and clathrin. 
Prior to the generation of recombinant viruses, to initially assess the role of the NPF 
motifs on actin tails formation, the individual NPF motifs in full length A36 were 
substituted to alanines. Individual A36 ∆NPF constructs were transiently transfected in 
∆A36R infected HeLa cells. After 8 hours of infection and transfection cells were fixed 
and stained for immunofluorescence imaging. Compared to expression of wild type A36, 
all three single NPF mutants (∆NPF1, ∆NPF2, ∆NPF3) induced the formation of long 
actin tails (Figure 4.4). Expression of wild type A36 induced actin tails with a mean 
length of 3.1 ± 0.8 µm. The length of vaccinia-induced actin tails upon expression of 
A36 ∆NPF1, 2, or 3 was significantly longer, ranging between 5.16 ± 1.1 – 5.5 ± 1.4 
µm (Figure 4.4).  
 
Although transient transfection of the A36 ∆NPF mutants may lead to artefacts as a 
result of overexpression, this data provides initial evidence for a role of the A36 NPF 
motifs to regulate actin dynamics during actin tail formation. In contrast to in vitro 
peptide pull-down assays in Chapter 3, this data also suggests that the loss of a single 
A36 NPF motif is sufficient to result in changes in actin tail length to the same extent as 
depletion of intersectin-1 and AP-2, which also result in a long tail phenotype (Figure 
4.1 A). This suggests that during infection all three NPF motifs play a functional role in 
the recruitment of EH domain containing proteins and AP-2 to some extent, in 
agreement with GFP-Trap assays (Figure 3.4 C) 
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Figure 4.4. Loss of individual A36 NPF motifs results in longer actin tails 
 A Representative immunofluorescence images from HeLa cells infected with ∆A36R and 
transfected with A36 wild type and ∆NPF mutants (residues 1-221). Cells were fixed at 8 hpi 
and stained for extracellular virus (B5) and actin (phalloidin). Scale bar = 10 µm. B 
Quantification of actin tail length following infection with ∆A36R and transfection of WT and 
A36 ∆NPF mutants. A total of 400 actin tails per virus from 20 infected cells over three 
independent experiments were measured using ImageJ. Error bars represent SEM. A p value of 
<0.001 is represented by ***. 
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4.2.3 Generation of the recombinant A36 ∆NPF 1-3 virus 
Next to determine the role of the NPF motifs during infection, a recombinant A36 virus 
lacking the NPF motifs was generated. The ∆A36R virus contains an internal deletion in 
the A36R gene, and is therefore truncated to a non-functional gene product (Parkinson 
and Smith, 1994). Taking advantage of this, a functional A36R gene containing the 
desired NPF mutations was incorporated into the vaccinia ∆A36R genome via 
homologous recombination of the regions flanking the A36R locus. The A36R gene 
was amplified from vaccinia WR genomic DNA by PCR using primers 300bp upstream 
and downstream of the A36R locus (Figure 4.5 A). Using a two-step mutagenesis 
approach, individual A36 NPF to AAA (∆NPF1, 2, and 3) substitution mutants were 
generated and confirmed by sequencing. Sequential rounds of mutagenesis were carried 
out in order to generate the A36 triple NPF to AAA construct (hereon referred to as A36 
∆NPF1-3).  
 
Given the requirement of A36 for both microtubule-based transport to the cell periphery 
and actin tail formation, infection with the ∆A36R virus results in significantly 
defective viral spread and therefore leads to the formation of small viral plaques in a 
confluent monolayer of BS-C-1 cells compared to WR (Figure 4.5 B) (Parkinson and 
Smith, 1994; Ward and Moss, 2001; Wolffe et al., 1998). The A36 ∆NPF mutants 
generated still contain the kinesin-1 binding WE/WD motifs and tyrosine 112 and 132, 
therefore are able to traffic to the plasma membrane and induce actins tails, as observed 
following transient transfection (Figure 4.4). Taking advantage of the ∆A36R rescue 
with A36, positive recombinants were identified by screening for an increase in plaque 
size above that of ∆A36R. A36 ∆NPF plaques were purified through four rounds of 
plaque selection in order to prevent cross contamination by ∆A36R. Recombinants were 
additionally screened for correct insertion and expression of A36 at every round by both 
PCR and immunoblot analysis (Figure 4.5 C). During previous characterisation of A36 
phosphorylation during infection, a recombinant virus expressing a truncated A36 
protein was generated (Weisswange, 2008). This recombinant expressed A36 truncated 
from residue 155 onwards (A36 1-155). The C-terminal deletion did not affect levels of 
tyrosine phosphorylation of A36, however this virus also lacks all three NPF motifs.  
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Figure 4.5. Generation of recombinant A36 NPF mutant viruses 
A Targeting strategy for the generation of the A36 ∆NPF mutant viruses. 1. PCR of the A36 
targeting vector from viral genomic DNA. 2. Subsequent mutagenesis of the NPF motifs to 
alanines (AAA). 3. Incorporation into the ∆A36R genome. B Plaque size 48 hours post 
infection of BS-C-1 cells with WR verses ∆A36R. White arrows indicate ∆A36R plaques. 
Quantification of WR and ∆NPF plaque diameter from N=100 plaques. Error bars represent 
SEM. A p value of <0.001 is represented by ***. C Representation of the generation and 
purification of the A36 ∆NPF viruses following initial homologous recombination. 
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To confirm that the loss of NPF motifs did not impact on the temporal dynamics of A36 
expression or its stability during infection A36 expression was analysed during the 
course of infection. HeLa cell lysates were collected at 1 hour intervals following 
infection with each recombinant A36 virus and A36 expression determined by 
immunoblot analysis. In all cases A36 was expressed both early and late during 
infection, commencing at 1-2 hours post infection (Figure 4.6 A). Protein levels were 
comparable to those observed during WR infection and there was no obvious protein 
degradation, suggesting that the loss of the NPF motifs does not impact on the stability 
of A36. A36 is not required for viral replication or entry, however in order to rule out a 
possible early-stage defect of the A36 ∆NPF mutants, single-step growth curves were 
carried out. Single-step growth analysis is used to study a single replication cycle during 
viral infection. BS-C-1 cells were infected with high multiplicity of infection (MOI = 
10) of each virus in order to synchronise infection of all cells. Infected cells were 
harvested at 0, 4, 8, 12, and 24 hours post infection (hpi), and viral titres determined by 
plaque assay on confluent BS-C-1 monolayers. At 24 hpi there was no significant 
change in total virus produced with the ∆NPF mutant viruses or vaccinia expressing 
truncated A36 1-155 compared to WR (Figure 4.6 B).  
          
Figure 4.6. Loss of NPF motifs does not impact on A36 expression or virus replication 
A Immunoblot analysis of A36 expression every hour post infection with the A36 recombinant 
viruses. Cells were infected with a MOI=1. Whole-cell lysates were collected at 0-8 hpi. 
Vinculin is shown as a cellular loading control. B Single step growth curves following infection 
with A36 recombinant viruses compared to WR. BS-C-1 cells were infected with MOI=10 of 
the indicated viruses. At the indicated times cells were collected and viral titres determined by 
plaque assay on BS-C-1 cells. This graph shows mean titres from two independent experiments.   
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4.2.4 The A36 NPF motifs recruit intersectin-1 and Eps15 to Vaccinia virus  
In vitro biochemical analysis showed that the loss of all three A36 NPF motifs 
abolished the interaction of intersectin-1, Eps15, and AP-2 with A36 (Figure 3.4 C). I 
next sought to address whether this also the case during infection. During infection with 
WR, N-WASP dependent actin tails propel viral particles away from clathrin and AP-2 
at the plasma membrane. Previous data has determined that cells lacking N-WASP (N-
WASP -/- MEFs) are unable to form actin tails following WR infection (Donnelly et al., 
2013; Snapper et al., 2001; Weisswange et al., 2009). The inability of vaccinia to 
nucleate an actin tail in N-WASP -/- MEFs, results in an increase of virus particles at 
the membrane that are still associated with clathrin and AP-2 (Humphries et al., 2012). 
Following infection of N-WASP +/+ MEFs with WR, only 18% of CEV co-localise 
with AP-2 (Humphries et al., 2012). Following WR infection of N-WASP -/- MEFs, the 
level of co-localisation increases to around 30% (Humphries et al., 2012). This increase 
in AP-2 recruitment was used to our advantage, in order to give a greater dynamic range 
from which differences in the recruitment of clathrin, AP-2, intersectin-1 and Eps15 
could be discerned between the A36 ∆NPF recombinant viruses.  
 
N-WASP -/- MEFs were infected with WR, and the A36 ∆NPF1, 2, 3, A36 ∆NPF1-3, 
and A36 1-155 viruses for 8 hours before being fixed and processed for 
immunofluorescence imaging. Co-localisation of clathrin, AP-2, intersectin-1 and 
Eps15 to CEV was determined using immunofluorescence staining of the respective 
endogenous proteins (Figure 4.7 A). Co-localisation was quantified manually in an 
unbiased manner. Following WR infection, the percentage of clathrin, AP-2, intersectin-
1, and Eps15 associated with CEV was in the range of 50-65%, consistent with their co-
recruitment to viral particles. Depletion of individual A36 NPF motifs (A36 ∆NPF1, 2, 
3) did not result in a significant change in the recruitment of clathrin, AP-2, intersectin-
1 or Eps15 to CEVs compared to WR infection (Figure 4.7 B). Although the loss of 
individual NPF motifs abolished binding of AP-2, intersectin-1 and Eps15 from cell 
lysates in vitro, this is not the case during infection (Figure 3.4 C, 4.7 B).  
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Figure 4.7. Three A36 NPF motifs are required to recruit clathrin, AP-2, intersectin-1, and 
Eps15 to CEV 
A Representative immunofluorescence images of vaccinia infected N-WASP -/- cells fixed at 8 
hours post infection. Cells were stained prior to permeabilization with a B5 antibody to detect 
CEV. Images highlight examples of co-localisation with clathrin, AP-2, intersectin-1 and Eps15 
following infection with the indicated viruses (white arrows). B Graph shows the percentage co-
localisation of CEV with clathrin, AP-2, intersectin-1, and Eps15. Error bars represent SEM 
from 100 particles counted per cell, in 30 cells, in three independent experiments. A p value of 
<0.001 is represented by ***. ns indicates a p value > 0.05. 
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Infection with A36 ∆NPF1-3 and the A36 1-155 truncation mutant lacking all three 
NPF motifs, however, led to a significant decrease in the recruitment of clathrin, AP-2, 
intersectin-1, and Eps15 to CEV (Figure 4.7 B). This is in agreement with peptide pull-
downs from cell lysates, whereby Eps15 and AP-2 could still be recruited to A36157-196 
peptides lacking the individual NPF motifs (∆1, ∆2, ∆3) (Figure 3.6 F). Conversely, 
following A36157-196 peptide pull-down assays with either recombinant or endogenous 
intersectin-1, intersectin-1 could not bind A36157-196 peptides lacking NPF3 (∆3) (Figure 
3.6 E, F). This may indicate that intersectin-1 recruitment to NPF3 during infection is 
mediated or enhanced by Eps15.  
4.2.5 Yaba-like disease virus YL126 is unable to recruit intersectin-1 and Eps15 
The significant loss of clathrin, AP-2, intersectin-1 and Eps15 to both the A36 ∆NPF 
virus and the A36 1-155 virus also suggests that during infection A36 alone is sufficient 
for recruitment of the endocytic machinery during egress. In order to confirm that A36 
was necessary and sufficient to mediate binding of clathrin, AP-2, intersectin-1 and 
Eps15 during infection, infection with ∆A36R virus was carried out. The inability of 
∆A36R to mediate microtubule-based transport to the cell periphery, however, leads to 
a significant decrease in the number of CEV. As a result of this an alternative approach 
was used. Previous work in our lab demonstrated that the A36 orthologue in Yaba-like 
disease virus (YLDV), YL126 was able to recruit both Nck and N-WASP and induce 
actin tail polymerisation when expressed in the vaccinia A36R gene locus (WR ∆A36R-
YLDV126R)(Dodding and Way, 2009). YL126, however, does not contain any NPF 
motifs (Figure 3.7). N-WASP -/- cells were infected with WR ∆A36R-YLDV126R and 
processed for immunofluorescence 8 hours post infection. Immunofluorescence analysis 
revealed that clathrin, AP-2, intersectin-1 and Eps15 are unable to be substantially 
recruited to the WR ∆A36R-YLDV126R virus (Figure 4.8). YL126 has less than 15% 
homology with vaccinia A36, and the loss of the NPF motifs in YL126 may contribute 
to the observed altered actin tail dynamics and decrease in cell-to-cell spread of YLDV 
compared with that of vaccinia virus (Dodding and Way, 2009). Taken together, co-
localisation analysis indicates that the A36 NPF motifs are essential for the recruitment 
of clathrin, AP-2, intersectin-1, and Eps15 to CEVs during their egress, and that there is 
functional redundancy between the NPF motifs. The contribution of other IEV proteins 
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to the recruitment of clathrin, AP-2, intersectin-1, and Eps15 to CEVs if it occurs at all, 
must be minimal or supportive in its nature.  
 
 
 
 
Figure 4.8. YLDV YL126 is unable to recruit endocytic machinery 
A Immunofluorescence images of vaccinia infected N-WASP -/- MEFs fixed at 8 hours post 
infection with the WR ∆A36R-YLDV126R virus. Cells were stained prior to permeabilisation 
with a B5 antibody to detect CEV, alongside clathrin, AP-2, intersectin-1, and Eps15 post- 
permeabilisation B Graphs show the percentage co-localisation of extracellular viral particles 
with clathrin, AP-2, intersectin-1, and Eps15. Error bars represent SEM from 50 particles in 30 
cells over three independent experiments. A p value of < 0.001 is indicated by ***. 
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4.2.6 NPF motifs are required for robust actin tail formation 
Having determined that the A36 NPF motifs are essential for the recruitment of clathrin, 
AP-2, intersectin-1 and Eps15, it was next established how their loss impacts on actin 
tail formation. Transient transfection of the individual A36 ∆NPF mutants during 
∆A36R infection resulted in the formation of long actin tails (Figure 4.4). I next sought 
to determine to what extent actin tail formation and dynamics were altered following 
infection with individual and triple A36 ∆NPF recombinant viruses. Structured 
illumination imaging revealed that AP-2 facilitates the polarisation of A36 beneath the 
CEV, resulting in a robust N-WASP signalling platform (Humphries et al., 2012). RNAi 
depletion of AP-2 resulted in a more disperse localisation of A36 and N-WASP beneath 
the virus. In turn this led to fewer, longer, and faster moving actin tails. (Humphries et 
al., 2012).  
 
Following 8 hours of infection with the A36 ∆NPF recombinant viruses and WR, HeLa 
cells were fixed and the number of actin tails induced was quantified from 
immunofluorescence images (Figure 4.9 A). All viruses resulted in the formation of 
between 51.5 ± 4.0 to 65.9 ± 4.2 actin tails per cell (Figure 4.9 B). In contrast to the 
RNAi mediated loss of AP-2, this revealed that there was no significant difference in 
the ability of the A36 ∆NPF viruses to induce actin tails compared to WR. The A36 
∆NPF recombinant viruses (∆NPF1, 2, 3, and ∆NPF 1-3) and the A36 1-155 virus 
however did result in the induction of significantly longer actin tails compared to WR 
(Figure 4.9 A, C). A36 ∆NPF 1-3 and A36 1-155 lead to the greatest increase in actin 
tail length, both with an average actin tail length of 4.54 ± 0.03 µm compared to WR 
(2.65 ± 0.02 µm) (Figure 4.9 C). These actin tail lengths were consistent with those 
measured following transient transfection of the single A36 ∆NPF mutants in ∆A36R 
virus infected cells (Figure 4.4).  
 
 To determine whether the observed increase in actin tail length also resulted in an 
increase in actin tail velocity, live cell imaging of infected HeLa cells stably expressing 
LifeAct-Cherry, was carried out. The speed of actin tails induced 8 hours post infection 
with the A36 ∆NPF mutants and the A36 1-155 virus was measured and compared to 
WR. The A36 ∆NPF 1-3 and A36 1-155 viruses induced actin tails that moved at an 
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average speed of 0.29 ± 0.01 µm/s and 0.31 ± 0.01 µm/s respectively, significantly 
faster than those induced following WR infection (0.20 µm/s ± 0.01 µm/s) (Figure 4.9 
D). There was no change in the velocity of actin tails induced by the individual A36 
∆NPF1, 2, or 3 viruses, despite the increase in actin tail length (Figure 4.4, 4.9 C). 
 
Live-cell imaging in phase contrast allows visualisation of the movement of viral 
particles undergoing both microtubule-based and actin-based transport during infection. 
The time taken for the WR virus to nucleate an actin tail, was recorded from the point a 
viral particle becomes stationary at the cell periphery (indicative of viral fusion after 
microtubule-based transport) until the initiation of the phase dense structure of the actin 
tail. During viral egress it has been previously reported that the WR virus takes 
approximately 30 seconds upon arrival at the plasma membrane to nucleate an actin tail 
(Humphries et al., 2012). Following RNAi depletion of AP-2 this value increases ~ two-
fold (Humphries et al., 2012). Previous experiments have additionally determined that 
fusion of the virus is not affected by the loss of either AP-2 or clathrin (Humphries et al., 
2012). Live-cell imaging was carried out in HeLa cells from 8 hours post infection with 
WR and A36 ∆NPF 1-3 in order to determine actin tail nucleation dynamics. During 
infection with the A36 ∆NPF 1-3 virus it takes 67.6 ± 3.4 seconds to nucleate an actin 
tail, over double that of observed during WR infection (29.9 ± 1.0 seconds) (Figure 
4.10). The lifetime of actin tails induced by the A36 ∆NPF 1-3 virus was also reduced 
to 176.8 ± 14.4 seconds compared to those induced by WR (253 ± 9.3 seconds).  
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Figure 4.9. Loss of the A36 NPF motifs leads to longer, faster moving actin tails 
A Immunofluorescence images of HeLa cells infected with WR, A36 ∆NPF mutant viruses, and 
A36 1-155 at 8 hpi. Cells were stained with phalloidin and B5 (prior to permeabilization). Scale 
bar = 10 µm (inset = 5 µm). B Quantification of number of actin tails induced per cell. N=30 
cells. C Quantification of actin tail length. N=400 tails in 60 cells. D Quantification of actin tail 
speed. N=150 tails in 30 cells.  Error bars represent SEM over 3 independent experiments in all 
cases. A p value of <0.0001 is represented by ****. ns indicates a p value > 0.05. 
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Figure 4.10. Actin tail nucleation is facilitated by the A36 NPF motifs  
A Phase contrast images from live-cell imaging of infected cells to visualize the movement of 
viral particles and subsequent actin tail formation. Microtubule-based motility is detected by a 
fast linear trajectory (green dashed line). Blue arrows indicate the stationary virus particle. Red 
arrows show the initiation of actin-based motility. B Quantification of the time taken to induce 
an actin tail once the virus particle becomes stationary in the periphery of the cell (first blue 
arrow) until the induction of an actin tail (first red arrow). Error bars represent SEM from 60 
events in 3 independent experiments in A and B. A p value of < 0.001 is indicated by ***.  
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4.2.7 Recruitment of N-WASP, WIP, Grb2, and Nck is not NPF dependent 
It is clear that the dynamics of the actin tail are significantly altered in vaccinia lacking 
all three A36 NPF motifs. Previous work has demonstrated the highly dynamic nature 
of the actin-signalling network beneath the virus (Weisswange et al., 2009). Moreover, 
this study also highlighted the role that the rate of N-WASP exchange plays in 
determining the rate of actin tail motility (Weisswange et al., 2009). In order to 
ascertain whether the changes in actin tail length and speed observed upon infection 
with A36 ∆NPF 1-3 were as a consequence of an altered recruitment of the actin-
signalling complex, recruitment of the core vaccinia actin-signalling complex was 
investigated in the absence of the A36 NPF motifs. As previously described N-WASP is 
recruited in complex with WIP, and stabilised beneath the CEV by a network of 
interactions mediated by Nck and Grb2. Arp2/3 can then be recruited and activated by 
N-WASP leading to the formation of robust actin tails to promote viral spread. The loss 
of any one of these components of the vaccinia actin-signalling network results in 
disruption of the vaccinia actin-signalling network, in the case of Grb2 for example the 
loss of recruitment results in shorter yet faster moving actin tails (Weisswange et al., 
2009).  
 
To determine whether these core components remained present on CEV in the absence 
of the A36 NPF motifs, HeLa cells were first infected with the A36 ∆NPF 1-3 virus and 
transfected with GFP-N-WASP, GFP-WIP, GFP-Grb2, and GFP-Nck. Cells were fixed 
at 8 hours post infection and the ability of vaccinia-induced actin tails to recruit these 
components was determined via immunofluorescence staining. Interestingly, the 
localisation of GFP-N-WASP, GFP-WIP, GFP-Grb2, and GFP-Nck to the tips of actin 
tails was not affected by the loss of the A36 NPF motifs (Figure 4.11). This suggests 
that it is not the absence of a component of the core actin-signalling network that is 
responsible for the change in actin tail parameters measured thus far.  
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Figure 4.11 A36 ∆NPF 1-3 is able to recruit the core vaccinia actin-signalling network 
Representative immunofluorescence images from HeLa cells infected with A36 ∆NPF 1-3 and 
transfected with GFP-tagged Grb2, Nck, WIP, and N-WASP (green). Nck, N-WASP, Grb2, and 
WIP can still be recruited to vaccinia induced actin tails in the absence of the A36 NPF motifs. 
Scale bar = 10 µm.  
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4.3 Summary 
The NPF motifs in vaccinia A36 identified in the previous chapter have a clear 
functional role during viral egress at the plasma membrane. In this chapter RNAi 
depletion experiments have shown that the EH domain containing proteins, intersectin-1 
and Eps15 act upstream and in the same pathway as AP-2. Depletion of intersectin-1 or 
Eps15 individually commonly resulted in a decrease in levels of both EH domain 
containing proteins, in agreement with intersectin-1 constitutively associating with 
Eps15 to form a complex. The generation of A36 ∆NPF recombinant viruses facilitated 
closer examination of the significance of the A36 NPF motifs during infection. In 
contrast to in vitro biochemical assays in Chapter 3, during infection all three NPF 
motifs must be lost to abolish the viral recruitment of clathrin, AP-2, intersectin-1 and 
Eps15. Intersectin-1 was unable to bind A36 peptides in the absence of NPF3 (Figure 
3.6 F). The A36 ∆NPF3 virus is in contrast able to mediate intersectin-1 recruitment 
during infection (Figure 4.7). This may indicate that Eps15 mediates intersectin-1 
binding to A36 ∆NPF3 in this case, or that multiple interactions between all three NPF 
motifs with both intersectin-1 and Eps15 occur during infection to stabilise recruitment 
beneath the virus.  
 
Curiously the loss of an individual A36 NPF motif, which remains able to recruit 
clathrin, AP-2, intersectin-1 and Eps15 to wild type levels in N-WASP -/- cells, resulted 
in an increase in actin tail length in HeLa cells. It is known that clathrin and AP-2 
disassociate from the CEV upon the initiation of actin tails, whereas both intersectin-1 
and Eps15 can be recruited to actin tails. (Figure 3.5) (Humphries et al., 2012). The 
increase in actin tail length induced by the single A36 ∆NPF viruses may suggest that 
recruitment of intersectin-1 and Eps15 is less stable or abolished following the initiation 
of actin polymerisation, an avenue that will require future research.  
 
The A36 ∆NPF 1-3 virus lacking all NPF motifs induces longer, faster moving actin 
tails, that take longer to nucleate and have a shorter lifetime that WR induced actin tails, 
all in all resulting in a less robust actin tail.  
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Chapter 5. The role of the A36 NPF motifs during 
Vaccinia virus spread 
5.1 Introduction 
A combination of biochemical techniques and a recombinant virus approach has 
demonstrated that the three NPF motifs in A36 are essential for the recruitment of 
clathrin, AP-2, Eps15, and intersectin-1 to vaccinia. When these motifs are lost this 
results in marked defects in N-WASP dependent actin tails. The next key question is 
how these conserved motifs affect the cell-to-cell spread of vaccinia. Determining the 
spread of vaccinia through a tissue remains a technical challenge for the virus 
community. To evaluate viral spread, current research is largely limited to the analysis 
of viral spread through cultured monolayers. While this allows evaluation of viral 
plaque size, and is amenable to fixed and live cell imaging, it may not reflect the 
situation in a tissue. Assessment of the spread of viruses through monolayers, however, 
remains a useful tool that enables the spatial and temporal analysis of cell-to-cell 
infection, and has also unveiled novel mechanisms governing how viruses are 
transmitted from cell-to-cell.  The clustering of IEV proteins, actin tail formation, the 
release of CEVs from the plasma membrane, and the correct entry and fusion of EEVs 
with neighbouring cells all contribute to efficient viral dissemination (Horsington et al., 
2013; Humphries et al., 2012; Payne, 1980; Smith et al., 2003). The loss of any one of 
these processes results in defective viral spread to some extent.  
 
Deletion of IEV proteins that are required for the both the formation of IEVs and the 
formation of actin tails universally results in a small plaque phenotype in cell 
monolayers (Smith and Law, 2004; Smith et al., 2002). The loss of A36 leads to the loss 
of microtubule-based motility of IEV to the periphery and the induction of actin-tails by 
CEV. This consequently results in a significant decrease in the size of viral plaques 
formed in a monolayer of cells and also in a decrease in the release of viral particles 
(EEV) (Figure 4.5 B) (Parkinson and Smith, 1994; Sanderson et al., 1998; Wolffe et al., 
1998). Recent studies have proposed a novel model in which the ability of EEV to 
induce actin tails on recently infected cells promotes rapid viral spread through a 
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monolayer (Doceul et al., 2012; Doceul et al., 2010). This super-repulsion of viral 
particles requires the early expression of A36 and A33 in order to induce actin tails on 
recently infected cells that are not yet producing infectious viral particles. Actin 
mediated propulsion of EEVs across these cells is thought to increase the infectious 
range and plaque size during infection (Doceul et al., 2012; Doceul et al., 2010). Given 
the importance of A36 in both short and long-range spread of vaccinia EEVs, an 
interesting question is how the recruitment of AP-2, intersectin-1, and Eps15 via the 
NPF motifs impacts on viral spread, release, or super-repulsion. RNAi depletion 
experiments in the previous chapter revealed that the loss of both AP-2 and intersectin-1 
resulted in a small plaque phenotype, suggesting that the A36 NPF motifs play a role in 
viral spread (Figure 4.3). 
5.2 Results 
5.2.1 A36 NPF motifs promote viral spread 
In order to ascertain the affect of the loss of the A36 NPF motifs on viral spread, 
confluent monolayers of BS-C-1 cells were infected at a low MOI with WR, A36 ∆NPF 
mutant viruses (∆NPF1, 2, 3 and ∆NPF1-3) and the truncated A36 1-155 virus. One 
hour after viral adsorption, media was replaced with a semi-solid carboxy-methyl 
cellulose overlay in order to limit infection to that mediated by cell-to-cell transmission. 
Infected monolayers were fixed 48 hours post infection (hpi) and stained with crystal 
violet to reveal viral plaques (Figure 5.1 A). The diameter of viral plaques was 
subsequently measured.  
 
Plaques formed by the single A36 ∆NPF mutant viruses had a small but not statistically 
significant decrease in plaque diameter compared to WR (Figure 5.1 A, B). Infection 
with the A36 ∆NPF 1-3 and A36 1-155 viruses, however, resulted in a significantly 
smaller plaque compared to that of WR. On average WR plaques were 1.22 ± 0.04 mm 
in diameter, whereas plaques formed by A36 ∆NPF 1-3 and A36 1-155 were almost 
half the size (0.72 ± 0.05 mm and 0.70 ± 0.04 mm respectively) (Figure 5.1). The 
∆A36R virus led to the formation of even smaller plaques (0.23 mm ± 0.01 mm). 
Although ∆A36R can still produce IEV particles, the loss of A36-mediated microtubule 
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transport to the periphery results in a severe defect in viral spread in agreement with 
earlier studies (Dodding et al., 2011; Parkinson and Smith, 1994; Rietdorf et al., 2001). 
This data shows that the loss of all three NPF motifs significantly impacts on viral 
spread, and that there are no additional factors in the C-terminus of A36 (residues 156-
221), that contribute to viral cell-to-cell spread.  
 
A recombinant virus has been previously engineered to express the Yaba-like disease 
virus YL126 protein in place of A36 in vaccinia virus (Dodding and Way, 2009). The 
WR-∆A36R-YL126R virus has been shown to recruit the actin-signalling complex and 
induce actin tail formation in the absence of A36 (Dodding and Way, 2009). YL126 as 
indicated earlier in this thesis, does not contain any NPF motifs and is unable to recruit 
clathrin, AP-2, intersectin-1, or Eps15 to the virus during egress (Figure 3.7, Figure 4.8). 
I therefore sought to determine how the cell-to-cell spread of WR-∆A36R-YL126R 
compared to that of A36 ∆NPF 1-3.  
 
After 48 hours of infection in a confluent monolayer of BS-C-1 cells, WR and the A36 
∆NPF 1-3 virus formed plaques that were 1.43 ± 0.02 mm and 0.88 ± 0.02 mm in 
diameter respectively, in agreement earlier observations (Figure 5.2 A, B). Plaques 
formed by WR-∆A36R-YL126R were even smaller, averaging at 0.52 ± 0.01 mm in 
diameter (Figure 5.2 A, B). WR-∆A36R-YL126R however did result in a rescue in 
plaque size compared that that observed in ∆A36R (Figure 5.1, 5.2). The decrease in 
WR-∆A36R-YL126R plaque size is in agreement with the lack of NPF motifs in YL126. 
Therefore like A36 ∆NPF 1-3, WR-∆A36R-YL126R results in diminished cell-to-cell 
spread compared to WR expressing wild type A36. The additional decrease in plaque 
size observed between vaccinia expressing YLDV126R verses A36 ∆NPF 1-3 is likely 
to be due to intrinsic differences in the organisation of the YL126 actin-signalling 
complex. In support of this, previous work has shown that YL126 induced actin tails are 
less robust and more chaotic in their directionality compared to A36 (Dodding and Way, 
2009). Differences between WR-∆A36R-YL126R and A36 ∆NPF 1-3 may also be due 
to altered intermolecular interactions between the vaccinia IEV proteins, which may 
impact on both viral assembly and spread. Although A36 is not directly required for 
IEV formation, substituting A36 for YL126 may impact on viral assembly due to 
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altered interactions with other IEV proteins that are required for viral assembly such as 
A34, B5 or F13 (Rottger et al., 1999). Together these experiments further support the 
advantage of NPF motifs to promote viral spread. Although not conserved among the 
Orthopoxvirus A36 orthologues as a whole, the NPF motifs may confer a host or cell 
specific advantage amongst the poxvirus family. 
 
 
 
 
 
 
Figure 5.1 The A36 NPF motifs promote viral spread 
A Representative images of viral plaques produced by the indicated viruses in confluent BS-C-1 
cells revealed by staining with crystal violet 48 hpi. B Graph shows quantification of plaque 
diameters produced by the indicated viruses. Error bars represent SEM from N = 100 plaques in 
3 independent experiments. A p value of < 0.001 is indicated by ***. ns indicates a p value > 
0.05. 
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Figure 5.2 The A36 ∆NPF 1-3 and YL126R viruses are deficient in viral spread 
A Representative images of viral plaques produced by the indicated viruses in confluent BS-C-1 
cells revealed by staining with crystal violet 48 hpi. B Graph shows quantification of plaque 
diameters produced by the indicated viruses. Error bars represent SEM from N = 60 plaques in 
3 independent experiments. A p value of < 0.001 is indicated by ***.  
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5.2.2 A36 NPF motifs promote viral release 
A key aspect of viral spread is the ability of EEV to be released from infected cells 
(Horsington et al., 2013). The amount of EEVs produced from infected cells was 
therefore quantified in order to determine whether a release defect might contribute to 
the decrease in plaque size observed following infection with A36 ∆NPF 1-3. 
Monolayers of BS-C-1 cells were infected with WR and A36 ∆NPF 1-3 at a low 
multiplicity of infection (MOI = 0.1). In order to quantify EEV numbers, media was 
collected from infected cells at 16 hpi and infected cells were collected separately to 
determine the amount of cell-associated virus (IMVs, IEVs, and CEVs) produced. Both 
EEV fractions and cell-associated virus fractions were quantified by plaque assay 
titration on monolayers of BS-C-1 cells. Cells were fixed 48 hpi and stained with crystal 
violet to visualise the number of plaques formed, and therefore determine the number of 
viral particles produced (pfu/ml). The total cell-associated virus did not differ following 
infection with WR or A36 ∆NPF 1-3 in agreement with initial growth curves (Figure 
4.6 B) (Figure 5.3 A). Both WR and A36 ∆NPF 1-3 led to the production of around 2 x 
105 infectious particles (IMVs, IEVs, and CEVs) after 16 hours of infection. Infection of 
BS-C-1 cells with WR lead to the release of 664 EEV/ml. In contrast, A36 ∆NPF 1-3 
led to a four-fold decrease in the number of EEV released (149 EEV/ml) (Figure 5.3 B).  
 
A time course of EEV release was carried out in order to assess the dynamics of EEV 
release between WR and the A36 ∆NPF 1-3 virus. Viral proteins are recycled from the 
plasma membrane to the TGN in order to facilitate the continuous generation of new 
IEV and EEV, therefore I sought to determine whether A36 ∆NPF 1-3 EEV were 
continually released over time, or were stalled due to a recycling defect. As in the 
previous experiment, confluent BS-C-1 cells were infected with WR and A36 ∆NPF 1-3 
at an MOI = 0.1. Supernatants were collected every hour for 16 hours and the numbers 
of EEVs released were quantified following titration on confluent BS-C-1 monolayers. 
The amount of EEV released by both viruses increases over time, however, in the case 
of A36 ∆NPF 1-3 virus this increase is significantly delayed compared to WR (Figure 
5.3 C). Taken together this data suggests that the decrease in plaque size observed in the 
absence of the A36 NPF motifs is due to a significant defect in the release of EEV from 
the plasma membrane, and is not indicative of a recycling defect.  
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Figure 5.3 The A36 NPF 1-3 virus is deficient in EEV release  
A Quantification of the number of cell-associated virus particles at 16 hpi following the 
infection of BS-C-1 cells with WR or A36 ∆NPF 1-3 viruses. The number of cell-associated 
virus particles was determined by plaque assay in duplicate on BS-C-1 monolayers. At 48 hpi 
plaques were fixed, stained with crystal violet, and enumerated. B Quantification of the number 
of EEV released into 1 ml of supernatant at 16 hpi following the infection of BS-C-1 cells with 
WR or A36 ∆NPF 1-3 viruses. The number of EEVs released was determined by plaque assay 
as above. C Time course of EEV release was determined as above, however, supernatants were 
collected every hour post infection. Error bars represent SEM over 3 independent experiments. 
All release assays were carried out in triplicate per experiment. A p value of < 0.001 is indicated 
by ***. ns indicates a p value > 0.05. 
 
 
  Chapter 5. Results 
 
 135 
5.2.3 The role of the A36 NPF motifs during vaccinia super-repulsion  
Following EEV release viral particles must reach a neighbouring cell in order for 
infection to progress. Once on the plasma membrane of an adjacent cell the EEV may 
directly infect this cell. However, if an adjacent cell is already infected, reinfection is 
inhibited by the presence of the early viral A56-K2 complex present on the plasma 
membrane, in process termed superinfection exclusion (Laliberte and Moss, 2014; 
Wagenaar and Moss, 2009). The early expression of the viral proteins A36 and A33 in 
newly infected cells is however sufficient for EEV to induce an actin tail and be 
propelled to a non-infected cell (Doceul et al., 2010). This allows vaccinia to spread and 
infect cells distal from the initial site of infection four-fold faster than would be 
predicted from the rate of vaccinia virus replication alone (Figure 5.4).  
 
 
 
 
 
 
 
 
Figure 5.4 Does A36 clustering enhance accelerated viral spread? 
A36 and A33 mediate both primary and secondary actin tail formation in order to enhance viral 
spread via super-repulsion. The role of the A36 NPF motifs to facilitate clustering of viral 
proteins and mediate super-repulsion in newly infected cells was investigated.  
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Given the essential role of A36 in actin tail formation, I next investigated the role of the 
NPF motifs in the formation of actin tails during super-repulsion. In order to do this a 
similar approach was utilised as in Doceul et al 2010. The natural promoter of the A36R 
gene induces A36 expression both early and late during infection (Figure 4.6) 
(Parkinson and Smith, 1994). To separate the early and late expression of A36 during 
infection, a recombinant virus was generated that expressed A36 solely under a late 
promoter. Following infection with this virus, recently infected cells are unable to 
express A36. Therefore upon arrival at the plasma membrane of these cells, EEVs are 
incapable of inducing secondary actin tails, thus decreasing overall viral spread (Doceul 
et al., 2010).  
 
In order to generate a virus expressing A36 under a late promoter, WR-∆A36R was 
used as the viral backbone. A synthetic late promoter (4b) was synthesised and ligated 
to the 5’ end of the A36R coding region of both wild type and ∆NPF 1-3 A36 (Figure 
5.5). This 4b-A36R construct was subcloned into a plasmid containing the right and left 
arms of homology of the vaccinia thymidine kinase (TK) locus (Chakrabarti et al., 
1997). The A36 ∆NPF recombinants generated in the previous chapter were inserted 
into the endogenous A36R locus, upstream of which contains the endogenous early-late 
viral promoter. In order to limit A36R expression to late alone, the TK locus was used 
as an insertion site, as in Doceul et al 2010. Vaccinia thymidine kinase is non-essential, 
and is expressed during the first 4 hours post infection, after which it is subsequently 
switched off by a number of viral proteins in a translational repression mechanism 
(Byrd and Hruby, 2004). Vaccinia strains lacking thymidine kinase have, however, been 
shown to be less virulent in mice (Buller et al., 1985). The vector consisting of the TK 
locus homology arms and 4b-A36R (TKLA-4b-A36R-TKRA) was transfected into 
∆A36R infected HeLa cells in order to generate recombinants by homologous 
recombination as described in the previous chapter (Figure 5.5 A). Recombinants were 
selected by the rescue in plaque size compared to the ∆A36R virus and purified over 
four rounds of selection (Figure 5.5 B). Viruses expressing A36 wild type or A36 ∆NPF 
1-3 under the late 4b promoter will subsequently be referred to as A36late and ∆NPFlate 
respectively.  
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In order to confirm that expression of A36 was solely under the control of the 4b late 
promoter a time course was carried out to determine the temporal expression pattern of 
A36. HeLa cells were infected with an equal MOI of the WR, A36late, and ∆NPFlate 
viruses. Lysates were collected every hour post infection and A36 expression assessed 
by immunoblot analysis. As observed previously, following infection with WR and A36 
∆NPF 1-3, expression of A36 commenced at 1-2 hpi (Figure 4.6 A). In contrast, 
expression of A36 from A36late and ∆NPFlate viruses only began from 7 hpi (Figure 5.6). 
To confirm late expression of A36, infected cells were also treated with arabinosyl 
cytosine (AraC). AraC, is a well-characterised inhibitor of DNA synthesis, and during 
vaccinia infection only permits early gene expression to proceed (Taddie and Traktman, 
1993). HeLa cells were treated 1 hour prior to infection with 50 µm/ml of AraC that 
was maintained throughout infection. HeLa cells were infected with WR, A36late and 
∆NPFlate viruses in the presence or absence of AraC and cell lysates processed for 
immunoblot analysis after 12 hpi. A36 is present in WR infected cells with and without 
AraC treatment, indicating that A36 is expressed both early and late during infection 
(Figure 5.6). However, following infection with the A36late and ∆NPFlate viruses, the 
presence of AraC prevented expression of A36, indicating that there is no early 
component of A36 expression, and confirming that expression of A36 in these viruses is 
solely under the control of a late promoter (Figure 5.6).  
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Figure 5.5 Generation of A36 wild type and ∆NPF 1-3 under a late promoter 
A The sequence of the 4b promoter used is shown, with the ‘late’ elements underscored. 
Schematic detailing the cloning steps taken to generate the late A36 targeting vector. 1. 4b was 
ligated with full length A36R. 2. 4b-A36R was subcloned into restriction sites flanked by the 
left and right homology arms of the thymidine kinase gene locus. 3. This was used as the 
targeting vector in ∆A36R infected HeLa cells. B Plaques depicting the rescue in plaque size 
above that of ∆A36R used to select positive recombinants.  
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Figure 5.6. Characterisation of the A36late and the ∆NPFlate viruses 
Immunoblot showing the expression of A36 in cells infected with late A36 viruses compared to 
WR. AraC treatment of infected HeLa cells blocks expression of late A36 but not A36 
expression early during infection. Vinculin is shown as a cellular loading control. 
 
 
In order to confirm the published defect in viral spread upon late expression of A36, I 
measured the size of plaques formed in BS-C-1 monolayers following infection with 
A36late compared to WR at 48 hpi. In agreement with Doceul et al, plaques formed by 
the A36late virus were significantly smaller than WR (0.61 ± 0.03 mm and 1.21 ± 0.04 
mm respectively) (Figure 5.7 A, B). As observed in Chapter 4 expression of A36 ∆NPF 
1-3 under the endogenous A36 promoter, led to smaller plaques than those induced by 
WR (0.71 ± 0.04 mm and 1.21 ± 0.04 mm respectively). Interestingly, there was no 
significant difference in plaque size between A36 ∆NPF 1-3 under its endogenous 
promoter compared to wild type A36 expressed under the late promoter (A36late). To 
determine whether the presence of the A36 NPF motifs contributes to a further decrease 
in spread when A36 is expressed late during infection, the plaques formed by ∆NPFlate 
viruses were also measured. ∆NPFlate also induced smaller plaques than WR, however, 
these were the same size as both A36 ∆NPF 1-3 and A36late (0.61 ± 0.03 mm) (Figure 
5.7 A, B). The loss of the NPF motifs when A36 is expressed late in infection does not 
result in a further decrease in plaque size, suggesting that the NPF motifs do not 
contribute to super-repulsion. 
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Figure 5.7 The A36late and ∆NPFlate viruses are equally deficient in viral spread  
A Representative images of viral plaques produced by the indicated viruses in confluent BS-C-1 
cells revealed by staining with crystal violet 48 hpi. Scale bar = 5 mm. B Graph shows 
quantification of plaque diameters produced by the indicated viruses. Error bars represent SEM 
from N = 100 plaques from 3 independent experiments. A p value of < 0.0001 is indicated by 
****. A p value of < 0.001 is indicated by ***. ns indicates a p value > 0.05. 
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I next investigated whether there was a decrease in EEV release at 16 hpi between the 
A36late and ∆NPFlate viruses, as is the case following A36 ∆NPF1-3 infection (Figure 
5.3). A36 ∆NPF1-3, A36late, and ∆NPFlate all exhibited a significant defect in EEV 
release, with all three A36 recombinant viruses releasing a quarter of the number of 
EEVs than WR (Figure 5.8 A). This raises several interesting questions regarding super-
repulsion. This data suggests that the plaque size defect observed following infection 
with the late A36 viruses is largely due to the production of significantly fewer EEVs 
compared to WR. This implies that while the ability to propel EEV along recently 
infected cells via early expression of A36 may contribute to viral spread through a 
monolayer, it may not have as great a contribution as previously suggested.  
 
To examine the process of super-repulsion more closely, I assessed the ability or lack 
thereof of vaccinia to produce secondary actin tails in cells in the early hours of 
infection. A time course of infection was carried out in order to determine the optimal 
time point at which to visualise secondary actin tails by immunofluorescence imaging. 
Monolayers of BS-C-1 cells fixed at 10-12 hpi resulted in a cluster of 1-2 heavily 
infected cells surrounded by newly infected cells. The late stage of viral infection was 
determined based on several criteria such the presence of a large well established viral 
DNA factory, and a large number of viral particles in the cell periphery. Newly infected 
cells were classified based on the absence of viral particles, and the lack of a viral DNA 
factory. In addition plaques were stained for the early viral protein I3, which localises to 
initial sites of viral replication that precede the formation of the viral factory (Rochester 
and Traktman, 1998; Welsch et al., 2003). As the number of EEV in contact with 
neighbouring recently infected cells would directly impact on the ability to induce an 
actin tail, the ability of viruses to induce secondary actin tails was therefore quantified 
as a percentage of EEV in contact with neighbouring cells. Although initial 
quantification suggested a decrease in the ability of A36 ∆NPF 1-3 virus to induce 
secondary actin tails to the same extent as that of both A36late and ∆NPFlate, this was 
consequently found not to be the case when quantified in a double-blind experiment to 
eliminate human bias.  
 
  Chapter 5. Results 
 
 142 
The quantification of secondary actin tails proved challenging due to the rarity of such 
events. The total number of secondary actin tails observed on recently infected cells was 
extremely low and in the range of 0-10. Analysis of super-repulsion was also 
complicated by the fact that the morphology of secondary actin tails induced during 
super-repulsion differed from those produced during primary infection. Secondary actin 
tails were less uniform, and often punctate or elongated in appearance (Figure 5.8 B). 
Only actin structures that were distinct from cellular actin staining and resembled an 
actin tail (albeit long or short) were counted. In addition, it could not always be 
determined from which cell actin tail-like structures originated, further complicating 
analysis.   
 
Unbiased experiments which were scored double-blind, were unable to detect a 
significant difference in the ability of the WR and A36 ∆NPF 1-3 viruses to induce 
secondary actin tails on recently infected cells (Figure 5.8 B, C). In WR and A36 ∆NPF 
1-3 infected BS-C-1 cells approximately 5% of EEVs in contact with recently infected 
cells were observed to induce an actin tail-like structure. Both A36late and ∆NPFlate did 
exhibit a decrease in the number of secondary actin tails compared to WR and A36 
∆NPF 1-3, although there was no significant difference between the two late A36 
viruses (Figure 5.8 C). It is worth noting that on average 1% of both A36late and 
∆NPFlate EEVs were determined to produce secondary actin tails. As earlier work has 
shown the requirement of early A36 expression for this process, it can be presumed this 
1% represents error in detection of actin tails. This error margin is most likely derived 
from actin tails counted on the surface of recently infected cells, which are in fact a 
result of actin tails projecting from the adjacent heavily infected cell. Given the 
significant challenge in the identification of secondary actin tails, the role of the A36 
NPF motifs during this process remains an open question. If correct however, this 
preliminary analysis would suggest that the A36 NPF motifs do not play an active role 
in the ability to nucleate actin tails on recently infected cells. Further analysis must be 
carried out to validate the contribution of this mechanism of spread. Infection with a 
virus unable to induce the formation of primary actin tails (A36 YdF) would more 
clearly determine whether the actin structures observed in this analysis were a result of 
active viral recruitment of the actin-signalling network.  
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Figure 5.8 Do A36 NPF motifs contribute to super-repulsion? 
A The EEV release of late A36 viruses compared to WR and A36 ∆NPF 1-3. EEV were 
quantified per ml of supernatant at 16 hpi as previously described. Error bars represent SEM 
over 3 independent experiments. B Representative images of monolayers of infected BS-C-1 
cells fixed at 12 hpi. Cells were stained with B5 and phalloidin to visualize EEV and actin tails 
respectively. A dashed yellow line designates heavily infected cells producing EEV. Scale bar = 
20 µm. Secondary actin tails on recently infected cells are inset and indicated by white arrows. 
Scale bar = 10 µm. C Quantification of the percentage of EEV inducing secondary actin tails. 
Error bars represent SEM of N = 60 cells in 3 independent experiments. A p value of < 0.001 is 
indicated by ***. ns indicates a p value > 0.05.  
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5.2.4 A36 NPF motifs are required for Cdc42 recruitment 
Despite an uncharacterised role during the process of super-repulsion mediated spread, 
it is clear that the presence of the A36 NPF motifs results in enhanced viral spread 
through a monolayer of cells, and the ability to release greater numbers of EEV. In 
Chapters 3 and 4 it was shown that the A36 NPF motifs are required to bind and recruit 
intersectin-1. In addition RNAi depletion experiments determined that intersectin-1 
(along with Eps15) are required to mediate AP-2 recruitment to CEV. Intersectin-1 has 
been recently shown to promote actin tail formation via its activation of Cdc42 
(Humphries et al., 2014). However the mechanism of intersectin-1 and Cdc42 
recruitment to vaccinia had not been investigated up to this point. I therefore 
investigated the role of the A36 NPF motifs during Cdc42 recruitment and whether this 
facilitates viral spread and release.    
 
To explore whether the recruitment of Cdc42 was dependent on the A36 NPF motifs, 
HeLa cells were infected with WR or the A36 ∆NPF 1-3 virus, subsequently transfected 
with GFP-Cdc42, and processed for immunofluorescence at 8 hpi. In contrast to the 
recruitment of N-WASP observed in Chapter 4, GFP-Cdc42 localises to WR but not the 
A36 ∆NPF 1-3 virus (Figure 5.9). This confirms that in addition to recruiting AP-2 prior 
to actin tail formation, intersectin-1 is also required for the localisation of Cdc42 on the 
virus during egress (Humphries et al., 2014). Intersectin-1 must therefore play a crucial 
role in both the polarisation of A36 and N-WASP (via AP-2) and N-WASP activation 
(via Cdc42).   
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Figure 5.9 A36 NPF motifs are required to recruit Cdc42  
Representative immunofluorescence images of HeLa cells expressing GFP-Cdc42 and infected 
with WR and A36 ∆NPF 1-3 respectively. CEV were stained with B5 antibody prior to 
permeabilization (white arrows). Scale bars = 10 µm. 
 
To probe the effect of the loss of Cdc42 recruitment to the virus, mouse embryo 
fibroblasts from N-WASP -/- mice were used that stably express GFP-N-WASP or the 
GFP-N-WASP H208D mutant that lacks the ability to bind activated Cdc42 (Humphries 
et al., 2014; Miki et al., 1998; Moreau et al., 2000). The loss of Cdc42 binding to N-
WASP H208D was confirmed by GFP-Trap pull-down assays (Figure 5.10). MEFs 
stably expressing GFP-N-WASP or GFP-N-WASP H208D were transfected with GST-
Cdc42 and infected with either WR or A36 ∆NPF 1-3. GFP-Trap pull-downs were 
carried out from infected cell lysates and analysed by immunoblot. Wild type N-WASP 
was able to bind GST-Cdc42 and in agreement with published data, the N-WASP 
H208D mutant was unable to associate with Cdc42 (Figure 5.10) (Humphries et al., 
2014; Miki et al., 1998; Moreau et al., 2000). Curiously, while wild type N-WASP 
could also pull down A36 during infection with WR, the H208D mutant was unable to 
bind A36. Previous work has established that the N-WASP H208D mutant can still be 
recruited to CEV at the plasma membrane, although it has an increased turnover rate 
(Humphries et al., 2014). N-WASP H208D forms a less stable actin-signalling complex 
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beneath the CEV, which may explain why binding of N-WASP H208D and A36 is not 
observed in this assay (Humphries et al., 2014). Similarly, A36 ∆NPF 1-3 is unable to 
associate with either wild type N-WASP or the H208D mutant, despite the fact that N-
WASP is detected on virus particles 8 hpi with A36 ∆NPF 1-3 (Figure 4.11). Together 
this suggests less robust N-WASP recruitment in the absence of the NPF motifs. 
 
                                                
 
Figure 5.10 N-WASP cannot form a stable complex with A36 ∆NPF 1-3  
Immunoblot analysis of GFP-Trap pull-downs performed on N-WASP -/- MEFs infected with 
WR and A36 ∆NPF 1-3 viruses. MEFs expressing the indicated GFP-N-WASP constructs were 
transfected with GST-Cdc42. Binding of endogenous A36 or A36 ∆NPF 1-3 expressed during 
the course of infection is indicated by A361-221.  
 
5.2.5 Distinguishing the duel roles of intersectin-1 
Intersectin-1 clearly plays two roles; I therefore sought to address the relative 
contributions of AP-2 recruitment and N-WASP activation during viral spread and 
release. The role that the A36 NPF motifs play in viral spread was examined in the 
absence of Cdc42-mediated activation of N-WASP by taking advantage of N-WASP -/- 
MEFs expressing GFP-N-WASP-H208D (hereon referred to as NW-H208D). The 
diameter of WR and A36 ∆NPF 1-3 plaques in confluent monolayers of N-WASP wild 
type (NW-WT), H208D (NW-H208D), and null (-/-) cell lines were measured. Plaques 
were visualized by staining with anti-B5 antibody (Figure 5.11 A). In agreement with 
plaque assays carried out in BS-C-1 cells, infection of NW-WT cells with A36 ∆NPF 1-
3, resulted in a significant decrease in plaque diameter at 48 hpi compared to WR 
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infection (0.92 ± 0.02 mm and 1.18 ± 0.02 mm respectively) (Figure 5.11 B). Infection 
of WR in NW-H208D cells also results in significantly smaller plaques than in NW-WT 
cells (0.95 ± 0.02 mm and 1.18 ± 0.02 mm respectively) (Figure 5.11 B). Infection of 
NW-H208D cells with the A36 ∆NPF 1-3 virus led to an addition decrease, with viral 
plaques averaging 0.78 ± 0.01 mm in diameter.  
 
During infection with WR, the decrease in plaque size between NW-WT and NW-
H208D cells results due to the loss of the ability Cdc42 to bind and locally activate N-
WASP H208D beneath the virus (Figure 5.11 D) (Humphries et al., 2014). Plaques 
induced by WR in NW-H208D cells and those induced by A36 ∆NPF 1-3 in NW-WT 
cell lines have an equivalent decrease in plaque size. This confirms that intersectin-1 
recruitment (via the A36 NPF motifs) is required to recruit and locally activate Cdc42 
(Figure 5.11 D). This in turn results in N-WASP activation and enhanced Arp2/3-
mediated actin polymerisation. Infection of NW-H208D cells with A36 ∆NPF 1-3 did 
however result in an additional decrease in plaque size. This suggests that the NPF 
motifs play an additional role independent of Cdc42. This additive plaque defect is 
likely to represent the contribution of AP-2 mediated clustering at the plasma membrane.  
 
In order to determine whether the defect in viral spread is mirrored by a reduction in 
viral release, the extent of EEV released during infection of N-WASP MEFs was 
determined as previously described (Figure 5.11 C). Following infection with WR, NW-
WT cells produced on average 660 EEVs/ml after 16 hours of infection, comparable to 
WR EEV release from BS-C-1 cells (Figure 5.3). In NW-H208D cells WR EEV release 
decreased by half to 338 EEVs/ml (Figure 5.11 C). Loss of the A36 NPF motifs led to a 
significant defect in EEV release in both the WT and H208D N-WASP cell lines. 
Following infection with A36 ∆NPF 1-3, NW-WT cells produced on average 311 
EEV/ml, in N-WASP H208D cells this further decreased to an average of 197 EEV/ml. 
Taken together this data supports a role for intersectin-1 upstream of Cdc42 and N-
WASP to enhance both viral spread and release. This role is dependent on the presence 
of the A36 NPF motifs, which also mediate AP-2 and clathrin recruitment.  
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In order to obtain further evidence for this model I used a selective small molecular 
inhibitor (ZCL278) that disrupts Cdc42-intersectin-1 binding (Friesland et al., 2013). 
This inhibitor results in the disruption of a number of Cdc42-intersectin-1 specific 
functions such as golgi organisation, cell motility and grown cone dynamics (Friesland 
et al., 2013).  The size of plaques were measured following infection with WR or A36 
∆NPF 1-3 viruses in N-WASP WT or H208D cell lines in the presence of ZCL278. 
Plaque assays in the presence of DMSO were used as controls (Figure 5.11 A). In all 
cases plaques formed on NW-WT and NW-H208D cells were significantly decreased in 
size compared to controls (Figure 5.11 A, Figure 5.12 A). In contrast, plaques formed in 
N-WASP -/- cells were the same size with or without drug treatment (Figure 5.11 A, 
Figure 5.12 A). This implies that ZCL278 treatment does not have any N-WASP 
independent off target effects during vaccinia infection.  
 
NW-WT and NW-H208D cells were infected with WR or A36 ∆NPF 1-3 in the 
presence of ZCL278. After 48 hours plaques were fixed, permeabilized, stained with B5 
antibody, and measured as previously described. In the presence of ZCL278 WR 
plaques in NW-WT and NW-H208D cells were equal in size (0.68 ± 0.02 mm and 0.69 
± 0.01 mm respectively), confirming that drug treatment was successful in blocking 
Cdc42 activity in a viral context (Figure 5.12 A, B, C). Following ZCL278 treatment of 
A36 ∆NPF 1-3 infected NW-WT cells, there was no additional decrease in plaque size 
(0.64 ± 0.01 mm). A36 ∆NPF 1-3 infection of NW-H208D cells, however, once again 
led to a further decrease in plaque size to 0.55 mm ± 0.01 in the presence of ZCL278 
(Figure 5.12 A, B).  
 
Taken as a whole, this data supports the crucial role that intersectin-1 plays in mediating 
N-WASP activation via Cdc42. This data also confirms that the NPF motifs are 
primarily responsible for recruitment of intersectin-1 to the virus, which is essential for 
Cdc42 mediated activation of N-WASP. WR infection of NW-H208D cells and A36 
∆NPF 1-3 infection of NW-WT cells both led to an equivalent decrease in spread and 
release compared to WR infection of NW-WT cells. This decrease results due to the 
loss of Cdc42 mediated activation of N-WASP in both cases (Figure 5.11 D). In NW-
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H208D cells, Cdc42 is unable to bind N-WASP, and during A36 ∆NPF 1-3 infection 
Cdc42 is not recruited to CEV.  
 
The additional contribution of the NPF motifs to mediate AP-2 recruitment and 
clustering of the actin signalling complex was revealed following A36 ∆NPF 1-3 
infection of NW-H208D cells compared to WT-NW cells. Infection of NW-H208D 
cells with the A36 ∆NPF 1-3 exhibited an additional decrease in plaque size and release, 
however plaques did not diminish to those formed in N-WASP -/- cells. This highlights 
a Cdc42-independent, N-WASP dependent role of intersectin-1, and is indicative of the 
requirement of intersectin-1 to recruit AP-2. Moreover this suggests that clathrin 
mediated clustering of A36 and its actin-polymerisation machinery is primarily to 
facilitate the formation of a dense N-WASP signalling network, and does not provide 
any additional force to extrude the virus from the membrane or release IEV tethering to 
the membrane. Consistent with this, plaques in N-WASP -/- MEFs are equivalent 
following infection with WR or A36 ∆NPF 1-3, confirming the A36 NPF motifs do not 
play a role in viral spread independent of N-WASP.  
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Figure 5.11 Loss of N-WASP-Cdc42 interaction mimics the loss of the A36 NPF motifs  
A Representative images of WR and A36 ∆NPF 1-3 plaques formed in N-WASP -/- MEFs 
expressing GFP-N-WASP or GFP-N-WASP-H208D and stained with anti-B5 antibody. B 
Quantification of plaque diameter at 48 hpi. Error bars represent SEM of N=100-150 plaques in 
three independent experiments. C Quantification of EEV release at 16 hpi from GFP-N-WASP 
cell lines infected with WR or A36 ∆NPF 1-3. Error bars represent SEM over 3 independent 
experiments. A p value of < 0.001 is indicated by ***. A p value of < 0.01 is indicated by **. ns 
indicates a p value > 0.05.  D Schematic illustrating the intersectin-1-Cdc42-N-WASP 
signalling network mediated by A36. 
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Figure 5.12 ZCL278 treatment of GFP-N-WASP cell lines confirms the requirement of the 
NPF motifs for viral spread 
A Representative images of WR and A36 ∆NPF 1-3 plaques formed in N-WASP -/- MEFs 
expressing GFP-N-WASP or GFP-N-WASP-H208D and stained with anti-B5 antibody. Cells 
were maintained in 50 µM ZCL278 during the course of infection.  B Quantification of plaque 
diameter at 48 hpi. Error bars represent SEM of N=100-150 plaques in three independent 
experiments. A p value of < 0.0001 is indicated by ****. A p value of < 0.01 is indicated by **. 
ns indicates a p value > 0.05.  C Schematic illustrating the additional effect of ZCL278 
treatment in the vaccinia actin-signalling network. 
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5.2.6 Viral release mediated by the A36 NPF motifs is actin-dependent  
Given the marked defect in viral release upon loss of the A36 NPF motifs, I sought to 
more closely investigate the mechanism governing release of CEV from the plasma 
membrane. My data suggest that the primary role of the A36 NPF motifs is to recruit 
intersectin-1 and mediate Cdc42 dependent N-WASP activation. The A36 YdF mutant 
contains two phenylalanine substitutions in place of A36 tyrosine 112 and 132 (Rietdorf 
et al., 2001). This A36 mutant cannot be phosphorylated and therefore cannot recruit the 
vaccinia actin-polymerisation machinery (Moreau et al., 2000; Rietdorf et al., 2001). 
A36 YdF can, however, associate with AP-2 via the three NPF motifs (Figure 5.13 A). 
It has been previously established that infection with a virus expressing A36 YdF 
results in a small plaque phenotype and is defective in its ability to release EEV 
(Horsington et al., 2013). It has been suggested that without actin polymerisation as a 
driving force, the A36 YdF virus remains trapped in invaginated pits at the plasma 
membrane, this in turn inhibits EEV release (Horsington et al., 2013). A36 ∆NPF1-3 
despite releasing fewer EEV can make still make actin tails. Given the reduced EEV 
release of both A36 YdF and A36 ∆NPF1-3 viruses, I sought to determine the 
contribution of the actin driving force for viral release. 
 
In order to address this question, I combined the YdF and ∆NPF 1-3 mutations in a 
single A36 recombinant virus. The A36 YdF-∆NPF recombinant virus was created via 
homologous recombination into the A36R locus in cells infected WR-∆A36R as 
previously described (see Figure 4.5). The temporal expression of A36 following 
infection with A36 YdF and A36 YdF-∆NPF viruses in HeLa cells was unchanged from 
that of WR (Figure 5.13 B & Figure 4.6). In order to determine how the spread of 
vaccinia is affected in the absence of both actin polymerisation and AP-2 recruitment, I 
initially measured the size of plaques induced by A36 YdF-∆NPF compared to the A36 
YdF and A36 ∆NPF 1-3 viruses. Infection with A36 YdF and A36 YdF-∆NPF resulted 
in plaques that were both on average 0.61 ± 0.02 mm in diameter, significantly smaller 
that those observed following infection with both WR and A36 ∆NPF 1-3 (1.4 ± 0.01 
mm and 0.93 ± 0.02 mm respectively) (Figure 5.13 C).  
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Next I sought to determine whether the combination of the loss actin tails (YdF) and 
clathrin recruitment (∆NPF) lead to an additive decrease in EEV release at 16 hpi. 
Curiously, both A36-YdF and A36-YdF-∆NPF viruses were found to release an 
equivalent number of EEVs as each other, as well as, that of the A36 ∆NPF 1-3 virus 
(on average 200 EEVs/ml) (Figure 5.13 D). Although A36 ∆NPF 1-3 induces 
significantly larger plaques than either of the A36-YdF or A36-YdF-∆NPF viruses, 
EEV release was equally low in all viruses compared to WR (Figure 5.13 C, D).  
 
As there is no additive defect in either plaque size or EEV release between the A36-
YdF and A36-YdF-∆NPF viruses, this confirms that clathrin alone in the absence of 
actin polymerisation is not sufficient to aid CEV release from the plasma membrane. 
This supports the notion that an actin-dependent step is required to promote viral release 
from the plasma membrane. The increase in plaque size of A36 ∆NPF 1-3 compared to 
both the A36-YdF and A36-YdF-∆NPF viruses may be indicative of differences in the 
extent of viral presentation on the plasma membrane. A36 ∆NPF 1-3 although defective 
in viral release, would however be predicted to be extruded from the plasma membrane 
in the membrane in an actin-dependent manner, and therefore able to mediate direct 
cell-to-cell spread to some extent. In contrast, both A36-YdF and A36-YdF-∆NPF 
viruses are predicted to be trapped within membrane in the absence of actin 
polymerisation, and thus unable to contact neighbouring cells, and limiting their spread.   
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Figure 5.13 Loss of NPF motifs does not impact viral spread in the absence of actin 
polymerisation 
A GFP-Trap pull-down assay on GFP-A36 1-221 WT, YdF and ∆NPF 1-3 mutants. The YdF 
mutant does not prevent AP-2 recruitment. B Immunoblot showing a time course of A36 
expression. HeLa cells were infected with YdF and YdF-∆NPF viruses respectively and 
samples collected every hour for 12 hpi. C Quantification of WR, A36-∆NPF 1-3, YdF, and 
YdF-∆NPF plaque diameter in BS-C-1 cells. Cells were fixed and stained with crystal violet 48 
hpi to visualise plaques. N=100. D The number of EEV released/ml following infection of BS-
C-1 cells with WR, A36-∆NPF 1-3, YdF, and YdF-∆NPF viruses. Supernatants were collected 
at 16 hpi and EEV numbers quantified by plaque assay after 48 hpi. Error bars represent SEM 
over 3 independent experiments. A p value of < 0.001 is indicated by ***. ns indicates a p value 
> 0.05.   
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5.3 Summary 
In this chapter I have investigated the role of the endocytic NPF motifs during viral 
release and spread. The loss of the NPF motifs reduces cell-to-cell spread of the virus, 
and this is as a direct consequence of reduced viral release from primary infected cells. 
To investigate a possible role for the A36 NPF motifs during super-repulsion of viral 
particles, EEV release of the late viruses was quantified. Interestingly the ability of 
vaccinia to release EEV when A36 (wild type or ∆NPF) was solely under a late 
promoter was diminished by a quarter, as was the case with the A36 ∆NPF 1-3 virus. 
No evidence, however, could be found to link the role of NPF motifs to the ability to 
induce actin tails during super-repulsion. It is highly likely, however, that the dynamics 
of actin tail formation induced by EEVs (secondary actin tails) would differ from those 
induced from cell derived IEVs (primary actin tails).  
 
The A36 NPF motifs are however required to recruit Cdc42 via intersectin-1, and thus 
to promote N-WASP activation beneath the virion. Loss of the NPF motifs in the 
absence of Cdc42 activity indicated that the ability of the virus to recruit AP-2 and 
clathrin machinery to enhance viral spread was also dependent on N-WASP mediated 
actin-polymerisation. Generation of the A36 YdF-∆NPF virus allowed the closer 
investigation of the role of the NPF motifs independent of tyrosine phosphorylation. 
This confirmed that clathrin is unable to facilitate CEV release in the absence of the 
actin-polymerisation complex. 
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Chapter 6. Discussion  
The functional characterisation of the vaccinia IEV protein A36 has revealed an 
intricate and highly complex signalling network that enables and promotes viral egress. 
N-WASP is recruited together with WIP, and is stabilised beneath the virus via a 
network of interactions with Nck, Grb2, and Cdc42 (Donnelly et al., 2013; Humphries 
et al., 2014; Weisswange et al., 2009). Prior to actin polymerisation, AP-2 and clathrin 
are recruited to cluster the actin-signalling network, resulting in highly efficient actin 
tail formation (Humphries et al., 2012). In this thesis, I aimed to characterise the 
mechanism governing AP-2 and clathrin recruitment, and have revealed that A36 
utilises host like NPF motifs to recruit the EH domain containing proteins intersectin-1 
and Eps15. I showed that intersectin-1 and Eps15 are required to mediate AP-2 
recruitment via A36, and also that the NPF motifs of A36 are necessary and sufficient 
for recruitment of the endocytic machinery. Furthermore, intersectin-1 appears to act as 
a key modulator, regulating both AP-2 and actin dependent processes in order to 
enhance viral spread and release.   
 
6.1 The first characterised viral NPF motifs 
During the course of this study, I aimed to characterise the molecular mechanism 
governing the recruitment of AP-2 and clathrin to vaccinia during viral egress. I 
identified and characterised three Asn-Pro-Phe (NPF) motifs in A36 that are highly 
conserved among the Orthopoxviruses and essential for the recruitment of AP-2 and 
clathrin (Figure 3.7, 4.7). These NPF motifs were shown to mediate binding of AP-2 
and clathrin via the EH domain containing proteins, intersectin-1 and Eps15 (Figure 
3.6). Eps15 is a key component of clathrin-coated pits, and acts to facilitate recruitment 
of AP-2 to early endocytic sites (Benmerah et al., 1998; Benmerah et al., 2000; Tebar et 
al., 1996). Intersectin-1 plays a role in the regulation of actin dynamics, and has also 
been linked to exocytic events at the plasma membrane (Hussain et al., 2001; Yamabhai 
et al., 1998). Intersectin-1 and Eps15 both bind NPF motifs in a range of host factors, 
however no NPF motifs have been identified or characterised in a viral context up to 
this point. 
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Multiple pathogens utilise short host-like motifs to promote all stages of infection. Short 
linear peptide motifs are extremely advantageous as they can be easily packaged into 
viral genomes, and enable single viral proteins, such as A36, to mediate many different 
processes (Davey et al., 2012; Dinkel et al., 2014; Hagai et al., 2014; Handa et al., 
2013). A36 alone facilitates binding to kinesin-1 via the WE/WD motifs, Nck and Grb2 
via phosphotyrosine 112 and 132, and has in this thesis been shown to recruit 
intersectin-1 and Eps15 via conserved NPF motifs (Figure 3.7, 4.7) (Dodding et al., 
2011; Frischknecht et al., 1999a; Scaplehorn et al., 2002; Weisswange et al., 2009). 
Closer analysis of the primary sequence of A36 also reveals the presence of the 
endocytic internalization motif, NPxY at residues 155-158 as well as a predicted PDZ-
binding motif at its C-terminus (216-221: SVVSLV) (Figure 6.1) (Chen et al., 1990; 
Davey et al., 2012). NPxY motifs are found in receptor tyrosine kinases and typically 
mediate binding to Dab-2 PTB domains and have also been shown to bind to FERM-
like domains in sorting nexins (Ghai and Collins, 2011; Keyel et al., 2006; Morris and 
Cooper, 2001; Smith et al., 2006).  
 
 
 
 
 
 
 
Figure 6.1 A36 contains two low complexity regions (LCRs), a NPxY motif, and a PDZ-
binding motif 
Primary sequence of A36. The characterised NPF, phosphotyrosine motifs, and kinesin-1 
binding WE/WD motifs are highlighted in red. Additional motifs included NPxY Dab2 binding 
motif and a predicted PDZ binding motif (both highlighted in blue). Predicted low complexity 
regions (LCRs) are underscored. Transmembrane domain is shown in green. 
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These predicted motifs, however, do not yet have a clear functional role during vaccinia 
infection. The truncated A36 1-155 virus was initially generated to ascertain the role of 
C-terminal tyrosines Y158, Y166, Y200. Early studies showed, that loss of these 
residues did not affect the tyrosine phosphorylation levels of A36 (Frischknecht et al., 
1999a; Weisswange, 2008). The A36 1-155 virus lacks all three NPF motifs, the 
predicted PDZ motif and also disrupts the NPxY motif. Multiple assays presented in 
this thesis have shown that A36 ∆NPF 1-3 and A36 1-155 viruses exhibit identical 
phenotypes. Both recombinant viruses induced longer, faster actin tails than those 
induced by WR (Figure 4.9). Neither virus could recruit clathrin, AP-2, intersectin-1 or 
Eps15, leading to equally defective cell-to-cell spread (Figure 4.7, 5.1). Further 
investigation of the NPxY and PDZ-binding motifs in isolation, would shed light as to 
whether these potential motifs have a functional role during earlier stages of infection. 
 
The residues flanking the NPF motifs have been previously implicated in the specificity 
and binding to EH domains (de Beer et al., 2000; Enmon et al., 2000; Rumpf et al., 
2008; Salcini et al., 1997; Wong et al., 1995). Analysis of intersectin-1 EH1 binding to 
a panel of NPF peptides concluded that intersectin-1 EH1 preferentially binds NPF 
motifs at the C terminus, and is prevented from binding internal NPF motifs (Yamabhai 
et al., 1998). Neither of the A36 NPF motifs are located in close proximity to the C-
terminus, this may explain the observation that intersectin-1 EH1 binds A36 NPF motifs 
with lower affinity compared to intersectin-1 EH2 (Figure 3.6 D). Similarly, the high 
prevalence of S/T residues at positions -1 and -2 respective to the NPF motif in host 
endocytic proteins, suggests that an additional level of regulation mediating EH domain 
binding may be conferred via S/T phosphorylation (Paoluzi et al., 1998; Salcini et al., 
1997; Yamabhai et al., 1998). In accordance with this, A36 NPF1 contains a serine at -1 
and -2, and NPF2 contains a serine residue at position -1. Previous work has shown that 
A36 is heavily phosphorylated on serine residues, which may be therefore be required 
to mediate NPF to EH domain binding specificity (Wolffe et al., 2001). Comparison of 
peptide pull-downs with recombinant Eps15 EH domains 1-3 varied from those carried 
out in the presence of endogenous Eps15 from cell extracts. While endogenous Eps15 
was able to bind NPF2 in isolation, recombinant GST-Eps15 showed clearly reduced 
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binding to NPF2 (Figure 3.6 E, F). This difference may be a direct result of 
phosphorylation of the serine preceding NPF2 to enhance binding to Eps15. 
 
While peptide pull down assays determined that the C-terminus of A36 can directly 
bind both Eps15 and intersectin-1 via their respective EH domains, future in vitro ITC 
measurements may reveal specificity of certain EH domains to particular NPF motifs 
(Fig 3.6). Together with live cell imaging during infection, this approach would assist in 
uncovering both the stoichiometry and hierarchy of A36-mediated recruitment at the 
plasma membrane. It remains unknown whether A36 preferentially binds intersectin-1 
or Eps15, or whether binding of one is sufficient, which in turn localises the other to 
A36 via hetero-oligomerization of their respective coiled-coil domains in vivo (Cupers 
et al., 1997; Wong et al., 2012). Interestingly, imaging during infection showed only a 
small subset of viral particles recruited both simultaneously (Figure 3.5 C).  
 
Knowledge of the preferred binding of A36 to particular EH domains and EH domain 
containing proteins will lead to greater insight into the complex regulation of the 
endocytic machinery during viral egress. A fascinating property of many viral proteins 
is the ability to coordinate multiple signalling networks. How A36 is spatially regulated 
during kinesin-based transport of IEV, after fusion with the plasma membrane, and 
during recruitment of endocytic and actin components, remains to be elucidated. 
Structural analysis of A36 binding to the EH domains of intersectin-1 or Eps15 could 
lead us some way towards understanding the conformation of A36 at a distinct stage of 
viral egress, and how binding of distinct cellular machinery is coordinated in three-
dimensional space. 
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6.2 Interactions and organisation of A36  
During the generation of the C- and N-terminal truncations of A36 described in chapter 
3, it was observed that the full-length cytoplasmic domain could biochemically interact 
with itself (Figure 6.2). How A36 is trafficked to the TGN prior to wrapping, how A36 
is specifically localised to the outer IEV membrane and how A36 is subsequently 
retrieved from the plasma membrane after viral egress, remain key open questions at 
this time.  
 
We now understand the roles that AP-2 and clathrin play in clustering of A36 beneath 
the virus (Humphries et al., 2012). In addition, it would be interesting to determine 
whether the intra- and intermolecular interactions of A36 with other IEV proteins and 
itself plays a part in the maintenance of a tightly clustered IEV scaffold after clathrin 
dissociates from the viral particle, maintaining a robust actin-signalling network 
(Humphries et al., 2012). The self-interaction of A36 may provide an additional layer of 
regulation during egress at the plasma membrane, and perhaps even earlier during viral 
morphogenesis.  
 
As it stands, the minimal region of A36 that can self-interact consists of residues 120-
155, which is able to associate with the N-terminal of A36 spanning residues 55-120 
(Figure 6.2). One attractive hypothesis may be that a central hub of residues in A36 may 
act as a hinge in order to shift the conformation state of the protein from closed to open 
conformation. This may additionally be dependent on the phosphorylation state of A36. 
 
The cytoplasmic region of A36 is predicted to be largely disordered, and SMART 
sequence analysis of A36 identified two low complexity regions (LCRs) spanning 
residues 42-62 and 134-150 (underlined in Figure 6.1, 6.2 B) (Letunic et al., 2015; 
Schultz et al., 1998). Both of these regions of low complexity lie within the regions of 
self-interaction identified experimentally and therefore may act as sticky patches, 
mediating open and closed conformations of A36 in vivo and/or be responsible to 
facilitate clustering of the actin-signalling network beneath the CEV during egress. 
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Figure 6.2 Mechanisms of A36 self-organisation  
A Immunoblot following GFP-Trap pull-downs on truncations of GFP-A36 with GST-A3624-221 
or GST-A36120-155. In both cases GST-A36120-155 can mediate binding to A3624-221 and vice versa. 
In addition GST-A36120-155 can specifically bind the N-terminal A3655-120. B Model of the 
potential inter- and intra-molecular organisation of A36. Pull-down assays have identified 
residues 55-120 (red) and 120-155 (blue) as regions mediating self-interaction. Tyrosine motifs 
(112 and 132), and kinesin-1 binding WE/WD motifs (64/97) are highlighted in bold. The two 
low complexity regions (LCRs) (residues 42-62 and 134-150) are underscored.   
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6.3 Interplay between clathrin machinery and actin dynamics 
6.3.1 Recruitment and activation of intersectin-1 
The discovery and characterisation of the A36 NPF motifs described in this thesis 
uncovers the role of the EH domain containing protein, intersectin-1, to enhance viral 
spread and release (Figure 4.3). Intersectin-1 has been shown to act as a Cdc42 GEF, 
activating Cdc42 via direct binding to its C-terminal DH domain (Hussain et al., 2001; 
Kintscher et al., 2010). In addition, intersectin-1 can directly bind the central proline-
rich region of N-WASP via multiple interactions with its SH3 domains; this upregulates 
intersectin-1 GEF activity and enhances binding of intersectin-1 to Cdc42 (Hussain et 
al., 2001; Rohatgi et al., 1999; Zamanian and Kelly, 2003). This in turn activates a feed-
forward loop, which enhances activation of N-WASP via Cdc42, thus promoting 
Arp2/3-dependent actin polymerisation (Humphries et al., 2014; Hussain et al., 2001). It 
is now clear that this canonical signalling pathway is activated by vaccinia during actin 
tail formation as well as EEV release (Figure 5.11, 5.12) (Humphries et al., 2014). 
Interestingly, recent work has also implicated intersectin-1 (and its homologue, 
intersectin-2) in the formation of actin-rich invadopodia, via direct binding to WIP 
(Gryaznova et al., 2015). WIP binding is directly mediated via the SH3A, C, E domains 
of intersectin-1/2, and was shown to occur independently of N-WASP.  
 
 As N-WASP and WIP are recruited to A36 in complex with one another, it could be 
predicted that intersectin-1 recruitment to vaccinia occurs directly via the WIP, N-
WASP, Cdc42 signalling network (Donnelly et al., 2013; Weisswange et al., 2009). I 
have determined that although A36 ∆NPF 1-3, can recruit WIP and N-WASP, it is 
unable to recruit either intersectin-1 or Cdc42 to the virus, thus neither WIP nor N-
WASP are sufficient to recruit intersectin-1 to vaccinia in the absence of the A36 NPF 
motifs (Figure 4.11, 4.7, 5.9). Furthermore, co-localisation analysis determined that 
approximately 60% of CEV could recruit intersectin-1 in N-WASP -/- cells, confirming 
that intersectin-1 is recruited to vaccinia independently of N-WASP (Figure 4.7). 
Analysis of cell-to-cell spread and EEV release demonstrated that WR infection of a N-
WASP mutant that is unable to bind Cdc42 (N-WASP H208D) resulted in decreased 
viral spread and release to the same extent as that of N-WASP wild type cells infected 
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with A36 ∆NPF 1-3 (Figure 5.11). Overall, this strongly suggests that the A36 NPF 
motifs are required to mediate Cdc42 activation of N-WASP. 
 
Following its recruitment via the A36 NPF motifs, intersectin-1 must then itself be 
activated. Intersectin-1 is regulated by an autoinhibition mechanism, mediated by a 
conserved tryptophan (W1221) within the short linker region between the fifth SH3 
domain (SH3E) and the DH domain (Ahmad and Lim, 2010; Kintscher et al., 2010). 
Although N-WASP is still able to bind the intersectin-1 SH3 domains in its 
autoinhibited state, N-WASP binding is unable to relieve this autoinhibition (Hussain et 
al., 2001; Kintscher et al., 2010; Zamanian and Kelly, 2003). This demonstrates that N-
WASP binding alone is not sufficient to reveal the catalytically active DH-PH domains 
of intersectin-1, and therefore cannot stimulate its GEF activity (Kintscher et al., 2010). 
How autoinhibition of intersectin-1 is relieved is at present unknown. One possibility is 
that binding of the N-terminal EH domains to the A36 NPF motifs mediates a 
conformation change to release binding. While an alternative hypothesis is that direct 
AP-2 binding to the SH3A-B linker via the WADF motif (residues 843-846) releases 
the autoinhibited conformation of intersectin-1 (Pechstein et al., 2010). Following 
release of autoinhibition, intersectin-1 can then bind and activate Cdc42, and in turn 
activate N-WASP (Hussain et al., 2001; Kintscher et al., 2010; Zamanian and Kelly, 
2003). The relative proximity of the tryptophan (W1221) responsible for maintaining 
autoinhibition of intersectin-1 with the AP-2 binding site (residues 843-846) suggests 
this may be a likely scenario (Figure 6.3). Following activation of intersectin-1, 
enhanced binding of activated N-WASP via multiple interactions with the SH3 domains 
of intersectin-1 could subsequently disrupt AP-2 binding. This hypothetical model may 
explain the mechanism governing the temporal dissociation of AP-2 and the clathrin 
coat upon actin tail formation (Humphries et al., 2012). Future studies involving the 
disruption of the intersectin-1 AP-2 binding site would give valuable insight regarding 
both the release of intersectin-1 autoinhibition, and also as to whether the dissociation 
of AP-2 and clathrin is dependent on N-WASP binding to intersectin-1. 
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Figure 6.3 Updated model of the A36 vaccinia actin and clathrin signaling network  
The multiple interactions that form between the various components of the actin-signaling 
network. The A36 NPF motifs directly recruit intersectin-1 and Eps15 which in turn mediate 
binding of AP-2 and clathrin. Recruitment of intersectin-1 mediates binding of Cdc42 and N-
WASP, stabilizing the actin-signaling network. Intersectin-1 has also been shown to recruit AP-
2 via the WADF motif within SH3A-SH3B linker region (843-846). Red asterisk indicates 
SH3E-DH linker region that mediates autoinhibition of intersectin-1 via a conserved tryptophan 
(W1221). 
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6.3.2 Atypical EH domain containing proteins  
N-WASP plays an essential role in promoting Arp2/3 activation, which in turn 
facilitates the formation of actin tails to enhance viral egress and spread. Numerous 
studies have found that N-WASP utilises multiple cellular inputs to enhance its 
activation and to provide tight regulation of its actin nucleation activity. Aside from the 
known vaccinia mediated signalling pathways mentioned thus far, Grb2 can function 
alongside Cdc42 to enhance N-WASP activation, while Nck and PI(4,5)P2 are also able 
to act together to activate N-WASP in a Cdc42-independent manner (Carlier et al., 
2000; Rohatgi et al., 2001). In addition, PI(4,5)P2 can promote the activation of N-
WASP in a Cdc42-dependent manner in the presence of WIP (Bu et al., 2010; Ho et al., 
2006; Martinez-Quiles et al., 2001; Takano et al., 2008).  
 
The precise role and function of PI(4,5)P2 at the vaccinia plasma membrane interface is  
currently unknown. It has been suggested that PI(4,5)P2 can facilitate the activation of 
Cdc42, prior to N-WASP activation (Rohatgi et al., 2000; Rohatgi et al., 1999; Rohatgi 
et al., 2001). In addition, the recruitment of clathrin during endocytic events occurs at 
PI(4,5)P2-rich membranes, acting as a hub to link the clathrin machinery and actin-
dependent events during clathrin-mediated endocytosis (Cocucci et al., 2012). In the 
context of vaccinia infection, PI(4,5)P2-rich membranes may play a similar role to 
coordinate the temporal and spatial events at the membrane during viral egress.  
 
A unique family of EH domain containing proteins, EHD1-4, are atypical in containing 
a single C terminal EH domain (Grant and Caplan, 2008; Kieken et al., 2010; Salcini et 
al., 1997). EHDs localize to distinct membrane compartments and have been implicated 
in endosomal recycling and sorting, and more recently in direct lipid binding (Caplan et 
al., 2002; Naslavsky et al., 2009; Naslavsky et al., 2006). EHD2 specifically localize to 
the plasma membrane, and has been shown to directly interact with PI(4,5)P2 (Blume et 
al., 2007; Daumke et al., 2007; Naslavsky et al., 2009; Simone et al., 2013). EHD2 has 
also been observed to associate with multiple actin rich structures such as filopodia, 
microspikes, and actin-rich ruffles at the plasma membrane (George et al., 2007; 
Guilherme et al., 2004). Curiously, evidence of a link between EHD2 and the actin 
cytoskeleton comes in the form of a conserved cluster of acidic residues directl
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preceding the C terminal EH domain (Guilherme et al., 2004). This acidic cluster has 
been postulated to mimic the acidic cluster found in the WCA domain of N-WASP, thus 
actively promoting Arp2/3-dependent actin polymerization (Guilherme et al., 2004; 
Simone et al., 2014). 
 
I have shown that the loss of the A36 NPF motifs inhibits viral spread and release, and 
more specifically that this is dependent on Cdc42 activation (Figure 5.11, 5.12). While 
it is presumed that intersectin-1 is the crucial link between the NPF motifs and Cdc42, it 
cannot be ruled out that another EH domain containing protein additionally promotes 
Cdc42 activation. For example, the recruitment of EHD2 could facilitate localization of 
IEVs to PI(4,5)P2-rich membranes, promoting Cdc42 activation in a PI(4,5)P2 
dependent manner, thus enhancing viral spread and release. The role of EHDs in a viral 
context are yet to be examined, however, they may act as a crucial link between 
PI(4,5)P2 -rich sites at the plasma membrane and the actin-polymerization machinery. 
 
6.4 The super-repulsion hypothesis 
Vaccinia is able to enhance the rate and spread of infection in an A36 dependent manner, 
via the induction of actin tails. The A36 NPF motifs support actin polymerisation in two 
ways. Firstly, they facilitate clustering of the A36 and N-WASP signalling complex that 
supports actin tail formation (Figure 4.7) (Humphries et al., 2012). Secondly, the A36 
NPF motifs recruit intersectin-1 and Cdc42 to facilitate N-WASP activation and 
enhance actin polymerisation beneath the virus (Figure 4.7, 5.9). I initially sought to 
determine whether the decrease in viral spread observed upon infection with A36 ∆NPF 
1-3 could be due to a loss or decrease in the ability of this virus to induce secondary 
actin tails during super-repulsion of EEV.  
 
The mechanisms governing actin tail formation must differ between actin tails 
generated by CEVs during egress from heavily infected cells (primary actin tails), and 
actin tails induced on recently infected cells by released EEV (secondary actin tails).  
During fusion of CEV with the plasma membrane, A36 is delivered to the membrane 
pre-clustered beneath the virion. In addition CEV-induced actin tails at the plasma 
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membrane during egress are supported by luminal interactions of the IEV proteins, B5 
and A34, tightly localised beneath the virus. In contrast during the formation of 
secondary actin tails during super-repulsion, only A36 and A33, expressed early during 
infection, are present at the surface of recently infected cells. The delivery of early A36 
and A33 to the plasma membrane via endosomal trafficking, would instead result in a 
more disperse localisation of A36 and A33 at the membrane. Therefore, I would predict 
that the A36 NPF motifs play an even more important role by mediating AP-2 
recruitment at the membrane. Thereby, inducing clustering of A36 in a clathrin-
dependent manner, to zip up the actin-polymerisation machinery beneath the incoming 
EEV, analogous to clathrin pit formation. 
 
Preliminary identification of secondary actin tails was challenging, due to the rarity of 
capturing such events in fixed cells and difficulty of capturing actin tails in early 
infected highly motile cells, during live cell imaging. However, my analysis could not 
detect a significant change in the number of superinfecting actin tails between WR and 
the A36 ∆NPF 1-3 virus (Figure 5.8). This data agrees with the fact that the loss of the 
A36 NPF motifs does not impact on the number of primary actin tails induces by CEV 
(Figure 4.9). This also implies that neither A36 clustering nor Cdc42 recruitment are 
essential for the induction of secondary actin tails formed during super-repulsion. 
 
My data however, impacts on the current interpretation of the importance of super-
repulsion to enhance viral spread. While EEV are typically released from cells 6-8 
hours following initial infection, the decrease in plaque size observed following 
infection with A36late compared to that of wild type A36 may be largely due to the 
defect or delay in EEV release observed (Figure 5.7, 5.8) (Payne and Kristenson, 1979). 
A36 is crucial for both microtubule-mediated transport to the cell periphery and 
nucleation of actin tails in order to enhance viral spread. In the absence of microtubule-
mediated transport, IEV are estimated to diffuse through the cytosol to the cell 
periphery, at a rate of 5.7 hours / 10µm of cytoplasm (Smith et al., 2003; Sodeik, 2000). 
The loss of A36 expression during the early hours of infection is therefore hugely 
detrimental to virus spread and release. The late A36 recombinant viruses generated in 
chapter 5, commenced A36 expression at 7 hpi, compared to 1-2 hpi when expressed 
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under the endogenous A36 promoter (Figure 5.6). When EEV release was determined at 
16 hpi, the late A36 viruses would have been undergoing extremely limited ∆A36-like 
diffusion through the cytosol for 7 hours prior to A36 expression. In contrast, during 
endogenous A36 expression, infected cells have been actively releasing EEV for 
approximately 10 hours. While a decrease in super-repulsion may play an additional 
role, I would argue that the ability of the virus to release large numbers of EEV would 
heavily outweigh the affect of super-repulsion in this case.  
 
6.5 What governs viral release? 
In Chapter 5, I demonstrated that the interaction between the EH domain containing 
proteins, via A36 NPF motifs, is required for efficient viral dissemination. Despite this, 
little is known about mechanisms of virus release, in vivo. Evidence suggests that EEV 
mediated release, rather than IMVs released following cell lysis, is primarily 
responsible for dissemination of the virus through tissue (Payne, 1980). Unlike IMV 
particles, EEVs have greater resistance to antibody-mediated neutralization and 
complement-mediated viral lysis (Benhnia et al., 2009; Cohen et al., 2011; Ichihashi, 
1996; Wolffe et al., 1998).  
 
The loss of the A36 NPF motifs resulted in a significant decrease in the ability of the 
virus to release EEV (Figure 5.3). Interestingly, this defect was to the same extent as 
that of the A36 YdF virus, which cannot induce actin tails (Figure 5.13, 6.4). This, 
however, raises the question as to how both impact EEV release to such a great extent. 
Actin polymerisation beneath the virus has been shown to enhance clustering of A36 
and provide the driving force to push the virion out of invaginations in the membrane 
(Horsington et al., 2013). A36 YdF cannot recruit Nck or Grb2 and therefore lacks the 
ability to induce actin tails (Rietdorf et al., 2001; Scaplehorn et al., 2002; Ward and 
Moss, 2001). The loss of actin polymerisation is thought to trap A36 YdF virions in 
invaginated pits at the plasma membrane, thus inhibiting both the release of EEV and 
the extent of viral presentation on the cell surface. This additionally limits contact with 
neighbouring cells, and disrupts CEV mediated cell-to-cell spread (Figure 6.4).  
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In the absence of Cdc42, intersectin-1, AP-2 and clathrin, A36 ∆NPF 1-3 still recruits 
the core components of the actin-signalling complex, and is able to induce actin tails, 
though they are less robust (Figure 4.10, 4.11, 6.4). This extent of actin polymerisation 
clearly enhances cell-to-cell spread through a plaque, as A36 YdF forms significantly 
smaller plaques than A36 ∆NPF 1-3 (Figure 5.13). Both A36 YdF and A36 ∆NPF 1-3, 
however, led to a similar reduction in EEV release (Figure 5.13). This calls into 
question the importance of actin polymerisation in the final step of EEV release as a 
driving force to release tethering of EEV from the plasma membrane during virus 
release. If actin polymerisation were an essential process for the physical release of 
EEV, one would expect to see a far greater decrease in EEV release in A36 YdF 
compared to A36 ∆NPF 1-3. 
 
Interestingly, infection with the A36 YdF-∆NPF virus did not result in additive defects 
in either plaque size or EEV release compared to A36 YdF alone (Figure 5.13 C, D). 
This confirms that the role of clathrin during viral egress is primarily to enhance actin 
polymerisation, as without the capacity to induce actin tails the ability of clathrin to 
cluster A36 is redundant. In order to determine whether viral presentation on the plasma 
membrane varied amongst the A36 recombinant viruses, preliminary EM imaging was 
carried out, however further analysis is required in order to fully appreciate how 
differences in virion presentation at the plasma membrane affects both the release and 
spread of EEV. 
 
These findings provide interesting insight for the design of oncolytic poxviruses, as the 
increase in viral spread mediated by the NPF motifs, could be harnessed to increase 
oncolytic potential. To date four poxviruses have been investigated as an oncolytic viral 
backbone: vaccinia virus, myxoma virus, racoonpox virus, and yaba-like disease virus 
(Chan et al., 2013; Evgin et al., 2010; Hu et al., 2001; Kochneva et al., 2012). Several 
strategies have been utilised in order to enhance EEV release in these viruses. Examples 
include the generation of a recombinant virus that encoded matrix metallopeptidase 9 
(MMP9) to enhance the spread of EEV (Schafer et al., 2012). Similarly the introduction 
of mutations in vaccinia A34 that are known to disrupt tethering of the CEV to the host 
cell and promote EEV release, results in recombinant strains with enhanced EEV spread 
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through tumours and greater anti-tumour effects (Thirunavukarasu et al., 2013). The 
presence of the NPF motifs to promote viral spread can now be considered 
advantageous in the rational choice and design of future oncolytic viruses, as viral 
strains lacking these motifs, including both yaba-like disease virus and mxyoma virus, 
may need to be additionally modified to further enhance EEV spread. This has been 
carried out to great effect in myxoma virus, whereby insertion of vaccinia F11 resulted 
in enhance viral spread (Irwin and Evans, 2012). It is worth noting in the future that any 
combination therapy which disrupts the conserved intersectin-1:Cdc42:N-WASP 
signalling pathway, may also hinder the spread of oncolytic poxviruses through tissue.  
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Figure 6.4 Models of actin-mediated vaccinia egress 
A WR is able to recruit clathrin to cluster the vaccinia-signalling network and promote actin-
mediated release from the plasma membrane. B All three recombinant viruses (A36 ∆NPF 1-3, 
A36 YdF, and A36 YdF-∆NPF) result in defective EEV release to the same extent, despite 
differences in recruitment of the clathrin and actin signalling networks, and proposed 
differences in the extent of viral presentation on the plasma membrane (Figure 5.13).   
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6.6 NPF motifs as a conserved pathogen signalling scaffold 
Multiple viral and bacterial pathogens hijack clathrin in order to enhance their entry and 
spread, and EPEC and vaccinia also appear to use similar clathrin adaptors proteins to 
do so. Vaccinia virus hijacks AP-2, Eps15 and intersectin-1 to facilitate clathrin 
recruitment; similarly EPEC recruits Eps15, and epsin-1 alongside the clathrin adaptor, 
Dab2 (Bonazzi et al., 2011; Humphries and Way, 2013; Lin et al., 2011). Given these 
similarities it would be interesting to determine whether epsin-1 and Dab2 are also 
recruited during A36 dependent actin polymerisation. Although EPEC Tir protein does 
not contain NPF or NPxY motifs, A36 contains an NPxY internalisation motif, 
discussed earlier that may play a role in mediating Dab2 recruitment.  
 
Yaba-like disease virus encodes a functional A36 orthologue, 126R that has been shown 
to rescue actin-based motility during ∆A36R infection. YLDV-126R, does not contain 
NPF motifs and consequently was unable to restore recruitment of clathrin, AP-2, 
intersectin-1 or Eps15, when expressed in place of vaccinia A36 (Figure 4.8). 
Subsequent bioinformatic analysis of the YLDV proteome reveals, however, that the 
protein encoded by the YLDV 150R gene contains two NPF motifs. The functional role 
of YLDV-150R is yet to be determined. YLDV-150R encodes a 100 aa protein, 
containing a predicted transmembrane domain at its N-terminus as well as two NPF 
motifs at residues 52-54 and 72-74 (Figure 6.5). This as of yet uncharacterised protein is 
highly conserved amongst multiple genera of the Chordopoxvirus family. The Tanapox 
(Yatapoxvirus), Swinepox (Suipoxvirus), Lumpy skin disease virus (Capripoxvirus), 
and Myxoma virus (Leporipoxvirus) homologues of YL150R each contain two 
conserved NPF motifs.  
 
These NPF motifs may be predicted to play a functional role during viral spread and act 
to compensate for the lack of NPF motifs in the YLDV A36 homologue. It could be 
predicted in these viruses’ 150R and the A36 orthologue, 126R acts together in trans to 
couple recruitment of the endocytic machinery with that of actin polymerisation. This 
avenue will require further investigation in order to ascertain the broader functional 
relevance of the NPF motifs during viral pathogenesis. 
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Figure 6.5 Yaba-like disease virus 150R reveals conserved NPF motifs  
Clustal omega alignment of YLDV (Yaba-like disease virus) – 150R (Q9DHG3), TNPX 
(Tanapox virus) – 150R (A7XCU1), SWPX (Swinepox virus Kasza) – C2L (VC02), LSDV 
(Lumpy skin disease virus) – LD153 (Q77GF7), and MYXV (Myxoma virus Lausanne) – 
MT4A (Q9YQ06). UniProtKD ID is shown in parenthesis. NPF motifs are highlighted in red, 
and predicted transmembrane domain in blue.  
 
 
6.7 Future Perspectives 
The discovery of functional NPF motifs in vaccinia A36 uncovers an additional layer of 
regulation during viral egress at the plasma membrane. This thesis has concentrated on 
the two best characterised EH domain containing proteins, intersectin-1 and Eps15.  The 
ability of intersectin-1 and Eps15 to act as multi-protein scaffolds during endocytic 
events and actin polymerisation makes them ideal candidates for hijacking by vaccinia, 
and other viruses. The closer analysis of the role of intersectin-2 and Eps15R, alongside 
other EH domain containing proteins such as the EHD (Eps15 Homology Domain) 
proteins must now be investigated further. It is clear from the conservation of the NPF 
motifs among the Chordopoxvirus family that EH domain containing proteins are a key 
strategy to promote viral infection. 
 
Crucially, the stoichiometry of the vaccinia actin-signalling complex remains unknown, 
and would reveal precisely how co-ordination of multiple signalling inputs are 
integrated in order to promote actin-polymerisation. Additionally, little is known about 
the regulation and stoichiometry of the EH domain containing proteins during canonical 
clathrin mediated endocytosis in vivo. Although in vitro assays have highlighted the 
ability of intersectin-1/2 and Eps15/15R to hetero- and homo-oligomerise, how different 
complexes of EH domains assemble, and whether they mediate distinct functions 
remains to be understood. Vaccinia A36R will in future provide a useful tool to 
determine how intersectin-1 along with Eps15 together coordinate N-WASP, Cdc42, 
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AP-2 at the plasma membrane. Furthermore, while clathrin is only present at the virus 
during egress briefly prior to actin tail formation, intersectin-1 and Eps15 remain on the 
actin tail following initiation of actin polymerisation. How vaccinia is able to dissociate 
from the vast clathrin cage remains to be determined. Whether actin is required to 
disassemble the clathrin cage or clathrin disassembly must first occur prior to actin tail 
formation remains unknown at present. Release of intersectin-1 autoinhibition may 
reveal vital clues to the coordination of clathrin disassembly via competing N-WASP 
and AP-2 interactions. 
 
Vaccinia A36 once again proves to be a crucial multifunctional protein, and the analysis 
of how the vast cellular endocytic and actin components are regulated and coordinated 
by intersectin-1 and other EH domain containing proteins, will no doubt uncover further 
levels of complexity and enhance our understanding of both viral egress and the 
interface of actin and clathrin dynamics in vivo.  
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